ArticlePDF AvailableLiterature Review

Abstract

Background: Stroke can affect people's ability to swallow, resulting in passage of some food and drink into the airway. This can cause choking, chest infection, malnutrition and dehydration, reduced rehabilitation, increased risk of anxiety and depression, longer hospital stay, increased likelihood of discharge to a care home, and increased risk of death. Early identification and management of disordered swallowing reduces risk of these difficulties. Objectives: Primary objective • To determine the diagnostic accuracy and the sensitivity and specificity of bedside screening tests for detecting risk of aspiration associated with dysphagia in people with acute stroke Secondary objectives • To assess the influence of the following sources of heterogeneity on the diagnostic accuracy of bedside screening tools for dysphagia - Patient demographics (e.g. age, gender) - Time post stroke that the study was conducted (from admission to 48 hours) to ensure only hyperacute and acute stroke swallow screening tools are identified - Definition of dysphagia used by the study - Level of training of nursing staff (both grade and training in the screening tool) - Low-quality studies identified from the methodological quality checklist - Type and threshold of index test - Type of reference test SEARCH METHODS: In June 2017 and December 2019, we searched CENTRAL, MEDLINE, Embase, CINAHL, and the Health Technology Assessment (HTA) database via the Centre for Reviews and Dissemination; the reference lists of included studies; and grey literature sources. We contacted experts in the field to identify any ongoing studies and those potentially missed by the search strategy. Selection criteria: We included studies that were single-gate or two-gate studies comparing a bedside screening tool administered by nurses or other healthcare professionals (HCPs) with expert or instrumental assessment for detection of aspiration associated with dysphagia in adults with acute stroke admitted to hospital. Data collection and analysis: Two review authors independently screened each study using the eligibility criteria and then extracted data, including the sensitivity and specificity of each index test against the reference test. A third review author was available at each stage to settle disagreements. The methodological quality of each study was assessed using the Quality Assessment of Studies of Diagnostic Accuracy (QUADAS-2) tool. We identified insufficient studies for each index test, so we performed no meta-analysis. Diagnostic accuracy data were presented as sensitivities and specificities for the index tests. Main results: Overall, we included 25 studies in the review, four of which we included as narratives (with no accuracy statistics reported). The included studies involved 3953 participants and 37 screening tests. Of these, 24 screening tests used water only, six used water and other consistencies, and seven used other methods. For index tests using water only, sensitivity and specificity ranged from 46% to 100% and from 43% to 100%, respectively; for those using water and other consistencies, sensitivity and specificity ranged from 75% to 100% and from 69% to 90%, respectively; and for those using other methods, sensitivity and specificity ranged from 29% to 100% and from 39% to 86%, respectively. Twenty screening tests used expert assessment or the Mann Assessment of Swallowing Ability (MASA) as the reference, six used fibreoptic endoscopic evaluation of swallowing (FEES), and 11 used videofluoroscopy (VF). Fifteen screening tools had an outcome of aspiration risk, 20 screening tools had an outcome of dysphagia, and two narrative papers did not report the outcome. Twenty-one screening tests were carried out by nurses, and 16 were carried out by other HCPs (not including speech and language therapists (SLTs)). We assessed a total of six studies as low risk across all four QUADAS-2 risk of bias domains, and we rated 15 studies as low concern across all three applicability domains. No single study demonstrated 100% sensitivity and specificity with low risk of bias for all domains. The best performing combined water swallow and instrumental tool was the Bedside Aspiration test (n = 50), the best performing water plus other consistencies tool was the Gugging Swallowing Screen (GUSS; n = 30), and the best water only swallow screening tool was the Toronto Bedside Swallowing Screening Test (TOR-BSST; n = 24). All tools demonstrated combined highest sensitivity and specificity and low risk of bias for all domains. However, clinicians should be cautious in their interpretation of these findings, as these tests are based on single studies with small sample sizes, which limits the estimates of reliability of screening tests. Authors' conclusions: We were unable to identify a single swallow screening tool with high and precisely estimated sensitivity and specificity based on at least one trial with low risk of bias. However, we were able to offer recommendations for further high-quality studies that are needed to improve the accuracy and clinical utility of bedside screening tools.
Cochrane
Library
Cochrane Database of Systematic Reviews
Screening for aspiration risk associated with dysphagia in acute
stroke (Review)
Boaden E, Burnell J, Hives L, Dey P, Clegg A, Lyons MW, Lightbody CE, Hurley MA, Roddam H,
McInnes E, Alexandrov A, Watkins CL
BoadenE, BurnellJ, HivesL, DeyP, CleggA, LyonsMW, LightbodyCE, HurleyMA, RoddamH, McInnesE, AlexandrovA,
WatkinsCL.
Screening for aspiration risk associated with dysphagia in acute stroke.
Cochrane Database of Systematic Reviews 2021, Issue 10. Art. No.: CD012679.
DOI: 10.1002/14651858.CD012679.pub2.
www.cochranelibrary.com
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
T A B L E  O F  C O N T E N T S
HEADER......................................................................................................................................................................................................... 1
ABSTRACT..................................................................................................................................................................................................... 1
PLAIN LANGUAGE SUMMARY....................................................................................................................................................................... 2
SUMMARY OF FINDINGS.............................................................................................................................................................................. 4
BACKGROUND.............................................................................................................................................................................................. 8
OBJECTIVES.................................................................................................................................................................................................. 9
METHODS..................................................................................................................................................................................................... 9
Figure 1.................................................................................................................................................................................................. 11
RESULTS........................................................................................................................................................................................................ 13
Figure 2.................................................................................................................................................................................................. 15
Figure 3.................................................................................................................................................................................................. 17
Figure 4.................................................................................................................................................................................................. 18
Figure 5.................................................................................................................................................................................................. 19
Figure 6.................................................................................................................................................................................................. 20
Figure 7.................................................................................................................................................................................................. 21
Figure 8.................................................................................................................................................................................................. 22
Figure 9.................................................................................................................................................................................................. 23
Figure 10................................................................................................................................................................................................ 24
DISCUSSION.................................................................................................................................................................................................. 24
AUTHORS' CONCLUSIONS........................................................................................................................................................................... 27
ACKNOWLEDGEMENTS................................................................................................................................................................................ 27
REFERENCES................................................................................................................................................................................................ 28
CHARACTERISTICS OF STUDIES.................................................................................................................................................................. 35
DATA.............................................................................................................................................................................................................. 78
Test 1. Registered Dietitian (RD) Dysphagia Screening tool - Huhmann (2004)................................................................................ 81
Test 2. Bedside aspiration - Combined WST & Oxygen Saturation - Lim (2001)................................................................................ 81
Test 3. Gugging Swallowing Screen (GUSS) - Group2 - Trappl (2007)................................................................................................ 81
Test 4. Toronto Bedside Swallowing Screening Test (TOR-BSST) - Martino (2009)........................................................................... 81
Test 5. Standardized Swallowing Assessment tool (SSA) - Test2 - Perry (2001) Test2...................................................................... 81
Test 6. Nursing Bedside Dysphagia Screen (NBDS) - Campbell (2016).............................................................................................. 81
Test 7. Emergency Department (ED) dysphagia screen - Turner-Lawrence (2009)........................................................................... 82
Test 8. Acute Stroke Dysphagia Screening (ASDS) - Aspiration - Edmiaston (2010).......................................................................... 82
Test 9. Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Aspiration - Edmiaston (2014)............................................. 82
Test 10. Edith-Huhn-Matesic Bedside Aspiration Screen (EHMBAS) plus water swallow test - Huhn-Matesic (2015)...................... 82
Test 11. Standardized Swallowing Assessment tool (SSA) - Test1 - Perry (2001).............................................................................. 82
Test 12. Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Dysphagia - Edmiaston (2014)........................................... 82
Test 13. Modified MASA (MMASA) Neurologist 1 - Antonios (2010).................................................................................................... 83
Test 14. Rapid Aspiration Screening for Suspected Stroke (RAS3) - Daniels (2016).......................................................................... 83
Test 15. Clinical examination - Daniels (1997).................................................................................................................................... 83
Test 16. Acute Stroke Dysphagia Screening (ASDS) Dysphagia - Edmiaston (2010).......................................................................... 83
Test 17. Nurse Dysphagia Screen - Cummings (2015)........................................................................................................................ 83
Test 18. Modified MASA (MMASA) Neurologist 2 - Antonios (2010).................................................................................................... 83
Test 19. Oxygen saturation ≥ 2% - Test2 for Aspiration - Smith (2000).............................................................................................. 84
Test 20. Bedside swallow test - WST only - Lim (2001)....................................................................................................................... 84
Test 21. Chinese version of the modified SSA original 8 items - Jiang (2019)................................................................................... 84
Test 22. Chinese version of the modified SSA reduced 6 items - Jiang (2019).................................................................................. 84
Test 23. Stroke Severity using National Institutes of Health Stroke Scale (NIHSS) - Bravata (2009)................................................ 84
Test 24. Nursing Bedside Swallowing Screen (NBSS) - Ellis (2013).................................................................................................... 84
Test 25. 2-step Swallowing Provocation Test (SPT) - step 1 - 0.4 mL - Warneke (2008).................................................................... 85
Test 26. Rapid Aspiration Screening for Suspected Stroke (RAS3) - WST only - Daniels (2016)........................................................ 85
Test 27. Gag function - Test3 - Perry (2001)........................................................................................................................................ 85
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
i
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 28. DePaul Hospital Swallow Screener (DHSS) for Aspiration Risk - Behera (2018).................................................................. 85
Test 29. DePaul Hospital Swallow Screener (DHSS) for Dysphagia - Behera (2018)......................................................................... 85
Test 30. Gag function - Test4 - Perry (2001)........................................................................................................................................ 85
Test 31. 2-step swallowing provocation test (SPT) step 2 - 2.0 mL - Warneke (2008)....................................................................... 86
Test 32. Johns Hopkins Hospital Brain Rescue Unit Modified 3 oz Swallow Screen - Mulheren (2019)........................................... 86
Test 33. Nursing Screening Tool - Bravata (2009)............................................................................................................................... 86
Test 34. Barnes-Jewish Hospital Stroke Dysphagia Screen (BJH-SDS) – Turkish version (T-BJH) - Eren (2019).............................. 86
Test 35. Clinical Predicative Scale of Aspiration (CPSA) - Zhou (2011).............................................................................................. 86
Test 36. TOR-BSST water swallow item - Martino (2014).................................................................................................................... 86
Test 37. Clinical swallowing tests - 6 oromotor examinations - Nishiwaki (2005)............................................................................. 87
Test 38. Index taxonomy - water only................................................................................................................................................. 87
Test 39. Index taxonomy - water plus other consistencies................................................................................................................. 87
Test 40. Index taxonomy - other.......................................................................................................................................................... 87
Test 41. Outcome - aspiration.............................................................................................................................................................. 88
Test 42. Outcome - dysphagia.............................................................................................................................................................. 88
Test 43. Reference test - Expert Assessment and MASA..................................................................................................................... 89
Test 44. Reference test - FEES.............................................................................................................................................................. 89
Test 45. Reference test - VF.................................................................................................................................................................. 89
Test 46. HCP - nurse.............................................................................................................................................................................. 90
Test 47. HCP - other.............................................................................................................................................................................. 90
ADDITIONAL TABLES.................................................................................................................................................................................... 90
APPENDICES................................................................................................................................................................................................. 93
WHAT'S NEW................................................................................................................................................................................................. 101
HISTORY........................................................................................................................................................................................................ 101
CONTRIBUTIONS OF AUTHORS................................................................................................................................................................... 102
DECLARATIONS OF INTEREST..................................................................................................................................................................... 102
SOURCES OF SUPPORT............................................................................................................................................................................... 102
DIFFERENCES BETWEEN PROTOCOL AND REVIEW.................................................................................................................................... 102
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ii
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
[Diagnostic Test Accuracy Review]
Screening for aspiration risk associated with dysphagia in acute stroke
Elizabeth Boaden1, Jane Burnell2, Lucy Hives2, Paola Dey3, Andrew Clegg2, Mary W Lyons4, C Elizabeth Lightbody5, Margaret A Hurley2,
Hazel Roddam6, Elizabeth McInnes7, Anne Alexandrov8, Caroline L Watkins5
1Faculty of Health and Care , University of Central Lancashire , Preston, UK. 2Faculty of Health and Care, University of Central Lancashire ,
Preston, UK. 3Faculty of Health and Social Care, Edge Hill University, Ormskirk, UK. 4Liverpool School of Tropical Medicine, Liverpool, UK.
5Faculty of Health and Care, University of Central Lancashire, Preston, UK. 6Faculty of Allied Health and Well-being, University of Central
Lancashire, Preston, UK. 7Nursing Research Institute, Australian Catholic University, Sydney, Australia. 8University of Tennessee Health
Science Center (UTHSC), Memphis, Tennessee, USA
Contact address: Elizabeth Boaden, eboaden1@uclan.ac.uk.
Editorial group: Cochrane Stroke Group.
Publication status and date: New, published in Issue 10, 2021.
Citation: BoadenE, BurnellJ, HivesL, DeyP, CleggA, LyonsMW, LightbodyCE, HurleyMA, RoddamH, McInnesE, AlexandrovA,
WatkinsCL. Screening for aspiration risk associated with dysphagia in acute stroke. Cochrane Database of Systematic Reviews 2021, Issue
10. Art. No.: CD012679. DOI: 10.1002/14651858.CD012679.pub2.
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Stroke can aect people’s ability to swallow, resulting in passage of some food and drink into the airway. This can cause choking, chest
infection, malnutrition and dehydration, reduced rehabilitation, increased risk of anxiety and depression, longer hospital stay, increased
likelihood of discharge to a care home, and increased risk of death. Early identification and management of disordered swallowing reduces
risk of these diiculties.
Objectives
Primary objective
• To determine the diagnostic accuracy and the sensitivity and specificity of bedside screening tests for detecting risk of aspiration
associated with dysphagia in people with acute stroke
Secondary objectives
• To assess the influence of the following sources of heterogeneity on the diagnostic accuracy of bedside screening tools for dysphagia
- Patient demographics (e.g. age, gender)
- Time post stroke that the study was conducted (from admission to 48 hours) to ensure only hyperacute and acute stroke swallow screening
tools are identified
- Definition of dysphagia used by the study
- Level of training of nursing sta (both grade and training in the screening tool)
- Low-quality studies identified from the methodological quality checklist
- Type and threshold of index test
- Type of reference test
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
1
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Search methods
In June 2017 and December 2019, we searched CENTRAL, MEDLINE, Embase, CINAHL, and the Health Technology Assessment (HTA)
database via the Centre for Reviews and Dissemination; the reference lists of included studies; and grey literature sources. We contacted
experts in the field to identify any ongoing studies and those potentially missed by the search strategy.
Selection criteria
We included studies that were single-gate or two-gate studies comparing a bedside screening tool administered by nurses or other
healthcare professionals (HCPs) with expert or instrumental assessment for detection of aspiration associated with dysphagia in adults
with acute stroke admitted to hospital.
Data collection and analysis
Two review authors independently screened each study using the eligibility criteria and then extracted data, including the sensitivity
and specificity of each index test against the reference test. A third review author was available at each stage to settle disagreements.
The methodological quality of each study was assessed using the Quality Assessment of Studies of Diagnostic Accuracy (QUADAS-2) tool.
We identified insuicient studies for each index test, so we performed no meta-analysis. Diagnostic accuracy data were presented as
sensitivities and specificities for the index tests.
Main results
Overall, we included 25 studies in the review, four of which we included as narratives (with no accuracy statistics reported). The included
studies involved 3953 participants and 37 screening tests. Of these, 24 screening tests used water only, six used water and other
consistencies, and seven used other methods. For index tests using water only, sensitivity and specificity ranged from 46% to 100% and
from 43% to 100%, respectively; for those using water and other consistencies, sensitivity and specificity ranged from 75% to 100% and
from 69% to 90%, respectively; and for those using other methods, sensitivity and specificity ranged from 29% to 100% and from 39% to
86%, respectively. Twenty screening tests used expert assessment or the Mann Assessment of Swallowing Ability (MASA) as the reference,
six used fibreoptic endoscopic evaluation of swallowing (FEES), and 11 used videofluoroscopy (VF). Fieen screening tools had an outcome
of aspiration risk, 20 screening tools had an outcome of dysphagia, and two narrative papers did not report the outcome. Twenty-one
screening tests were carried out by nurses, and 16 were carried out by other HCPs (not including speech and language therapists (SLTs)).
We assessed a total of six studies as low risk across all four QUADAS-2 risk of bias domains, and we rated 15 studies as low concern across
all three applicability domains.
No single study demonstrated 100% sensitivity and specificity with low risk of bias for all domains. The best performing combined water
swallow and instrumental tool was the Bedside Aspiration test (n = 50), the best performing water plus other consistencies tool was the
Gugging Swallowing Screen (GUSS; n = 30), and the best water only swallow screening tool was the Toronto Bedside Swallowing Screening
Test (TOR-BSST; n = 24). All tools demonstrated combined highest sensitivity and specificity and low risk of bias for all domains. However,
clinicians should be cautious in their interpretation of these findings, as these tests are based on single studies with small sample sizes,
which limits the estimates of reliability of screening tests.
Authors' conclusions
We were unable to identify a single swallow screening tool with high and precisely estimated sensitivity and specificity based on at least
one trial with low risk of bias. However, we were able to oer recommendations for further high-quality studies that are needed to improve
the accuracy and clinical utility of bedside screening tools.
P L A I N  L A N G U A G E  S U M M A R Y
Screening for aspiration risk associated with dysphagia in acute stroke
Question
How accurate are swallow screening tools for detecting when food and drink enter the airway in people with acute stroke?
Background
Stroke oen aects a person’s ability to swallow, allowing food and drink into the airway. This can cause choking, chest infection,
malnutrition, dehydration, and reduced rehabilitation, with increased risk of anxiety, depression, discharge to a care home, and death.
Early identification and management of disordered swallowing through the most accurate testing reduces these risks. If the test fails
to identify swallowing diiculties, the person will continue oral intake and may experience the diiculties identified above. If the test
incorrectly identifies swallowing diiculties, the person may not be given anything to eat or drink, significantly impacting quality of life,
until a more detailed assessment is undertaken (usually the next day).
Study characteristics
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
2
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
We identified 25 studies that used a total of 37 tools. Seven tools did not use water or other consistencies, 24 used only water, and six
considered water and other consistencies.
Key results
We were unable to identify a tool that could accurately identify everyone with food and drink entering their airway, as well as detect
all those who definitely did not. Many studies involved dierent healthcare professionals, food and fluid testing consistencies, and time
between stroke onset and the screening test, so it is unclear which tool is best. We were unable to directly compare the dierent tools
because most studies used dierent methods.
We were able to identify the tools most able to detect people with and without risk of swallowing diiculties from studies with good quality
evidence. The best combined water swallow and instrumental test was the Bedside Aspiration test, the best water plus other consistencies
tool was the Gugging Swallowing Screen, and the best water only tool was the Toronto Bedside Swallowing Screening Test. However,
clinicians should be cautious in their interpretation of these findings, as these tests are based on single studies with small sample sizes.
Quality of the evidence
Most included studies were poorly conducted or were unclear in reporting what they did (i.e. unclear or high risk of bias).
Conclusion
We were unable to identify a single tool with combined high levels of accuracy and good quality evidence. However, we are able to oer
recommendations for further high-quality studies that are needed to improve the accuracy and clinical utility of swallow screening tools.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
S U M M A R Y  O F  F I N D I N G S
Summary of findings 1.  Review criteria and findings
Review question What is the diagnostic accuracy of screening tools for aspiration risk associated with dysphagia in
acute stroke?
Importance A simple and reliable screening tool for identification of aspiration associated with dysphagia
would reduce diagnostic delay and the risk of developing pneumonia in acute stroke patients
Patients/population Patients (over the age of 18) who have been admitted to an acute hospital setting, where there is
a clinical diagnosis of stroke. Patients with subarachnoid haemorrhage were excluded from the
study
Settings Stroke units or hospital wards where acute stroke patients are admitted
Index tests Bedside swallowing screening tools carried out by healthcare professionals (excluding SLTs)
Reference standards Expert assessment, including the MASA
VF
FEES
Studies 25 studies were included, 4 of which are presented as narratives (with no accuracy statistics report-
ed). The included studies reported 37 screening tests
Overall judgement: poor quality for the majority of studies – only 6 studies were at low risk across
all 4 risk of bias domains, and 2 studies were at low risk of bias for 3 domains
Patient selection bias: high risk = 12 studies; unclear risk = 11 studies; low risk = 2 studies
Index test interpretation bias: high risk = 14 studies; unclear risk = 10 studies; low risk = 1 study
Reference standard interpretation bias: high risk = 16 studies; unclear risk = 8 studies; low risk = 1
study
Risk of bias
Flow and timing selection bias: high risk = 13 studies; unclear risk = 6 studies; low risk = 6 studies
Concerns regarding patient selection: high risk = 16 studies; unclear risk = 4 studies; low risk = 5
studies
Concerns regarding index test: high risk = 20 studies; unclear risk = 4 studies; low risk = 1 study
Applicability concern
Concerns regarding reference standard: high risk = 22 studies; unclear risk = 3 studies; low risk = 0
studies
The best performing swallow screening tools were the Combined WST and Oxygen Saturation
Test (Lim 2001a), GUSS (Trapl 2007b), and TOR-BSST (Martino 2009). The best water only swallow
screening test was the TOR-BSST (Martino 2009). All demonstrate a combined highest sensitivity
and specificity and low risk of bias across all domains. These tools may be considered useful in clin-
ical practice
The water plus various consistencies (n = 6) performed better than the water-only tools in terms of
sensitivity and specificity
Overall findings
Only a few studies (e.g. GUSS) (Trapl 2007b) gave direction on what food and drink consistencies
should be given to an individual following the screen
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
4
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
The quality of evidence varied. Studies often failed to distinguish between dysphagia and aspi-
ration as the primary outcome. Some did not identify the time interval between stroke onset or
admission to hospital and the screen, or the time interval between index test and reference test.
Training required by different healthcare professionals to implement the screening tool was not re-
ported well. This has implications for future research
FEES: fibreoptic endoscopic evaluation of swallowing.
MASA: Mann Assessment of Swallowing Ability.
SLT: speech and language therapist.
VF: videofluoroscopy.
WST: water-swallowing test.
Summary of findings 2.  Screening tests
Screening test N participants
(studies)
Reference stan-
dard
Diagnostic estimates
(95% CI)
Implications
Water-only tests 2914 (13)
Toronto Bedside Swallowing
Screening Test (TOR-BSST): Mar-
tino 2009 Study 1
24 (1) VFSS Sens = 1.00 (0.75 to 1.00)
spec = 0.64 (0.31 to 0.89)
Insufficient evidence to al-
low firm conclusions
Acute Stroke Dysphagia Screen-
ing (ASDS) Aspiration: Edmias-
ton 2010
300 (1) Expert assess-
ment and MASA
Sens = 0.95 (0.87 to 0.99)
spec = 0.69 (0.62 to 0.75)
Large study with unclear
risk of bias and low applic-
ability concerns
Barnes-Jewish Hospital-Stroke
Dysphagia Screen (BJH-SDS) As-
piration: Edmiaston 2014
223 (1) VFSS Sens = 0.95 (0.86 to 0.99)
spec = 0.50 (0.42 to 0.58)
Large study with un-
clear/low risk of bias and
low applicability concerns
Edith-Huhn-Matesic Bedside As-
piration Screen (EHMBAS) fol-
lowed by simple water swallow
test: Huhn-Matesic 2015
52 (1) Expert assess-
ment and MASA
Sens = 0.94 (0.71 to 1.00)
spec = 0.77 (0.60 to 0.90)
Insufficient evidence to al-
low firm conclusions
Barnes-Jewish Hospital-Stroke
Dysphagia Screen (BJH-SDS)
Dysphagia: Edmiaston 2014
225 (1) VFSS Sens = 0.94 (0.88 to 0.98)
spec = 0.66 (0.57 to 0.75)
Large study with low risk
of bias and low applicabili-
ty concerns.
Rapid Aspiration Screening
for Suspected Stroke (RAS3):
Daniels 2016
250 (1) VFSS Sens = 0.93 (0.77 to 0.99)
spec = 0.43 (0.36 to 0.50)
Large study with low risk
of bias and low applicabili-
ty concerns.
Clinical examination: Daniels
1997
59 (1) VFSS Sens = 0.92 (0.75 to 0.99)
spec = 0.64 (0.45 to 0.80)
Insufficient evidence to al-
low firm conclusions
Acute Stroke Dysphagia Screen-
ing (ASDS) Dysphagia: Edmias-
ton 2010
300 (1) Expert assess-
ment and MASA
Sens = 0.91 (0.83 to 0.96)
spec = 0.75 (0.68 to 0.80)
Large study with unclear
risk of bias and low applic-
ability concerns
Nurse Dysphagia Screen: Cum-
mings 2015
49 (1) Expert assess-
ment and MASA
Sens = 0.89 (0.65 to 0.99)
spec = 0.90 (0.74 to 0.98)
Insufficient evidence to al-
low firm conclusions
Bedside swallow test - WST on-
ly: Lim 2001
50 (1) FEES Sens = 0.85 (0.65 to 0.96)
spec = 0.75 (0.53 to 0.90)
Insufficient evidence to al-
low firm conclusions
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
5
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Chinese version of the modi-
fied SSA – original 8 items: Jiang
2019
127 (1) Expert assess-
ment and MASA
Sens = 0.83 (0.71 to 0.91)
spec = 0.59 (0.46 to 0.71)
Insufficient evidence to al-
low firm conclusions
Chinese version of the modified
SSA – reduced 6 items: Jiang
2019
127 (1) Expert assess-
ment and MASA
Sens = 0.81 (0.69 to 0.90)
spec = 0.64 (0.51 to 0.76)
Insufficient evidence to al-
low firm conclusions
2-step swallowing provocation
test (SPT) - step 1 - 0.4 mL: War-
necke 2008
100 (1) FEES Sens = 0.74 (0.63 to 0.83)
spec = 1.00 (0.82 to 1.00)
Insufficient evidence to al-
low firm conclusions
Rapid Aspiration Screening for
Suspected Stroke (RAS3) - WST
only: Daniels 2016
250 (1) VFSS Sens = 0.72 (0.53 to 0.87)
spec = 0.60 (0.53 to 0.66)
Large study with low risk
of bias and low applicabili-
ty concerns.
Gag function - Test3: Perry 2001
Study 1
22 (1) Expert assess-
ment and MASA
Sens = 0.71 (0.42 to 0.92)
spec = 0.63 (0.24 to 0.91)
Insufficient evidence to al-
low firm conclusions
DePaul Hospital Swallow
Screener (DHSS) Aspiration: Be-
hera 2018
226 (1) Expert assess-
ment and MASA
Sens = 0.70 (0.55 to 0.83)
spec = 0.90 (0.85 to 0.94)
Large study with unclear
risk of bias and unclear ap-
plicability concerns
DePaul Hospital Swallow
Screener (DHSS) Dysphagia: Be-
hera 2018
225 (1) Expert assess-
ment and MASA
Sens = 0.68 (0.55 to 0.80)
spec = 0.93 (0.88 to 0.96)
Large study with unclear
risk of bias and unclear ap-
plicability concerns
Gag function - Test4: Perry 2001
Study 1
157 (1) Expert assess-
ment and MASA
Sens = 0.67 (0.57 to 0.76)
spec = 0.78 (0.65 to 0.88)
Insufficient evidence to al-
low firm conclusions
2-step swallowing provocation
test (SPT) - step 2 - 2.0 mL: War-
necke 2008
100 (1) FEES Sens = 0.49 (0.38 to 0.61)
spec = 1.00 (0.82 to 1.00)
Insufficient evidence to al-
low firm conclusions
Johns Hopkins Hospital Brain
Rescue Unit Modified 3 oz Swal-
low Screen: Mulheren 2019
48 (1) VFSS Sens = 0.46 (0.28 to 0.66)
spec = 1.00 (0.83 to 1.00)
Insufficient evidence to al-
low firm conclusions
Water plus consistencies tests 412 (5)
Registered Dietitian (RD) Dys-
phagia Screening tool: Huh-
mann 2004
32 (1) Expert assess-
ment and MASA
Sens = 1.00 (0.69 to 1.00)
spec = 0.86 (0.65 to 0.97)
Insufficient evidence to al-
low firm conclusions
Gugging Swallowing Screen
(GUSS) - Group2: Trapl 2007
30 (1) FEES Sens = 1.00 (0.77 to 1.00)
spec = 0.69 (0.41 to 0.89)
Insufficient evidence to al-
low firm conclusions
Standardized Swallowing As-
sessment tool (SSA) – Test2: Per-
ry 2001 Study 1
68 (1) Expert assess-
ment and MASA
Sens = 0.97 (0.86 to 1.00)
spec = 0.90 (0.74 to 0.98)
Insufficient evidence to al-
low firm conclusions
Nursing Bedside Dysphagia
Screen (NBDS): Campbell 2016
75 (1) Expert assess-
ment and MASA
Sens = 0.97 (0.90 to 1.00)
spec = 0.75 (0.35 to 0.97)
Insufficient evidence to al-
low firm conclusions
Standardized Swallowing As-
sessment tool (SSA) - Test1: Per-
ry 2001 Study 1
161 (1) Expert assess-
ment and MASA
Sens = 0.94 (0.87 to 0.98)
spec = 0.75 (0.63 to 0.84)
Insufficient evidence to al-
low firm conclusions
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
6
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Nursing Bedside Swallowing
Screen (NBSS): Ellis 2013
46 (1) Expert assess-
ment and MASA
Sens = 0.75 (0.35 to 0.97)
spec = 0.89 (0.75 to 0.97)
Insufficient evidence to al-
low firm conclusions
Other tests 627 (5)
Bedside aspiration - Combined
WST & Oxygen Saturation: Lim
2001
50 (1) FEES Sens = 1.00 (0.87 to 1.00)
spec = 0.71 (0.49 to 0.87)
Insufficient evidence to al-
low firm conclusions
Emergency Department (ED)
dysphagia screen: Turn-
er-Lawrence 2009
84 (1) Expert assess-
ment and MASA
Sens = 0.96 (0.86 to 0.99)
spec = 0.56 (0.38 to 0.72)
Insufficient evidence to al-
low firm conclusions
Modified MASA (MMASA) Neurol-
ogist 1: Antonios 2010
150 (1) Expert assess-
ment and MASA
Sens = 0.93 (0.82 to 0.98)
spec = 0.86 (0.78 to 0.93)
Insufficient evidence to al-
low firm conclusions
Modified MASA (MMASA) Neurol-
ogist 2: Antonios 2010
150 (1) Expert assess-
ment and MASA
Sens = 0.87 (0.75 to 0.95)
spec = 0.84 (0.76 to 0.91)
Insufficient evidence to al-
low firm conclusions
Oxygen saturation ≥ 2% - Test2
for Aspiration: Smith 2000
53 (1) VFSS Sens = 0.87 (0.60 to 0.98)
spec = 0.39 (0.24 to 0.57)
Insufficient evidence to al-
low firm conclusions
Stroke Severity using National
Institutes of Health Stroke Scale
(NIHSS): Bravata 2009
101 (1) Expert assess-
ment and MASA
Sens = 0.79 (0.63 to 0.90)
spec = 0.68 (0.55 to 0.79)
Insufficient evidence to al-
low firm conclusions
Nursing Screening Tool: Bravata
2009
39 (1) Expert assess-
ment and MASA
Sens = 0.29 (0.08 to 0.58)
spec = 0.84 (0.64 to 0.95)
Insufficient evidence to al-
low firm conclusions
FEES: fibreoptic endoscopic evaluation of swallowing.
MASA: Mann Assessment of Swallowing Ability.
sens: sensitivity.
spec: specificity.
VFSS: videofluoroscopic swallowing study.
WST: water-swallowing test.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
7
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
B A C K G R O U N D
Stroke is the second most common cause of death worldwide
(Katan 2018), and it is the largest cause of complex preventable
disability in adults (WHF 2016). Over 13.7 million new strokes
are reported globally each year (Johnson 2019), with a projected
increase in incidence due to an ageing population (Avan 2019).
The reported incidence of dysphagia (swallowing diiculties)
following acute stroke varies between 37% and 78% (Martino
2005); this is related to type and severity of stroke and individual
characteristics (e.g. comorbidities). It is also related to the type
of diagnostic assessment used to detect dysphagia and time from
admission to that assessment. Dysphagia may lead to aspiration,
defined as food or fluid entering the airway below the level of
the vocal cords (Blitzer 1988), then into the trachea. People with
dysphagia are three times, and those with aspiration 11 times, more
likely to develop pneumonia (Kumar 2010; Rofes 2011), which is a
significant cause of further morbidity leading to increased hospital
stay and risk of death (Intercollegiate Stroke Working Party 2012).
Stroke-associated pneumonia is more common if identification
of dysphagia is delayed because of aspiration of food, drink,
medications, and oral secretions (Bray 2016). Therefore, early
screening for dysphagia may be an important avenue for reducing
deaths from acute stroke (Bray 2016; Donovan 2013).
Internationally, dierent clinical guidelines are available for
detecting swallowing diiculties in acute stroke. Identification of
dysphagia is a criterion that is considered for obtaining Stroke Unit
accreditation by the European Stroke Organisation. Within the UK,
Europe, Canada, the USA, and Australia, guidelines state that on
admission to hospital, people with acute stroke should have their
swallowing screened promptly following admission (European
Stroke Organisation 2015; Intercollegiate Stroke Working Party
2016; National Stroke Foundation 2010; Powers 2019; Teasell 2019).
Diagnostic methods such as videofluoroscopy (VF) and fibreoptic
endoscopic evaluation of swallowing (FEES) are available.
However, these methods have significant limitations when used
for early identification of dysphagia in acute stages of stroke.
Limitations may be patient specific (patients may be unable to
comply with instructions due to poor posture, cognition, medical
state, or fluctuating swallowing ability); organisational (speech and
language therapists (SLTs) may not be available in the acute setting,
and in most hospitals, instrumental examinations such as VF and
FEES can be requested only aer SLT evaluation; furthermore, not
all sta are trained to interpret the results of these reference tests);
or procedural (specialist equipment is not available in all acute
settings) (Boaden 2011). Therefore, screening tools are needed to
identify those likely to have dysphagia, who might be at greater risk
of aspiration, so that interventions can be put in place to reduce
morbidity until access to specialist equipment and sta is available
for assessment and/or until the patient is fit enough to undergo
the procedures. These screening tools are called bedside swallow
screening tools.
Bedside swallow screening tools must be quick and easy to
administer. To be clinically useful, screening tools must accurately
identify those with dysphagia with its associated risk of aspiration
(sensitivity), without leading to unnecessary restrictions (e.g.
withholding food and drinks) for those who do not have dysphagia
(specificity). The outcome of a screening test is binary (present or
not), although it is acknowledged there may be dierent levels of
severity of swallowing diiculty and subsequent management. A
positive test should lead to a referral for more definitive assessment
to confirm the presence of dysphagia or not, when this is available.
Screening tools also need to be acceptable and feasible for use
in people with a range of sequelae following stroke (e.g. dierent
levels of consciousness, cognitive levels, postural diiculties).
Screening tools must be undertaken prior to any oral intake and
therefore need to be administered by sta members who are at the
bedside throughout a 24-hour period.
There is wide variation in available screening tools. Some swallow
screening tools rely on questionnaires, whilst others use food and
drink as testing materials. Swallow screening tools vary in the
types of foods and fluids tested. Water swallow tools, such as the
Standardised Swallow Assessment (Perry 2001 Study 1), or the
Massey Bedside Swallow Screen (Massey 2002), are very similar in
that they oer people dierent quantities of fluids from assorted
utensils; some studies use water plus a range of consistencies
to prescribe food and drink consistency management plans. This
group of swallow screening tests are more dissimilar from each
other as they oer a variety of food and drink, give dierent
consistencies, trial dierent volumes, and alter the order in which
foods and drinks are oered. One concern is that some of these
tools have been developed and assessed with various reference
tests and dierent professional groups not routinely available at
the bedside, which limits their clinical utility.
There is no universally accepted screening tool for identification
and management of aspiration associated with dysphagia, and
a wide range of screening tests are used in clinical practice
throughout the world. A false-negative result is much worse than
a false-positive result. If the swallow screening test fails to identify
swallowing diiculties, the person will continue oral intake and
may experience the diiculties identified above. If the swallow
screening test erroneously identifies swallowing diiculties, the
patient is placed 'nil by mouth', with significant impact on quality of
life, until the SLT undertakes a more detailed assessment (usually
the next day). So a bedside swallow screening tool should be
chosen while taking into account this simple clinical reality. Hence,
there is a need to identify the most clinically useful screening test
or tools that most accurately identify the presence or absence of
aspiration associated with dysphagia, and to prescribe a food and
drink consistency management plan for individuals with aspiration
to improve their medical, social, and psychological outcomes.
Target condition being diagnosed
Aspiration risk associated with dysphagia in people who have had
an acute stroke.
Index test(s)
In this review, bedside swallowing screening tests not administered
by SLTs are the index tests. A wide range of index tests (swallow
screening tests) are used at the bedside by healthcare professionals
for recognition or determination of whether the patient is at risk of
aspirating food and fluids.
Clinical pathway
Bedside swallow screening tests are commonly used in the typical
care pathway in compliance with clinical guidelines for stroke.
However, there are varying degrees of compliance. Usually these
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
8
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
tests are implemented by allied healthcare professionals (mainly
nurses) following admission to the acute care sector. Patients who
are identified as at risk of swallowing diiculties are oen placed
'nil by mouth' while awaiting an expert assessment or a further
reference test. The care pathway for patients who have a negative
test result usually allows patients to continue to eat and drink
orally.
Prior test(s)
No tests to assess swallowing are conducted on patients before
hospital admission.
Role of index test(s)
Index tests, that is, bedside screening tests not administered by
SLTs, have the potential to improve the identification of people
with risk of aspiration associated with dysphagia following stroke.
Therefore, these tests may reduce the need for SLT evaluation and
for more complex, invasive, and more expensive imaging methods,
such as VF, FEES, or scintigraphy, which may not be available in
some healthcare settings.
Alternative test(s)
Other index tests include questionnaires that rely on self-
reported dysphagia symptoms. However, these tools, for example,
the Sydney Swallow Questionnaire (SSQ) and the Swallowing
Disturbance Questionnaire (SDQ), were used or designed and
validated for use in patient populations such as those with head
and neck cancer or Parkinson’s disease. These are not considered
in this review.
Rationale
We reviewed the diagnostic accuracy of currently available swallow
screening tests. A systematic review of published evaluations of
these screening tests will assist practitioners to identify those that
have undergone rigorous development and testing. This review will
also identify gaps in evidence for further research.
Healthcare professionals within acute stroke care settings are
responsible for deciding which bedside swallow screening test
they will use to detect people at risk of aspiration associated
with dysphagia in adult acute stroke patients. When a bedside
swallow screening test is considered, a test with high sensitivity and
specificity is paramount. False-negative results may lead to serious
consequences within the clinical context, as continued oral intake
may precipitate aspiration pneumonia and death. High specificity is
also beneficial, as false-positive results may result in patients being
designated ‘nil by mouth’ and provided with clinically assisted
nutrition and hydration unnecessarily. This adversely aects the
well-being of the patient and incurs unnecessary costs. However,
false-positive results are less dangerous, in that usually an SLT will
see the patient within 24 hours.
A recent systematic review of bedside swallow screening tests
provided a descriptive analysis of the dierent elements within
screening tests but did not compare these with a reference standard
(Almeida 2015). Other reviews have not specifically focused on
a stroke population (Brodsky 2016; O'Horo 2015), have included
studies in which screening was not undertaken in a timely manner
(Schepp 2012), have focused on individual clinical determinants
or behaviours associated with aspiration (Daniels 2012), have
reviewed only multi-consistency tests (Benfield 2020), or have
accepted delays longer than 24 hours between the index test and
the reference standard (Daniels 2012). The results of this review
will help guide policy makers and healthcare workers in acute
hospital settings on selection of the most appropriate bedside
swallow screening test from those currently available and might
also identify the research agenda going forward.
O B J E C T I V E S
Primary objective
To determine the diagnostic accuracy and the sensitivity and
specificity of bedside screening tests for detecting risk of
aspiration associated with dysphagia in people with acute
stroke
Secondary objectives
To assess the influence of the following sources of heterogeneity
on the diagnostic accuracy of bedside screening tools for
dysphagia
*Patient demographics (e.g. age, gender)
*Time post stroke that the study was conducted (from
admission to 48 hours) to ensure only hyperacute and acute
stroke swallow screening tools are identified
*Definition of dysphagia used by the study
*Level of training of nursing sta (both grade and training in
the screening tool)
*Low-quality studies identified from the methodological
quality checklist
*Type and threshold of index test
*Type of reference test
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered single-gate and two-gate studies if they compared
the accuracy of a bedside screening tool administered by
nursing sta or other healthcare professionals (excluding SLTs)
with identified reference tests (VF, FEES, scintigraphy, expert
assessment). We applied no restrictions in terms of language of
publication.
Participants
We included studies if they involved adults (aged 18 and over)
who had been admitted to an acute hospital setting with a clinical
diagnosis of stroke. We considered studies that were inclusive
of people with subarachnoid haemorrhage and we excluded
this sample subgroup from the analysis, when possible. We
excluded studies that included only patients with subarachnoid
haemorrhage. We also excluded studies that admitted patients with
trauma.
Index tests
We included studies if they evaluated a bedside swallow screening
test, used by nursing sta or other healthcare professionals
(excluding SLTs who have expert knowledge in this area), for
recognition or determination of whether patients were at risk of
aspiration associated with dysphagia.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
9
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Target conditions
We included studies if they reported the accuracy of the bedside
screening tool for identification of the risk of aspiration owing to
dysphagia post stroke.
Reference standards
We included studies if a bedside swallow screening test, carried
out by nursing sta or other healthcare professionals, was
compared with VF, FEES, scintigraphy, or an expert assessment.
Videofluoroscopy is an X-ray video of swallowing, allowing the
swallow to be analysed in real time. FEES involves insertion
of a fibreoptic flexible endoscope that is passed through the
nasal passages to view the throat pre-swallows and post-
swallows for secretion management, residue, and aspirated
material. Scintigraphy uses radioisotopes that are swallowed,
and the emitted radiation is captured by external detectors
(gamma cameras) to form images of swallowed material. Expert
assessments included assessments conducted by dysphagia-
trained professionals such as SLTs. All reference standards are
not equally valid and available (the SLT is not usually available
in the acute setting and is not available 24 hours each day and
seven days a week), and some procedures are more invasive than
others. Expert assessment was included as a reference standard
owing to the lack of immediate access to imaging or instrumental
assessment in many centres, and to the inability of some patients to
co-operate with these assessments. However, expert assessments
have limitations in their ability to identify at bedside those patients
who have swallowing diiculties owing to silent aspiration when
the patient demonstrates no clinical signs of aspiration.
Search methods for identification of studies
Electronic searches
The search strategy used was developed with the help of
the Cochrane Stroke Group Information Specialist. We searched
relevant electronic databases for eligible diagnostic studies from
inception until 9 December 2019: the Cochrane Central Register
of Controlled Trials (CENTRAL; 2019, Issue 12), in the Cochrane
Library; MEDLINE Ovid (from 1946); Embase Ovid (from 1980); the
Cumulative Index to Nursing and Allied Health Literature (CINAHL)
EBSCO (from 1937 onward), and the Health Technology Assessment
(HTA) Database via the Centre for Reviews and Dissemination
(University of York). The search strategy for MEDLINE is presented
in Appendix 1 and was adapted for CENTRAL (Appendix 2), Embase
(Appendix 3), CINAHL (Appendix 4), and HTA (Appendix 5).
Searching other resources
We checked the reference lists of all included studies, and we
performed a cited reference search using Science Citation Index, to
identify additional relevant studies and systematic reviews. We also
contacted experts in the field to identify ongoing studies and those
potentially missed by the search strategy.
We searched targeted grey literature sources, which we identified
from the the Canadian Agency for Drugs and Technologies in Health
(CADTH) Grey Matters document (CADTH 2018). A full list of the grey
literature sources searched is displayed in Appendix 6.
Data collection and analysis
Selection of studies
Two review authors from the team (EB, JB, HR, DD) independently
screened all titles and abstracts identified by the electronic
database searches and excluded duplications and irrelevant
records. Conflicts were resolved by involvement of a third
review author (PD, AA). We then obtained full-text articles for
the remaining studies, which were independently assessed for
inclusion by two review authors (EB, ML, HR, PD) using the
eligibility criteria described above. Disagreements were resolved
by consensus meetings, with arbitration provided by a third review
author (AA) who had not initially reviewed the paper. When multiple
papers used the same cohort of patients, we used the paper
with the most complete and up-to-date data. When we identified
relevant conference abstracts, we looked for the corresponding full-
text article. If we found no full-text article, we contacted the authors
of the conference abstract. We excluded conference abstracts with
insuicient data to calculate the 2 × 2 table. The selection process
is detailed in the PRISMA flow diagram in Figure 1.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
10
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 1.  PRISMA flow diagram.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
11
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 1.  (Continued)
Data extraction and management
Two review authors (JB, EM) designed a bespoke data extraction
form to collect details from the included studies. We piloted the
form on other diagnostic accuracy studies related to acute stroke
management that are beyond the scope of this review. For each
study, we extracted information related to characteristics of the
study, the patient population, index tests, reference standards, and
any relevant outcomes.
Among a group of review authors (JB, AC, LH, CEL, ML, CW), two
independently extracted the data to ensure adequate reliability and
quality. These two review authors then met to agree on final data
extractions for each included study. When there was disagreement
between the two review authors, a third review author from the
group acted as an arbitrator. Once data extraction was complete,
we entered the information into RevMan 5 (Review Manager 2014).
Assessment of methodological quality
Two review authors from the group (JB, AC, LH, CEL, ML,
CW) independently reviewed the methodological quality of each
included study, using criteria from the Quality Assessment of
Studies of Diagnostic Accuracy (QUADAS-2) tool, as recommended
by Cochrane (Appendix 7). As with previous diagnostic test accuracy
reviews (Gupta 2016), we changed the QUADAS-2 question "Was a
case-control design avoided?" to "Was a two-gate design avoided?".
We piloted the QUADAS-2 to promote agreement in interpretation
within the team. We resolved disagreements with a third review
author. We rated the QUADAS-2 criteria as ’yes, ’no’, or ’unclear’
for each included study. As stated in our protocol, guidance
indicates that criteria 1, 2, 3, and 9 should receive particular
attention regarding definitions used as the basis for decisions.
The other criteria are more self-explanatory with regards to their
interpretation.
Statistical analysis and data synthesis
From each index test, the parameters of interest were sensitivity
and specificity. For a majority of index tests, these were calculated
from the 2 × 2 tables. For other index tests, information from
reported parameters (sensitivity, specificity, or predictive values)
was used to inform the 2 × 2 table, yielding true-positive, false-
positive, true-negative, and false-negative values. From available
information, sensitivities, specificities, and their 95% confidence
intervals were calculated by RevMan 5 and plotted in forest plots
and summary receiver operating characteristic (SROC) plots. In
the absence of suicient data, to calculate the 2 × 2 tables, we
contacted study authors for further information. If this information
remained unavailable, we included the study in the review as a
narrative study.
Data from a single study were used only once in each analysis. We
checked all studies to see if all patients were included, or if the
number of patients was fixed, a priori in the design, from a condition
(from the reference test) or from the index test. If the numbers
of patients were fixed, the formulae for sensitivity and specificity
would be dierent. No included studies used such numbers fixed a
priori.
Pooling of sensitivity and specificity results was intended for each
index test. However, due to the small number of studies using the
same index test (three or fewer), we did not perform any meta-
analyses of diagnostic accuracy data. Pooling of screening tests
by general categories was performed as part of the descriptive
analysis, presented along with sensitivity and specificity.
Investigations of heterogeneity
Possible co-variates of interest were patient demographics (e.g.
age, gender), time post stroke that the study was conducted,
and level of training of nursing sta. However, the potential
influence of these co-variates could not be investigated due to
the small number of studies for each index test. The definitions
of dysphagia used by the study could have been grouped, and
the type and quality of the reference test, as well as the type
of index test, investigated as sources of heterogeneity. For the
same reason, no subgroup analyses were performed involving age,
gender, time post stroke of the index test, or index test type, and
whether there had been a significant change in the participant’s
condition between performance of index and reference tests. Index
tests were pooled by broad categories (by index test type, by
healthcare professional (HCP), by outcome, and by reference test),
and graphical comparisons were made. We therefore performed
only a narrative review running exploratory analysis in RevMan 5 to
show graphically if the co-variates of interest are likely to be related
to test accuracy, displayed using forest plots and SROC plots.
Sensitivity analyses
We did not carry out any sensitivity analyses due to the small
number of studies for each index test. We had proposed to exclude
low-quality studies and possibly reporting a delay in time between
index and reference tests due to potential changes in patient
consciousness and cognitive state.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
12
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Assessment of reporting bias
Since no methods are available to quantify publication bias in
diagnostic test accuracy reviews, we did not conduct an assessment
of reporting bias.
R E S U L T S
Results of the search
We conducted two searches - the first in June 2017 and the
same search in December 2019. We identified 26,701 papers
through database searches, and we found two additional studies
by handsearching the references of existing systematic reviews,
for a total of 20,567 articles once duplicates were removed. Aer
titles and abstracts of articles had been screened, we assessed
the full texts of 233 articles against the eligibility criteria. Of these,
we excluded 208 articles - 35 because they did not compare
appropriate index and reference tests, 24 because they did not
involve consecutive acute stroke patients, 16 because they did not
relate to screening for dysphagia, eight because index tests were
carried out by experts, three because they involved only patients
with dysphagia or aspiration and so sensitivity and specificity
could not be calculated, two because they were not single-gate
or two-gate studies, and one because not all patients received
the same reference test (see Characteristics of excluded studies).
Additionally, we excluded 57 references that were conference
abstracts, 38 that were not primary research studies, 12 that were
duplicate papers, six that had been withdrawn or were unavailable,
three that were research protocols or trial registrations, two that
were Master's or PhD theses, and one that was not relevant. Twenty-
five articles went through to data extraction and were included
in the final review. Four of the included articles did not include
enough detail for calculating the diagnostic accuracy of the index
test, thus we included these in narrative descriptions only. More
detail is shown in the PRISMA diagram (Figure 1).
We checked the reference lists of included studies, but this did
not reveal additional eligible papers. Details on participants, index
tests, reference tests, and sensitivity and specificity of each index
test are displayed in the Characteristics of included studies table.
The 25 included studies investigated a total of 37 screening tools,
most of which were dierent tools. All 25 studies are single-gate
studies. Of 37 screening tools, 21 were used by nurses and 16
by other HCPs. The other HCPs were doctor or physician (n = 6),
dietician (n = 1), neurologist (n = 2), multiple HCPs (n = 4), and HCP
not recorded (n = 3). Of the 37 screening tools, four could not be
included in an available quantitative analysis as 2 × 2 tables could
not be constructed to estimate sensitivity or specificity (Eren 2019;
Martino 2014; Nishiwaki 2005; Zhou 2011). Training was given for
screening tools used by 17 (81%) nurses and by four (25%) other
HCPs.
Demographic information and characteristics of all 37 screening
tests (including the four narrative tests) are given in Table 1. When
reported, mean age was 58.6 years to 76.8 years, the percentage
of males in the study was 35% to 100%, and the start date of
study recruitment was between 1995 and 2016. Twenty-two (59%)
tests were conducted in the USA and Canada, eight (22%) in the
UK and Europe, and six (16%) in other countries; in one (3%)
study, the country was not recorded. Only two (5%) studies used
an established classification system to record the location of the
stroke. The median sample size was 100, with an interquartile range
(IQR) of 50 to 161; 16 (48%) screening tools had a sample size less
than 100.
For 16 (43%) tests, admission to index test time was ≤ 24 hours, for
six (16%) between 24 hours and 72 hours, and for two (5%) ≥ 72
hours; for 13 (35%), this information was not recorded. For 28 (76%)
tests the index test was applied before the reference test, for one
(3%) the reference test was applied before the index test, for five
(14%) the order was not specified or mixed, and for three (8%) this
was not recorded. The time interval between index and reference
tests was ≤ 24 hours for 18 (49%) tests, was > 24 hours for 10 (27%)
tests, and was not recorded for nine (24%) tests.
Twenty-four (64.9%) screening tools used water only (Behera
2018a; Behera 2018b; Cummings 2015; Daniels 1997; Daniels 2016a;
Daniels 2016b; Edmiaston 2010a; Edmiaston 2010b; Edmiaston
2014a; Edmiaston 2014b; Eren 2019; Huhn-Matesic 2015; Jiang
2019a; Jiang 2019b; Lim 2001b; Martino 2009 Study 1; Martino
2014; Mulheren 2019; Nishiwaki 2005; Perry 2001 Study 1a; Perry
2001 Study 1b; Warnecke 2008a; Warnecke 2008b; Zhou 2011), six
(16.2%) used water and other consistencies (Campbell 2016; Ellis
2013; Huhmann 2004; Perry 2001 Study 1c; Perry 2001 Study 1d;
Trapl 2007b), and seven (18.9%) used other methods. The other
methods were evaluation of patient characteristics only (Antonios
2010a; Antonios 2010b; Bravata 2009a), notes review (Bravata
2009b), combined water swallow test and oxygen saturation
(Lim 2001a), oxygen saturation (Smith 2000), and evaluation of
patient characteristics followed by water swallow test and oxygen
saturation (Turner-Lawrence 2009). Several references reported use
of more than one screening tool as detailed in Table 2.
Expert assessment or the Mann Assessment of Swallowing Ability
(MASA) was utilised for 20 (54.1%) screening tools as the reference
test (Antonios 2010a; Antonios 2010b; Behera 2018a; Behera 2018b;
Bravata 2009a; Bravata 2009b; Campbell 2016; Cummings 2015;
Edmiaston 2010a; Edmiaston 2010b; Ellis 2013; Huhmann 2004;
Huhn-Matesic 2015; Jiang 2019a; Jiang 2019b; Perry 2001 Study
1a; Perry 2001 Study 1b; Perry 2001 Study 1c; Perry 2001 Study
1d; Turner-Lawrence 2009); six (16.2%) used FEES (Eren 2019; Lim
2001a; Lim 2001b; Trapl 2007b; Warnecke 2008a; Warnecke 2008b),
and 11 (29.7%) used VF (Daniels 1997; Daniels 2016a; Daniels 2016b;
Edmiaston 2014a; Edmiaston 2014b; Martino 2009 Study 1; Martino
2014; Mulheren 2019; Nishiwaki 2005; Smith 2000; Zhou 2011).
We identified 15 (40.5%) screening tools that had an outcome
of aspiration risk (Behera 2018a; Daniels 1997; Daniels 2016a;
Daniels 2016b; Edmiaston 2010a; Edmiaston 2014a; Huhn-Matesic
2015; Lim 2001a; Lim 2001b; Nishiwaki 2005; Smith 2000; Trapl
2007b; Turner-Lawrence 2009; Warnecke 2008a; Warnecke 2008b),
and we found 20 (54.1%) that had an outcome of dysphagia
(Antonios 2010a; Antonios 2010b; Behera 2018b; Bravata 2009a;
Bravata 2009b; Campbell 2016; Cummings 2015; Edmiaston 2010b;
Edmiaston 2014b; Ellis 2013; Eren 2019; Huhmann 2004; Jiang
2019a; Jiang 2019b; Martino 2009 Study 1; Mulheren 2019; Perry
2001 Study 1a; Perry 2001 Study 1b; Perry 2001 Study 1c; Perry
2001 Study 1d). Only two (5.4%) narrative papers did not record the
outcome (Martino 2014; Zhou 2011).
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
13
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Methodological quality of included studies
Risk of bias
Results of the methodological quality assessment for each of the 25
included studies are shown in Figure 2. We considered six studies to
be at low risk across all four risk of bias domains: patient selection,
index test, reference standard, and flow and timing (Daniels 2016;
Lim 2001; Martino 2009 Study 1; Martino 2014; Trapl 2007; Warnecke
2008). Two studies were at low risk of bias for three domains (index
test, reference standard, and flow and timing) but at uncertain risk
for patient selection (Edmiaston 2014; Mulheren 2019).
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
14
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 2.  Risk of bias and applicability concerns summary: review authors' judgements about each domain for each
included study.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
15
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 2.  (Continued)
A major concern for risk of bias across the other included studies
was that they had not enrolled consecutive patients. We identified
12 studies that had enrolled consecutive patients (Antonios 2010;
Daniels 1997; Daniels 2016; Jiang 2019; Lim 2001; Martino 2009
Study 1; Martino 2014; Nishiwaki 2005; Perry 2001 Study 1; Smith
2000; Trapl 2007; Warnecke 2008), but for 12 studies this was
unclear (Behera 2018; Bravata 2009; Campbell 2016; Cummings
2015; Edmiaston 2010; Edmiaston 2014; Ellis 2013; Eren 2019;
Huhmann 2004; Huhn-Matesic 2015; Mulheren 2019; Zhou 2011),
and one study employed a convenience sampling method (Turner-
Lawrence 2009). For 11 studies, it is unclear whether inappropriate
exclusions had been avoided when participants were recruited
(Behera 2018; Bravata 2009; Cummings 2015; Edmiaston 2010; Ellis
2013; Huhmann 2004; Huhn-Matesic 2015; Martino 2014; Perry 2001
Study 1; Turner-Lawrence 2009; Zhou 2011). Finally, it is unclear in
eight studies whether there had been an appropriate time interval
between the index test and the reference standard (Behera 2018;
Bravata 2009; Edmiaston 2010; Ellis 2013; Huhmann 2004; Huhn-
Matesic 2015; Perry 2001 Study 1; Zhou 2011), and it was reported
that the time interval was not appropriate in two studies (Daniels
1997; Nishiwaki 2005).
Applicability concerns
There were no applicability concerns for 15 studies across the three
applicability domains: patient selection, index test, and reference
standard (Antonios 2010; Bravata 2009; Daniels 2016; Edmiaston
2010; Edmiaston 2014; Eren 2019; Jiang 2019; Lim 2001; Martino
2009 Study 1; Martino 2014; Mulheren 2019; Perry 2001 Study 1;
Smith 2000; Trapl 2007; Warnecke 2008). However, concern was
high in five studies (Campbell 2016; Cummings 2015; Huhmann
2004; Nishiwaki 2005; Turner-Lawrence 2009), and concern was
unclear in four other studies (Behera 2018; Ellis 2013; Huhn-Matesic
2015; Zhou 2011), which included patients that did not match
the review question. Concern that the index test, its conduct, or
its interpretation diers from the review question was high in
Huhmann 2004 and unclear in four studies (Daniels 1997; Huhn-
Matesic 2015; Nishiwaki 2005; Zhou 2011).
Findings
Healthcare professionals’ level of training across studies
The level of training for healthcare professionals undertaking
the index test in dysphagia and/or use of the index test was
underreported, with only 21 of 37 screening tests stating that
training was oered. Of those that detailed the training, there was
variation in both length and content. Some index tests required 10
minutes of training (n = 4), some took several hours (n = 3), and
two detailed two days of training. The content of training varied
between training to use the test plus element of competence (n = 5),
instructions on how to use the index test (n = 4), instructions with
a practice component (n = 2), training in anatomy and physiology
of swallowing, identification and management of dysfunction and
five successful practice assessments (n = 2), on-line training in
swallowing anatomy and physiology (n = 1), clinical signs of
dysphagia and aspiration (n = 1), and digitised examples of five
stroke patients with a review of basic anatomy and physiology of
swallowing (n = 1). Some index tests reported that training was
oered but did not detail the contents (n = 5).
Synthesis of results
The high level of heterogeneity between studies as identified by
the review means that statistical pooling of diagnostic accuracy
data was not possible. We performed a descriptive analysis from
extracted data (2 × 2 tables) and sensitivity and specificity for all but
the four screening tests for which this data could not be extracted
(Eren 2019; Martino 2014; Nishiwaki 2005; Zhou 2011); these four
studies are not included from this point onwards.
Values for sensitivity and specificity presented here include
the point estimate (95% confidence interval (CI)). The criteria
of both high sensitivity and high specificity indicate that the
best performing test overall was the Standardized Swallowing
Assessment tool (SSA) (Perry 2001 Study 1d) (n = 68), which had
sensitivity of 0.97 (95% CI 0.86 to 1.00) and specificity of 0.90 (95%
CI 0.74 to 0.98). However, Perry 2001 Study 1 performed poorly
on the risk of bias assessment, showing, specifically, high risk of
bias in the flow and timing domain and unclear risk of bias in both
index test and reference standard domains, so this result should
be interpreted with caution. Several tests performed better on
sensitivity but less well on specificity: the Registered Dietician (RD)
Dysphagia Screening tool (n = 32) had sensitivity of 1.00 (95% CI
0.69 to 1.00) with specificity of 0.86 (95% CI 0.65 to 0.97) (Huhmann
2004); the Bedside Aspiration test (n = 50) had sensitivity of 1.00
(95% CI 0.87 to 1.00) with specificity of 0.71 (95% CI 0.49 to 0.87)
(Lim 2001a); the Gugging Swallowing Screen (GUSS) (n = 30) had
sensitivity of 1.00 (95% CI 0.77 to 1.00) with specificity of 0.69 (95%
CI 0.41 to 0.89) (Trapl 2007b); and the Toronto Bedside Swallowing
Screening Test (TOR-BSST) (n = 24) had sensitivity of 1.00 (95% CI
0.75 to 1.00) with specificity of 0.64 (95% CI 0.31 to 0.89) (Martino
2009 Study 1).
Of the best performing screening tests, we have the most
confidence in the following studies: Bedside Aspiration test (Lim
2001a), GUSS (Trapl 2007b), and TOR-BSST (Martino 2009 Study 1),
which we rated as having low risk of bias across all four QUADAS-2
risk of bias domains. Of those with low risk of bias, the best
performing screening test using only water was TOR-BSST (Martino
2009 Study 1), and the best performing screening test using water
plus other consistencies was GUSS (Trapl 2007b). A description
of these tests is provided in Appendix 8. However, all of these
screening tools had small sample sizes (n < 100), which limits
interpretation of the estimates of reliability of these tests.
Screening tests were grouped into general categories according
to taxonomy (water only tests, water plus other consistencies
tests, and other tests), healthcare professionals who administered
the test (nurses versus other healthcare professionals), types of
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
16
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
outcomes (aspiration versus dysphagia), and types of reference
standards (expert assessment or MASA versus VF versus FEES), and
we generated related summary receiver operating characteristic
(ROC) plots using RevMan 5 (see Figure 3; Figure 4; Figure 5; Figure
6). This informed the descriptive analysis, but no meta-analysis was
done because of the small number of studies identified for each
individual screening test.
Figure 3.  Summary ROC plot of tests: Grouped by Index taxonomy - water only, water plus bolus and other.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
17
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 4.  Summary ROC plot of tests grouped by index test healthcare professional - nurse and other.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
18
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 5.  Summary ROC plot of tests: grouping index tests by outcome - aspiration and dysphagia.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
19
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 6.  Summary ROC plot of tests: index tests grouped by reference test used - Expert Assessment, FEES and VS.
Type of test (water only tests versus water plus other
consistencies tests versus other tests)
Screening tools that used water and other consistencies (accuracy
ranged from sensitivity of 0.75 (95% CI 0.35 to 0.97) with specificity
of 0.89 (95% CI 0.75 to 0.97), to sensitivity of 1.00 (95% CI 0.69
to 1.00) with specificity of 0.86 (95% CI 0.65 to 0.97)) generally
were more accurate than screening tests that used only water
(accuracy ranged from sensitivity of 0.46 (95% CI 0.28 to 0.66) with
specificity of 1.00 (95% CI 0.83 to 1.00) to sensitivity of 1.00 (95%
CI 0.75 to 1.00) with specificity of 0.64 (95% CI 0.31 to 0.89)). Those
that used methods other than water only and water and other
consistencies had mixed results; some performed as well as the
water-only tests, with the most accurate scoring sensitivity of 1.00
(95% CI 0.87 to 1.00) with specificity of 0.71 (95% CI 0.49 to 0.87))
(Figure 7). Others performed worse, with the least accurate scoring
having sensitivity of 0.29 (95% CI 0.08 to 0.58) with specificity of
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
20
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
0.84 (95% CI 0.64 to 0.95)). Pooling of data by the screening test
taxonomy confirmed that screening tests that used water plus
other consistencies (participants n = 412) may be more sensitive
with similar or better specificity than screening tests that used
water only (participants n = 2914) or other methods (participants
n = 627) (Figure 3). However, only six tests used this method.
Screening tests that used only water had similar accuracy (in terms
of sensitivity and specificity) compared with screening tests using
other methods.
Figure 7.  Forest plot of tests grouped by Index Test Taxonomy - Water only, Water plus other consistencies, and
Other tests.
Type of reference standard (expert assessment or MASA versus
VF versus FEES)
Screening tools showed better agreement with expert assessment
or the MASA (accuracy ranged from sensitivity of 0.29 (95% CI 0.08
to 0.58) with specificity of 0.84 (95% CI 0.64 to 0.95) to sensitivity
of 1.00 (95% CI 0.69 to 1.00) with specificity of 0.86 (95% CI 0.65
to 0.97)) than they did with the instrument-based reference test
of FEES (accuracy ranged from sensitivity of 0.49 (95% CI 0.38 to
0.61) with specificity of 1.00 (95% CI 0.82 to 1.00) to sensitivity
of 1.00 (95% CI 0.87 to 1.00) with specificity of 0.71 (95% CI 0.49
to 0.87)) or VF (accuracy ranged from sensitivity of 0.46 (95%
CI 0.28 to 0.66) with specificity of 1.00 (95% CI 0.83 to 1.00) to
sensitivity of 1.00 (95% CI 0.75 to 1.00) with specificity of 0.64
(95% CI 0.31 to 0.89) (Figure 8). Pooling of screening tests by
reference test (Figure 6) confirmed that screening tests that used
expert assessment or the MASA (participants n = 2491) had the
highest accuracy. This may be expected, as the screening tests
will be more closely aligned to expert assessment methods than
to instrumental assessment. Screening tests that used VF as a
reference test had high sensitivity but lower specificity than those
using expert assessment or the MASA. However, the number of
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
21
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
index tests compared to instrument-based reference tests was low: five were compared to FEES (participants n = 330) and eight were
compared to VF (participants n = 1132).
Figure 8.  Forest plot of tests grouped by Reference Test - Expert Assessment and MASA, FEES, and VF.
Type of primary outcome (aspiration versus dysphagia)
Screening tests with dysphagia as the primary outcome (accuracy
ranged from sensitivity of 0.29 (95% CI 0.08 to 0.58) with specificity
of 0.84 (95% CI 0.64 to 0.95) to sensitivity of 1.00 (95% CI 0.69 to 1.00)
with specificity of 0.86 (95% CI 0.65 to 0.97)) generally performed
better than screening tests for which the primary outcome was
aspiration (accuracy ranged from sensitivity of 0.49 (95% CI 0.38 to
0.61) with specificity of 1.00 (95% CI 0.82 to 1.00) to sensitivity of
1.00 (95% CI 0.87 to 1.00) with specificity of 0.71 (95% CI 0.49 to
0.87)) (Figure 9). Pooling of screening tests by outcome (Figure 5)
showed that screening tests with the greatest accuracy, with both
high sensitivity and high specificity, had an outcome of dysphagia
(participants n = 2126). This was to be expected, as dysphagia is
more easily observed than aspiration. Several tests that detected
aspiration risk (participants n = 1827) had high sensitivity but
slightly lower specificity.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
22
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 9.  Forest plot of tests grouped by Index Test Outcome - aspiration and dysphagia.
Tests designed for nurses compared to tests designed for other
healthcare professionals
Screening tools carried out by nurses (accuracy ranged from
sensitivity of 0.29 (95% CI 0.08 to 0.58) with specificity of 0.84 (95%
CI 0.64 to 0.95) to sensitivity of 1.00 (95% CI 0.77 to 1.00) with
specificity of 0.69 (95% CI 0.41 to 0.89)) performed consistently
better than those carried out by other HCPs (excluding SLTs)
(accuracy ranged from sensitivity of 0.49 (95% CI 0.38 to 0.61) with
specificity of 1.00 (95% CI 0.82 to 1.00) to sensitivity of 1.00 (95% CI
0.69 to 1.00) with specificity of 0.86 (95% CI 0.65 to 0.97)) (Figure 10).
Generally, screening tests designed for use by nurses (participants
n = 2785) performed equally well as those designed for use by other
HCPs (excluding SLTs) (participants n = 1168) in terms of sensitivity
and specificity (Figure 4).
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
23
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Figure 10.  Forest plot of tests grouped by HCP - nurse and other.
Other considerations
Screening tests with larger sample sizes (n > 200) were Behera
2018a, Behera 2018b, Daniels 2016a, Daniels 2016b, Edmiaston
2010a, Edmiaston 2010b, Edmiaston 2014a, and Edmiaston 2014b.
Of these, screening tests with the greatest accuracy (both high
sensitivity and high specificity) were Edmiaston 2010a, Edmiaston
2010b, and Edmiaston 2014b. All of these had narrow 95% CIs for
estimates of sensitivity and specificity. Their lower 95% CIs for
sensitivity had a higher value than for some of the overall best
performing tests - Lim 2001a, Trapl 2007b, and Martino 2009 Study
1. None of the tests with a larger sample size were assessed as low
risk for all four QUADAS-2 risk of bias (ROB) domains. Edmiaston
2010a and Edmiaston 2010b were unclear for three domains in the
ROB and were low for one domain. Edmiaston 2014b was unclear
for one domain in the ROB and was low for the other three domains.
In summary, even though 95% CIs for estimates of sensitivity and
specificity are narrower for the best performing screening tests,
which used a larger sample size, their QUADAS-2 risk of bias is not
as low as that for the overall best performing tests.
D I S C U S S I O N
Numerous variables need to be systematically reported regarding
training required by the healthcare professional undertaking the
swallow screening tool, consistencies oered as part of the tool,
and food and drink consistency management options available
to the person undertaking the test post screen. From a clinical
perspective, some bedside swallow screening tests are criticised
for making recommendations for consistencies that have not
been assessed. For example, water-only tests allow normal dietary
intake without assessment. Similarly water and other consistency
screening tests show a discrepancy between diet and fluid
consistencies tested and those recommended. Future studies
should take these concerns into consideration.
Summary of main results
This review aimed to summarise the evidence regarding accuracy
of swallow screening tests to detect aspiration risk associated
with dysphagia in acute stroke. Studies did not always report
suicient information regarding study characteristics; therefore, it
is not possible to explore the influence of sources of heterogeneity.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
24
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Results show that a number of screening tools oered high
sensitivity. However, we were unable to identify a swallow
screening tool with concomitant high specificity. Furthermore, we
were unable to identify a diagnostically accurate swallow screening
tool that tests a variety of consistencies and oers immediate
management advice for healthcare settings that do not have the
facility to oer expert comprehensive assessments.
Population and setting
Although this review focused on acute stroke patients, some
studies did not define the time period (from stroke onset or from
admission) in which use of swallow screening tool was undertaken.
Owing to fluctuation in swallow function within a 24-hour period,
it is incumbent on researchers to specify the time period to
direct clinical practice (i.e. use of dierent screening tools at
dierent time periods post stroke) and to allow for comparisons of
sensitivity versus other studies. Screening tools that were used in
the outpatient setting or in the rehabilitation setting were excluded
from the review.
Index tests
The ideal balance of sensitivity and specificity may vary according
to the care setting. For example, a very sensitive screening test may
be appropriate for untrained sta who have professional backup
to rapidly identify false-positives. No screening test identified or
excluded swallowing diiculties with perfect accuracy. We were
able to identify tests with the best ability to detect people with
and without risk of aspiration from studies providing good quality
evidence. The best performing swallow screening tools were the
Bedside Aspiration test (Lim 2001a), the Gugging Swallowing
Screen (GUSS) (Trapl 2007b), and the Toronto Bedside Swallowing
Screening Test (TOR-BSST) (Martino 2009 Study 1). Although
screening tests with larger sample sizes (n > 200) had smaller
confidence intervals (CIs) in estimates of sensitivity and specificity,
they had higher risk of bias than the best performing tests so are
not among the recommended screening tests. For clinicians with a
variety of consistencies available, the best performing water plus
other consistencies test was GUSS (Trapl 2007b). Although GUSS
oers dierent consistencies as part of the assessment and oers
a consistency management plan for clinicians to implement, the
consistencies used are limited to puree, water, and solids, and
the test does not include all the consistencies identified in the
International Dysphagia Diet Standardised Initiative (International
Dysphagia Diet Std Initiative 2017). Therefore, this test may not
be suitable for implementation across all healthcare settings. The
best water-only swallow screening test was TOR-BSST (Martino
2009 Study 1). Although all tests demonstrate a combined highest
sensitivity and specificity and low risk of bias across all domains,
clinicians should be cautious in their interpretation of these
findings, as these tests are based on single studies with small
sample sizes, which limits the interpretation of estimates of
reliability for these screening tests.
Sensitivity is similar for tools with a primary outcome of dysphagia
or aspiration, but tools with dysphagia as their outcome perform
better in terms of specificity. This may be due to the greater number
of clinical signs of diiculty (e.g. chewing function) that may be
observed in dysphagia compared to aspiration, making it more
easily detected.
There is general agreement between index tests that some degree
of behavioural assessment (e.g. alertness), together with oromotor
assessment, was fundamental before progression to a test of oral
intake (either various sizes of water bolus or water plus various
consistencies). Generally, water plus various consistencies (n = 6)
performed better than water-only tools in terms of sensitivity and
specificity. The small number of index tests that did not use direct
patient assessment (e.g. used national stroke scales to identify risk
of swallowing diiculty) did not consistently perform well.
Only a few studies gave direction on what food and drink
consistencies should be given to an individual following the
screen (e.g. GUSS; Trapl 2007b). These studies will be useful in
healthcare settings, nationally and internationally, when an expert
assessment or an instrumental assessment is not available.
The best performing index tests are included in the group carried
out by nurses. Index tests carried out by other HCPs are less
consistent. This may be due to confounding factors regarding the
amount of training received by nursing sta within studies rather
than a reflection on the type of index test or professional group
undertaking the test. Of the 21 index tests undertaken by nurses, 17
(81.0%) recorded some form of training; for other HCPs, only four
(25.0%) papers reported a training element. Furthermore, papers
that reported training was required oen failed to present the
elements included in the training. In future studies, the type of
training delivered should be reported.
Reference standard
Reference tests were defined as either expert clinical assessments
(usually undertaken by speech and language therapists (SLTs))
or instrumental assessments. A variety of reference tests
were included to capture patients who could access dierent
instrumental assessments. However, the reliability of instrumental
assessments used to diagnostically identify aspiration is of clinical
concern.
Following the SLT opinion, we considered the Mann Assessment
of Swallowing Ability (MASA) as equivalent to an expert clinical
assessment and included the seven studies that used MASA as a
reference test. Tools that used the MASA or expert assessment for
reference testing had a better combined sensitivity and specificity
than tools that used instrumental tests of fibreoptic endoscopic
evaluation of swallowing (FEES) or videofluoroscopy (VF). This may
be due to the similarity between index tests and reference tests of
MASA/expert assessment in that both rely on clinical observations
rather than on instrumental assessment.
From summary receiver operating characteristic (SROC) plots,
which plot sensitivity versus (1-specificity), index tests that used
FEES as the reference test generally had higher sensitivity but
similar specificity than index tests that used VF or MASA as the
reference test combined with expert assessment. Most of the
studies that used FEES or VF report sensitivity greater than 85% but
poorer specificity than those that used MASA or expert assessments
as the reference test. No studies were compared to scintigraphy,
which remains mainly a research tool.
Quality of the evidence
The quality of evidence varied across included studies. The
most common reasons for reduced quality was considerable
heterogeneity between studies that aected our ability to combine
and directly compare results.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
25
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Studies oen failed to distinguish between dysphagia and
aspiration as the primary outcome. Some did not routinely identify
time between stroke onset or admission to hospital and time the
screen was undertaken. Similarly, some studies failed to report
time between index test and reference test, and the swallow may
have improved or deteriorated in the interval between tests. Many
studies failed to report the training required by dierent healthcare
professionals to implement the screening tool.
Strengths and weaknesses of the review
Strengths
This DTA undertook the literature search from an International
perspective and included all relevant studies irrespective of
language of publication. Therefore we can be assured that no
relevant publications were excluded from our searches. We were
able to identify the best performing tools within each category of
swallow screening tools that used water alone, water plus other
bolus consistencies, and other methods. We included as narrative
studies trials that did not report statistical results.
Weaknesses
Apart from one screening tool that was assessed by two studies,
all remaining screening tools were assessed by single studies. This
hampered the possibility to perform any meaningful meta-analysis.
Only descriptive analyses grouped by general categories were
presented. Studies oen failed to distinguish between dysphagia
and aspiration as the primary outcome. Most studies had small
sample sizes, which limits interpretation of the estimates of
reliability of the screening tests. Some did not routinely identify
time between stroke onset or admission to hospital and time the
screen was undertaken. Similarly, some studies failed to report time
between the index test and the reference test, and the swallow
may have improved or deteriorated in the interval between tests.
Many studies failed to report the training required by dierent
healthcare professionals to implement the screening tool. This has
had an impact on the quality of this review. We performed no formal
assessment of the overall quality of the evidence, for example, by
using GRADE. We have not included any ongoing studies.
Applicability of findings to the review question
This review demonstrates that currently, high-quality evidence
from research is insuicient to provide conclusive results regarding
the accuracy of bedside swallow screening tools in identifying
aspiration associated with dysphagia in the acute stage of stroke.
Applicability of evidence
The review authors are aware of ongoing international studies
that are currently unpublished and are not included as part of
this review. However, this review does identify currently available
swallow screening tools that screen with water and those that
screen with a variety of consistencies to oer an ongoing food and
drink consistency management plan that may be implemented in
the clinical setting.
Implications for research
High-quality, appropriately statistically powered studies are
needed to evaluate the accuracy of a swallow screening tool in
identifying aspiration associated with dysphagia in acute stages of
stroke.
Future research studies should clearly define their primary
outcomes. They should provide more detail regarding participant
inclusion and exclusion criteria, and when a study includes
individuals with diering underlying aetiologies that precipitate
swallowing diiculties, these data should be reported separately.
Future studies should provide greater detail on participant location
and timing of the swallow screening tool used post stroke or
post admission. This, together with a description of participant
characteristics and swallow severity, would allow researchers to
identify the accuracy of a screening tool within dierent time
frames, revealing alterations in swallow function post stroke onset.
Studies should clarify the reference tests used, and when several
tests are undertaken, these should be reported separately.
The level of training provided to healthcare professionals
undertaking the index test in dysphagia and/or using the index
test has been underreported, and studies that detailed the training
show variation in both length and content of training. Future
research should detail the amount and content of training oered
and should examine the impact of training on study fidelity and
outcomes.
In addition to technical performance in accurately identifying
patients with dysphagia with its associated risk of aspiration,
bedside swallow screening tools should demonstrate clinical
utility. Evaluation of both short-term and long-term participant
outcomes at defined periods would facilitate assessment of
whether incidence of aspiration pneumonia, quality of life, and
participant mortality were influenced by timing of the screening
test post stroke or post admission.
Bedside swallow screening test cost-eectiveness data should
be reported to support healthcare services with clinical
implementation.
Future studies should apply the better performing screening tests
that we have identified, making minor changes in their design
to ensure that they have low Quality Assessment of Studies of
Diagnostic Accuracy (QUADAS-2) risk of bias and using larger
sample sizes, rather than continuing to develop local screening
tests. This would build up a body of evidence, would reduce
heterogeneity between screening tests, and ultimately would allow
a meta-analysis of dierent tests to be conducted.
Researchers should be encouraged to consider inclusion of these
issues to when performing future comparative studies.
Agreements and disagreements with other studies or reviews
This is the largest, most inclusive international and current review
on identification of risk of aspiration associated with dysphagia as
the main symptom of concern in the acute phase of stroke. Several
recent systematic reviews have explored the accuracy of screening
tools. However, these studies have limited the scope of their review
owing to the restricted range of languages accepted by the search
(Brodsky 2016; Daniels 2012; Jiang 2016; Oliveira 2001; Schepp
2012), the heterogeneity of included disorders (Brodsky 2016; Jiang
2016; O'Horo 2015), the paucity of information available regarding
the healthcare professional undertaking the study (Brodsky 2016;
Chen 2016; Daniels 2012; O'Horo 2015), comparison of only water
swallow tools (Brodsky 2016; Chen 2016), exclusion of instrumental
assessments from reference tests (Jiang 2016), consideration of
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
26
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
only dysphagia as the primary outcome (Jiang 2016; Oliveira 2001;
Schepp 2012), and specification that no training in dysphagia
should be required (Schepp 2012). However, this current review
had no language restrictions, focuses on acute stages of stroke,
identifies the range of healthcare professionals undertaking the
test, explores the diagnostic accuracy of tools including water
and water with other consistencies, and includes instrumental and
expert assessments as reference tests with aspiration associated
with dysphagia as the focus of the assessment. Therefore, direct
comparisons are diicult to make.
A U T H O R S '  C O N C L U S I O N S
Implications for practice
This review demonstrates that current high-quality evidence from
research is insuicient to provide conclusive results regarding the
accuracy of bedside swallow screening tools to identify aspiration
associated with dysphagia in the acute stage of stroke.
Implications for research
We have identified the need for high-quality research. Study
authors should be encouraged to include information regarding
patient demographics (including comorbidities that may impact
outcome and stroke location or classification) and definitions
regarding dysphagia and aspiration and time intervals (admission
to index test and time from index test to reference test). We
recommend that future studies should apply better performing
screening tests, enhanced to ensure they have low QUADAS-2 risk
of bias domains, and should use larger sample sizes.
A C K N O W L E D G E M E N T S
The review authors acknowledge the contributions of Brigit
Chesworth, Kerry Hannah, Dawn Doran, Janet Reed, Hazel Fraser,
and Josh Cheyne.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
27
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
REFERENCES
References to studies included in this review
Antonios 2010 {published data only}10.1016/
j.jstrokecerebrovasdis.2009.03.007
AntoniosN, Carnaby-MannG, CraryM, MillerL, HubbardH,
HoodK, et al. Analysis of a physician tool for evaluating
dysphagia on an inpatient stroke unit: the Modified Mann
Assessment of Swallowing Ability. Journal of Stroke and
Cerebrovascular Diseases 2010;19(1):49-57.
Behera 2018 {published data only}10.1016/
j.jstrokecerebrovasdis.2018.02.038
BeheraA, ReadD, JacksonN, SaourB, AlshekhleeD,
MosierAK. A validated swallow screener for dysphagia and
aspiration in patients with stroke. Journal of Stroke and
Cerebrovascular Diseases 2018;27(7):1897-904. [DOI: 10.1016/
j.jstrokecerebrovasdis.2018.02.038]
Bravata 2009 {published data only}
BravataDM, DaggettVS, Woodward-HaggH, DamushT,
PlueL, RussellS, et al. Comparison of two approaches to
screen for dysphagia among acute ischemic stroke patients:
nursing admission screening tool versus National Institutes
of Health Stroke Scale. Journal of Rehabilitation Research and
Development 2009;46(9):1127-33.
Campbell 2016 {published data only}
CampbellGB, CarterT, KringD, MartinezC. Nursing bedside
dysphagia screen: is it valid? Journal of Neuroscience Nursing
2016;48(2):75-9.
Cummings 2015 {published data only}
CummingsJ, SoomansD, O'LaughlinJ, SnappV, JodoinA,
ProcoH, et al. Sensitivity and specificity of a nurse dysphagia
screen in stroke patients. MEDSURG Nursing 2015;24(4):219-63.
Daniels 1997 {published data only}10.1044/1058-0360.0604.17
DanielsSK, McAdamCP, BraileyK, FoundasAL. Clinical
assessment of swallowing and prediction of dysphagia
severity. American Journal of Speech-Language Pathology
1997;6(4):17-24.
Daniels 2016 {published data only}
DanielsSK, PathakS, RosenbekJC, MorganRO, AndersonJA.
Rapid aspiration screening for suspected stroke: part 1:
development and validation. Archives of Physical Medicine and
Rehabilitation 2016;97(9):1440-8.
Edmiaston 2010 {published data only}
EdmiastonJ, ConnorLT, LoehrL, NassiefA. Validation of a
dysphagia screening tool in acute stroke patients. American
Journal of Critical Care 2010;19(4):357-64.
Edmiaston 2014 {published data only}
EdmiastonJ, ConnorLT, Steger-MayK, FordAL. A simple
bedside stroke dysphagia screen, validated against
videofluoroscopy, detects dysphagia and aspiration with high
sensitivity. Journal of Stroke and Cerebrovascular Diseases
2014;23(4):712-6.
Ellis 2013 {published data only}
EllisAL, HannibalRR. Nursing swallow screens: why is testing
water only not enough? Journal of Neuroscience Nursing
2013;45(5):244-53.
Eren 2019 {published data only}10.5152/NSN.2019.10815
ErenY, KaracaEU, SaylamG, YaylaciA, AlicuraS, ÇomoğluSS.
Validity and reliability of the Turkish version of the Barnes-
Jewish Hospital stroke dysphagia screen test in patients with
acute stroke. Neurological Sciences and Neurophysiology
2019;36(2):78-83. [DOI: 10.5152/NSN.2019.10815]
Huhmann 2004 {published data only}
HuhmannM, DeckerRT, Byham-GrayL, MailletJO, VonHagenS.
Comparison of dysphagia screening by a registered dietitian
in acute stroke patients to speech language pathologist's
evaluation. Topics in Clinical Nutrition 2004;19(3):239-49.
Huhn-Matesic 2015 {published data
only}10.1891/1939-2095.8.1.117
Huhn-MatesicEK. Developing and testing a bedside aspiration
screen to protect stroke patients from aspiration and
mortality. Clinical Scholars Review 2015;8(1):117-24. [DOI:
10.1891/1939-2095.8.1.117]
Jiang 2019 {published data only}10.4103/tcmj.tcmj_158_18
JiangJ, YuJ, WangJ, WangY, WangW. Evaluation of the
Chinese version of the swallowing screen in stroke patients
with dysphagia. Tzu Chi Medical Journal 2019;31(4):270-5. [DOI:
10.4103/tcmj.tcmj_158_18]
Lim 2001 {published data only}
LimSHB, LieuPK, PhuaSY, SeshadriR, VenketasubramanianN,
LeeSH, et al. Accuracy of bedside clinical methods compared
with fiberoptic endoscopic examination of swallowing (FEES)
in determining the risk of aspiration in acute stroke patients.
Dysphagia 2001;16(1):1-6.
Martino 2009 Study 1 {published data only}10.1161/
STROKEAHA.107.510370
MartinoR, SilverF, TeasellR, BayleyM, NicholsonG, StreinerDL,
et al. The Toronto Bedside Swallowing Screening Test (TOR-
BSST) development and validation of a dysphagia screening
tool for patients with stroke. Stroke 2009;40(2):555-61.
Martino 2014 {published data
only}10.3109/17549507.2014.902995.
MartinoR, MakiE, DiamantN. Identification of dysphagia using
the Toronto Bedside Swallowing Screening Test (TOR-BSST®):
are 10 teaspoons of water necessary? International Journal of
Speech-Language Pathology 2014;16(3):193-8.
Mulheren 2019 {published data only}10.1016/
j.apmr.2018.12.032
MulherenRW, González-FernándezM. Swallow screen
associated with airway protection and dysphagia aer acute
stroke. Archives of Physical Medicine and Rehabilitation
2019;100(7):1289-93. [DOI: 10.1016/j.apmr.2018.12.032]
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
28
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Nishiwaki 2005 {published data only}
NishiwakiK, TsujiT, LiuM, HaseK, TanakaN, FujiwaraT.
Identification of a simple screening tool for dysphagia in
patients with stroke using factor analysis of multiple dysphagia.
Journal of Rehabilitation Medicine 2005;37:247-51.
Perry 2001 Study 1 {published data only}
PerryL. Screening swallowing function of patients with acute
stroke. Part one: identification, implementation and initial
evaluation of a screening tool for use by nurses. Journal of
Clinical Nursing 2001;10(4):463-73.
Smith 2000 {published data only}
SmithHA, LeeSH, O'NeillPA, ConnollyMJ. The combination
of bedside swallowing assessment and oxygen saturation
monitoring of swallowing in acute stroke: a safe and humane
screening tool. Age and Ageing 2000;29(6):495-9.
Trapl 2007 {published data only}10.1161/
STROKEAHA.107.483933
TraplM, EnderleP, NowotnyM, TeuschlY, MatzK,
DachenhausenA, et al. Dysphagia bedside screening for
acute-stroke patients: the Gugging Swallowing Screen. Stroke
2007;38(11):2948-52.
Turner-Lawrence 2009 {published data only}10.1016/
j.annemergmed.2009.03.007
Turner-LawrenceDE, PeeblesM, PriceMF, SinghSJ, AsimosAW.
A feasibility study of the Sensitivity of Emergency Physician
Dysphagia Screening in acute stroke patients. Annals of
Emergency Medicine 2009;54(3):344-8.e1.
Warnecke 2008 {published data only}10.1136/jnnp.2007.134551
WarneckeT, TeismannI, MeimannW, OlenbergS,
ZimmermannJ, KramerC, et al. Assessment of aspiration risk
in acute ischaemic stroke - evaluation of the simple swallowing
provocation test. Journal of Neurology, Neurosurgery and
Psychiatry 2008;79(3):312-4.
Zhou 2011 {published data only}
ZhouZ, SalleJY, DavietJC, StuitA, NguyenCL. Combined
approach in bedside assessment of aspiration risk post stroke:
PASS. European Journal of Physical and Rehabilitation Medicine
2011;47(3):441-6.
References to studies excluded from this review
Addington 1999 Study 1 {published data only}
AddingtonWR, StephensRE, GillilandK, RodriguezM.
Assessing the laryngeal cough reflex and the risk of developing
pneumonia aer stroke. Archives of Physical Medicine and
Rehabilitation 1999;80(2):150-4.
Addington 1999 Study 2 {published data only}
AddingtonWR, StephensRE, GillilandKA. Assessing
the laryngeal cough reflex and the risk of developing
pneumonia aer stroke: an interhospital comparison. Stroke
1999;30(6):1203-7.
Alsibai 2014 {published data only}
AlsibaiA, VoytasJ. Use of electrical stimulation in treatment of
dysphagia, a nursing home experience. Journal of the American
Geriatrics Society 2014;62:S37.
Anderson 2016 {published data only}
AndersonJA, PathakS, RosenbekJC, MorganRO, DanielsSK.
Rapid aspiration screening for suspected stroke: Part 2: initial
and sustained nurse accuracy and reliability. Archives of Physical
Medicine and Rehabilitation 2016;97(9):1449-55.
Archer 2015 Study 1 {published data only}
ArcherS, SmithC, NewhamD. Surface electromyography
biofeedback in dysphagia therapy: do patients think it helps?
International Journal of Stroke 2015;10:63.
Archer 2015 Study 2 {published data only}
ArcherS, SmithC, NewhamD. Surface electromyographic
biofeedback and the eortful swallow exercise for stroke-
related dysphagia. International Journal of Stroke 2015;10:63.
Armesto 2015 {published data only}
ArmestoA, HowaldR, RosemanE, Kitchen-ClarkT, ConveryC,
BoyleK, et al. Swallowing screening in the emergency
department: a collaborative eort to improve patient care.
International Journal of Stroke 2015;10:59-60.
Aviv 1997 {published data only}
AvivJE, SaccoRL, MohrJP, ThompsonJLP, LevinB, SunshineS,
et al. Laryngopharyngeal sensory testing with modified barium
swallow as predictors of aspiration pneumonia aer stroke.
Laryngoscope 1997;107(9):1254-60.
Aydogdu 2015 {published data only}
AydogduI, KiyliogluN, TarlaciS, TanriverdiZ, AlpaydinS,
AcarerA, et al. Diagnostic value of "dysphagia limit" for
neurogenic dysphagia: 17 years of experience in 1278 adults.
Clinical Neurophysiology 2015;126(3):634-43.
Babi 2014 {published data only}
BabiMA, GormanM, CommichauC, KenneyS, BoyleL,
ComeauM, et al. Failed bedside dysphagia screen predicts
pneumonia treatment in acute stroke: a resident quality
initiative project in a JC-certified primary stroke center.
Neurology 2014;82(10 Suppl 1).
Bahia 2014 {published data only}
BahiaMM, MouraoLF, LimaFO, LiLM. Clinical predictors of
oropharyngeal dysphagia following acute stroke. Dysphagia
2014;29(6):774.
Bahia 2016 {published data only}
BahiaMM, MouraoLF, ChunRYS. Dysarthria as a predictor
of dysphagia following stroke. NeuroRehabilitation
2016;38(2):155-62.
Bax 2013 {published data only}
BaxL, McFarlaneM, GreenE, MilesA. Introducing a speech and
language therapy (SLT) led fibre optic endoscopic evaluation
of swallowing (FEES): functional outcomes for acute stroke
patients. International Journal of Stroke 2013;8:40.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
29
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Bax 2014 {published data only}
BaxL, McFarlaneM, GreenE, MilesA. Speech-language
pathologist-led fiberoptic endoscopic evaluation of swallowing:
functional outcomes for patients aer stroke. Journal of Stroke
and Cerebrovascular Diseases 2014;23(3):e195-e200.
Benjamin 2015 {published data only}
BaxL, McFarlaneM, GreenE, MilesA. Introducing a speech and
language therapy (SLT) led fibre optic endoscopic evaluation
of swallowing (FEES): functional outcomes for acute stroke
patients. International Journal of Stroke 2013;8:40.
Burks 2011 {published data only}
BurksC, MeyerDM. Validation of the TOR-BSST swallow
screening tool. Stroke 2011;42(3):e129-e130.
Carnaby 2014 {published data only}
CarnabyGD. Relationships among videofluoroscopic scales and
stroke outcome. Dysphagia 2014;29(6):751.
Carrington 2013 {published data only}
CarringtonS, ArcherS, SmithC. Evaluating the impact of
fibreoptic endoscopic (FEES) evaluation of swallowing with
dysphagic patients on a stroke unit. International Journal of
Stroke 2013;8:27.
Chavarria 2015 {published data only}
ChavarriaM, ArauzA, BarbozaM, PatinoM, BecerrilM. Scale
for severe dysphagia in lateral medullary stroke. Journal of the
Neurological Sciences 2015;357:e108.
Choi 2010 {published data only}
ChoiMG, SungHY, KimJS, ChoYK, ParkJM, LeeIS, et al.
Usefulness of dysphagia screening protocol including high
resolution manometry in acute cerebrovascular accident.
Gastroenterology 2010;138(5 Suppl 1):S346.
Chong 2003 {published data only}
ChongMS, LieuPK, SitohYY, MengYY, LeowLP. Bedside
clinical methods useful as screening test for aspiration in
elderly patients with recent and previous strokes. Annals of the
Academy of Medicine Singapore 2003;32(6):790-4.
Cichero 2009 {published data only}
CicheroJA, HeatonS, BassettL. Triaging dysphagia: nurse
screening for dysphagia in an acute hospital. Journal of Clinical
Nursing 2009;18(11):1649-59.
Clayton 2006 {published data only}
ClaytonJ, JackCIA, RyallC, TranJ, HilalE, GosneyM. Tracheal
pH monitoring and aspiration in acute stroke. Age and Ageing
2006;35(1):47-53.
Collins 1997 {published data only}
CollinsMJ, BakheitAMO. Does pulse oximetry reliably
detect aspiration in dysphagic stroke patients? Stroke
1997;28(9):1773-5.
Crary 2013 Study 1 {published data only}
CraryM, CarnabyG, SuraL, SiaI, RolonS, LevienE, et al.
Spontaneous swallow frequency identifies dysphagia in acute
stroke. Dysphagia 2013;28(4):612.
Crary 2013 Study 2 {published data only}
CraryM, Carnaby-MannG, SuraL, SiaI. Spontaneous swallow
frequency as a screening protocol for dysphagia in acute stroke.
Neurology 2013;80(1 Meeting Abstracts).
Crary 2014 Study 1 {published data only}
CraryM, CarnabyG. Multidisciplinary clinical rehabilitation
spontaneous swallow frequency and dysphagia/stroke related
outcomes in acute stroke. International Journal of Stroke
2014;9:220.
Crary 2014 Study 2 {published data only}
CraryMA, CarnabyGD, SiaI. Spontaneous swallow frequency
compared with clinical screening in the identification
of dysphagia in acute stroke. Journal of Stroke and
Cerebrovascular Diseases 2014;23(8):2047-53.
Daniels 2009 {published data only}
DanielsSK, SchroederMF, DeGeorgePC, CoreyDM, FoundasAL,
RosenbekJC. Defining and measuring dysphagia following
stroke. American Journal of Speech-Language Pathology
2009;18(1):74-81.
Davis-De Geus 2009 {published data only}
Davis-De GeusM. Using an evidence-based bedside swallow
screen for all stroke patients: how health care providers can
improve stroke patients' outcomes. Dysphagia 2009;24(4):463.
DePippo 1992 {published data only}
DePippoKL, HolasMA, RedingMJ. Validation of the 3-oz
water swallow test for aspiration following stroke. Archives of
Neurology 1992;49(12):1259-61.
Farneti 2015 {published data only}
FarnetiD, PrencipeRS, MontanoL, NicoliniL, GenoveseE.
Reliability of screening and bedside procedures in the
management of acute stroke patients in a community hospital.
Dysphagia 2015;30(5):626.
Giraldo-Cadavid 2015 {published data only}
Giraldo-CadavidLF, BurgueteJ, RuedaF, GalvisAM,
CastanedaN, ArbuluM, et al. Accuracy of the laryngeal adductor
reflex explored by a new laryngo-pharyngeal esthesiometer
during the fiberoptic endoscopic evaluation of swallowing.
American Journal of Respiratory and Critical Care Medicine
2015;191:A2123.
Guerra 2011 {published data only}
GuerraL, OttavianiC, Grazia ScucchiM, AmendolaL,
MacchiaoloS, CapecchiD, et al. Assessment of dysphagia in
acute stroke: analysis of degree of agreement between nurses.
L'Infermiere 2011;48(2):e9-13.
Guillén-Solà 2011 {published data only}
Guillén-SolàA, Martínez-OrfilaJ, GómezRB, CastellóSM,
MarcoE. Screening of swallowing disorders in stroke: utility
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
30
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
of clinical signs and clinical examination method of volume-
viscosity in comparison with videofluoroscopy. Rehabilitacion
2011;45(4):293-300.
Guillén-Solà 2013 {published data only}
Guillen-SolaA, MarcoE, Martinez-OrfilaJ, Donaire MejiasMF,
Depolo PassalacquaM, DuarteE, et al. Usefulness of the
volume-viscosity swallow test for screening dysphagia
in subacute stroke patients in rehabilitation income.
NeuroRehabilitation 2013;33(4):631-8.
Gurcay 2018 {published data only}
GurcayE, BahceciK, OzturkE, YilmazV, GundogduI,
CeylanT, et al. Validity and reliability of Turkish version of
the gugging swallowing screen test in the early period of
hemispheric stroke. Neurological Sciences and Neurophysiology
2018;35(1):6-13.
Higo 2003 {published data only}
HigoR, TayamaN, WatanabeT, NitoT. Pulse oximetry
monitoring for the evaluation of swallowing function. European
Archives of Oto-Rhino-Laryngology 2003;260(3):124-7.
Joundi 2017 {published data only}
JoundiRA, MartinoR, SaposnikG, GiannakeasV, JimingF,
KapralMK, et al. Predictors and outcomes of dysphagia
screening aer acute ischemic stroke. Stroke 2017;48(4):900-6.
Karaca 2018 {published data only}
Karaca UmayE, GundogduI, GurcayE, OzturkE, YilmazV,
KaraahmetO, et al. The psychometric evaluation of the Turkish
version of the Mann assessment of swallowing ability in
patients in the early period aer stroke. Turkish Journal of
Medical Sciences 2018;48(6):1153-61.
Logemann 1999 {published data only}
LogemannJA, VeisS, ColangeloL. A screening procedure for
oropharyngeal dysphagia. Dysphagia 1999;14(1):44-51.
Mandysova 2015 {published data only}
MandysovaP, EhlerE, SkvrnakovaJ, CernyM, BartovaI,
PellantA. Development of the Brief Bedside Dysphagia
Screening Test - Revised: a cross-sectional Czech study. Acta
Medica (Hradec Kralove) 2015;58:49-55.
Marques 2008 {published data only}
MarquesCHD, De RossoALZ, AndreC. Bedside assessment
of swallowing in stroke: water tests are not enough. Topics in
Stroke Rehabilitation 2008;15(4):378-83.
Martino 2009 Study 2 {published data only}
MartinoR, StreinerD, MakiE, DiamantN. A sensitivity analysis
to determine whether ten teaspoons of water are really
necessary. Dysphagia 2009;24(4):473.
Massey 2002 {published data only}
MasseyR, JedlickaD. The Massey Bedside Swallowing Screen.
Journal of Neuroscience Nursing 2002;34(5):252-60.
McCullough 2001 {published data only}
McCulloughGH, WertzRT, RosenbekJC. Sensitivity and
specificity of clinical/bedside examination signs for detecting
aspiration in adults subsequent to stroke. Journal of
Communication Disorders 2001;34(1-2):55-72.
McCullough 2005 {published data only}
McCulloughGH, RosenbekJC, WertzRT, McCoyS, MannG,
McCulloughK. Utility of clinical swallowing examination
measures for detecting aspiration post-stroke. Journal of
Speech, Language, and Hearing Research 2005;48(6):1280-93.
Moalli 2016 {published data only}
MoalliD, Dell'AngeloD, BedardL. CVAS: a rapid dysphagia
evaluation tool. Connecticut Medicine 2016;80(4):205-7.
Moon 2010 {published data only}
MoonKH, SohnHS, LeeES, PaekEK, KangEJ, LeeSH, et
al. Comparison for risk estimate of aspiration between the
revised dysphagia assessment tool and videofluoroscopy in
post-stroke patients. Journal of Korean Academy of Nursing
2010;40(3):359-66.
Mozzanica 2017 {published data only}
MozzanicaF, ScarponiL, PedraliS, PizzorniN, PinottiC, FoieniF,
et al. Dysphagia screening in subacute care settings using the
Italian version of the Royal Brisbane and Women's Hospital (I-
RBWH) dysphagia screening tool [Screening della disfagia nelle
unita di cure sub-acute utilizzando la versione italiana del Royal
Brisbane and Women's Hospital (I-RBWH) dysphagia screening
tool]. Acta Otorhinolaryngologica Italica 2017;37(1):25-31.
Murray 2011 {published data only}
MurrayJ, MilichA, OrmerodD. Screening for dysphagia.
Australian Nursing Journal 2011;18(11):44-6.
NCT00306501 {published data only}
NCT00306501. Volitional swallowing in stroke patients with
chronic dysphagia. https://clinicaltrials.gov/ct2/show/record/
NCT00306501 (first received 23 March 2006).
NCT00580138 {published data only}
NCT00580138. Real-time Internet evaluation of swallowing.
https://clinicaltrials.gov/ct2/show/NCT00580138 (first received
24 December 2007).
NCT01765673 {published data only}
NCT01765673. The Passy Muir Swallowing Self Training Device
(PMSST). https://clinicaltrials.gov/ct2/show/NCT01765673 (first
received 10 January 2013).
NCT02080988 {published data only}
NCT02080988. Reflexive coughing force in severe aspirators.
https://clinicaltrials.gov/ct2/show/NCT02080988 (first received
7 March 2014).
NCT02848664 {published data only}
NCT02848664. Use of the Passy Muir Swallowing Self Trainer.
https://clinicaltrials.gov/ct2/show/NCT02848664 (first received
28 July 2016).
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
31
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
NCT03167892 {published data only}
NCT03167892. Oral Screens in Post Stroke Training. https://
clinicaltrials.gov/ct2/show/NCT03167892 (first received 30 May
2017).
Nomura 2014 {published data only}
NomuraJT, PooleCL, BoyerBW, PapasMA, ThomasJ,
GregoreDR, et al. Customized swallow screening tool to exclude
aspiration pneumonia risk in acute stroke patients. Academic
Emergency Medicine 2014;21(5 Suppl 1):S257.
Oh 2016 {published data only}
OhJC, ParkJH, JungMY, YooEY, ChangKY, LeeTY. Relationship
between quantified instrumental swallowing examination and
comprehensive clinical swallowing examination. Occupational
Therapy International 2016;23(1):3-10.
Ohira 2013 {published data only}
OhiraM, IshidaR, MakiY, OkuboM, SugiyamaT, SakayoriT, et
al. Evaluation of swallowing ability using Mann assessment
of swallowing ability (MASA) of dependent elderly in Japan.
Dysphagia 2013;28(4):635.
Ohira 2017 {published data only}
OhiraM, IshidaR, MakiY, OhkuboM, SugiyamaT, SakayoriT,
SatoT. Evaluation of a dysphagia screening system based
on the Mann Assessment of Swallowing Ability for use in
dependent older adults. Geriatrics & Gerontology International
2017;17(4):561-7.
Osawa 2013 {published data only}
OsawaA, MaeshimaS, TanahashiN. Water-swallowing test:
screening for aspiration in stroke patients. Cerebrovascular
Diseases 2013;35(3):276-81.
Ostrofsky 2016 {published data only}
OstrofskyC, SeedatJ. The South African dysphagia screening
tool (SADS): a screening tool for a developing context. South
African Journal of Communication Disorders 2016;63(1):1-9.
Palli 2017 {published data only}
PalliC, FandlerS, DoppelhoferK, NiederkornK, EnzingerC,
VettaC, et al. Early dysphagia screening by trained nurses
reduces pneumonia rate in stroke patients: a clinical
intervention study. Stroke 2017;48(9):2583-5.
Pennsylvania Patient Safety Authority 2009 {published data
only}
Pennsylvania Patient Safety Authority. Does your admission
screening adequately predict aspiration risk? Pennsylvania
Patient Safety Authority 2009;6(4):115-21. [http://
patientsafety.pa.gov/ADVISORIES/Pages/200912_115.aspx]
Perry 2000 {published data only}
PerryL, McLarenSM. Dysphagia screening, assessment and
outcomes in stroke patients: Phase 1 of an evidence-based
practice project. Journal of Clinical Excellence 2000;1(4):201-8.
Perry 2001 Study 2 {published data only}
PerryL. Screening swallowing function of patients with acute
stroke. Part two: detailed evaluation of the tool used by nurses.
Journal of Clinical Nursing 2001;10(4):474-81.
Radhakrishnan 2013 {published data only}
RadhakrishnanS, MenonUK, AnandakuttanA. A combined
approach of bedside clinical examination and flexible
endoscopic evaluation of swallowing in poststroke dysphagia:
a pilot study. Annals of Indian Academy of Neurology
2013;16(3):388-93.
Rosenbek 2004 {published data only}
RosenbekJC, McCulloughGH, WertzRT. Is the information
about a test important? Applying the methods of evidence-
based medicine to the clinical examination of swallowing.
Journal of Communication Disorders 2004;37(5):437-50.
Sato 2012 {published data only}
SatoM, ToharaH, IidaT, WadaS, InoueM, UedaK. Simplified
cough test for screening silent aspiration. Archives of Physical
Medicine and Rehabilitation 2012;93(11):1982-6.
Schrock 2011 {published data only}
SchrockJW, BernsteinJ, GlasenappM, DrogellK, HannaJ. A
novel emergency department dysphagia screen for patients
presenting with acute stroke. Academic Emergency Medicine
2011;18(6):584-9.
Sellars 1998 {published data only}
SellarsC, DunnetC, CarterR. A preliminary comparison
of videofluoroscopy of swallow and pulse oximetry in the
identification of aspiration in dysphagic patients. Dysphagia
1998;13(2):82-6.
Smith Hammond 2009 {published data only}
Smith HammondCA, GoldsteinLB, HornerRD, YingJ, GrayL,
Gonzalez-RothiL, et al. Predicting aspiration in patients with
ischemic stroke: comparison of clinical signs and aerodynamic
measures of voluntary cough. Chest 2009;135(3):769-77.
Sohn 2018 {published data only}
SohnD, Park G-Y, KooHJ, JangYJ, HanY, ImS. Determining
peak cough flow cuto values to predict aspiration pneumonia
among patients with dysphagia using the Citric Acid Reflexive
Cough Test. Archives of Physical Medicine & Rehabilitation
2018;99(12):2532-9.
Soria 2013 {published data only}
SoriaF, FurkimAM, NunesMC, PintoG, LangeM, ZetolaV.
Identification risk of aspiration pneumonia in two groups of
patients with stroke. Dysphagia 2013;28(2):325-6.
Stroke and Chewing 2012 {published data only}
Stroke and chewing. Dental Abstracts 2012;57(3):165.
Sung 2018 {published data only}
SungHY, LeeKS, ChoiMG, KimJS. Dysphagia screening using
high-resolution impedance manometry in acute stroke.
International Journal of Gerontology 2018;12(2):110-5.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
32
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Sørensen 2013 {published data only}
SørensenRT, RasmussenRS, OvergaardK, LercheA,
JohansenAM, LindhardtT. Dysphagia screening and intensified
oral hygiene reduce pneumonia aer stroke. Journal of
Neuroscience Nursing 2013;45(3):139-46.
Tanuma 2002 {published data only}
TanumaS, SudoE, TakahashiY, YoshidaA, KobayashiC,
OhamaY. The usefulness of the water swallowing test and
videofluorography in swallowing rehabilitation in patients with
cerebrovascular disease. Nippon Ronen Igakkai Zasshi Japanese
Journal of Geriatrics 2002;39(4):427-32.
Teramoto 2000 {published data only}
TeramotoS, FukuchiY. Detection of aspiration and swallowing
disorder in older stroke patients: simple swallowing
provocation test versus water swallowing test. Archives of
Physical Medicine and Rehabilitation 2000;81(11):1517-9.
Toscano 2019 {published data only}
ToscanoM, ViganoA, ReaA, VerzinaA, Sasso D'EliaT, PuleddaF,
et al. Sapienza Global Bedside Evaluation of Swallowing aer
Stroke: the GLOBE-3S study. European Journal of Neurology
2019;26(4):596-602.
Tuncay 2011 {published data only}
TuncayF, Tasbas Ö, BormanP, GeçeneM, Coskun Ö. The
bedside clinical evaluation of swallowing function of stroke
patients in acute stage. Journal of Physical Medicine &
Rehabilitation Sciences 2011;14(2):33-8.
Umay 2013 {published data only}
UmayE, UnluE, KilicG, CakciA, KorkmazH. Evaluation of
dysphagia in early period stroke patients by bedside screening
test, endoscopic and electrophysiological methods. Dysphagia
2013;28(3):395-403.
Virvidaki 2019 {published data only}
VirvidakiIE, GiannopoulosS, NasiosG, DimakopoulosG,
MichouE, MilionisH. Predictive value of a novel pragmatic
tool for post-stroke aspiration risk: the Functional Bedside
Aspiration Screen. Neurogastroenterology and Motility
2019;31(10):e13683.
Warnecke 2017 {published data only}
WarneckeT, ImS, KaiserC, HamacherC, OelenbergS,
DziewasR. Aspiration and dysphagia screening in acute stroke
- the Gugging Swallowing Screen revisited. European Journal of
Neurology 2017;24(4):594-601.
Weinhardt 2008 {published data only}
WeinhardtJ, HazelettS, BarrettD, LadaR, EnosT, KelemanR.
Accuracy of a bedside dysphagia screening: a comparison of
registered nurses and speech therapists. Rehabilitation Nursing
2008;33(6):247-52.
Ye 2018 {published data only}
YeT, HuangSY, DongY, DongQ. Bedside modified volume-
viscosity swallow test might be reliably to predict risk of
aspiration pneumonia aer stroke. Stroke 2019;50 Suppl
1:AWP479.
Yeh 2011 {published data only}
YehSJ, HuangKY, WangTG, ChenYC, ChenCH, TangSC, et al.
Dysphagia screening decreases pneumonia in acute stroke
patients admitted to the stroke intensive care unit. Journal of
the Neurological Sciences 2011;306(1-2):38-41.
Zhang 2004 {published data only}
ZhangJ, WangYJ, CuiT. Reliability and validity of nine rating
scales for dysphagia following stroke. Chinese Journal of Clinical
Rehabilitation 2004;8(7):1201-3.
Additional references
Almeida 2015
AlmeidaTM, ColaPC, PernambucoLA, Magalhaes HV Jr,
SilvaRG. Screening tools for oropharyngeal dysphagia in stroke.
Audiology - Communication Research 2015;20(4):361-70.
Avan 2019
AvanA, DigalehH, Di NapoliM, StrangesS, BehrouzR,
ShojaeianbabaeiG, et al. Socioeconomic status and stroke
incidence, prevalence, mortality, and worldwide burden: an
ecological analysis from the Global Burden of Disease Study.
BMC Medicine 2019;17(191). [DOI: 10.1186/s12916-019-1397-3]
Benfield 2020
BenfieldJK, EvertonLF, BathPM, EnglandTJ. Accuracy
and clinical utility of comprehensive dysphagia screening
assessments in acute stroke: a systematic review and meta-
analysis. Journal of Clinical Nursing 2020;29(9-10):1527-38. [DOI:
10.1111/jocn.15192]
Blitzer 1988
BlitzerA, KrespiYP, OppenheimerRW, LevineTM. Surgical
management of aspiration. Otolaryngologic Clinics of North
America 1988;4:743–50.
Boaden 2011
BoadenEE. Improving the identification and management of
aspiration aer stroke [Doctoral thesis]. University of Central
Lancashire 2011.
Bray 2016
BrayBD, SmithCJ, CloudGC, EnderbyP, JamesM, PaleyL, et al.
The association between delays in screening for and assessing
dysphagia aer acute stroke, and the risk of stroke-associated
pneumonia. Journal of Neurology, Neurosurgery and Psychiatry
2017;88(1):25-30.
Brodsky 2016
BrodskyMB, SuiterDM, Gonzalez-FernandezM, MichtalikHJ,
FrymarkTB, VenediktovR, et al. Screening accuracy for
aspiration using bedside water swallow tests: a systematic
review and meta-analysis. Chest 2016;150(1):148-63.
CADTH 2018
CADTH. Grey matters: a practical tool for searching health-
related grey literature [Internet]. Available from https://
www.cadth.ca/resources/finding-evidence 2018.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
33
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Chen 2016
ChenPC, ChuangCH, LeongCP, GuoSE, HsinYJ. Systematic
review and meta-analysis of the diagnostic accuracy of the
water swallow test for screening aspiration in stroke patients.
Journal of Advanced Nursing 2016;72(11):2575-86. [DOI:
10.1111/jan.13013]
Daniels 2012
DanielsSK, AndersonJA, WillsonPC. Valid items for screening
dysphagia risk in patients with stroke. Stroke 2012;43(3):892-7.
Donovan 2013
DonovanNJ, DanielsSK, EdmiastonJ, WeinhardtJ, SummersD,
MitchellPH. Dysphagia screening: state of the art: invitational
conference proceeding from the State-of-the-Art Nursing
Symposium, International Stroke Conference 2012. Stroke
2013;44(4):e24-31.
European Stroke Organisation 2015
European Stroke Organisation. The European Stroke
Organisation Guidelines: a standard operating procedure.
International Journal of Stroke 2015;10(SA100):128-35. [DOI:
10.1111/ijs.12583]
Gupta 2016
GuptaD, HullML, FraserI, MillerL, BossuytPMM,
JohnsonN, et al. Endometrial biomarkers for the non-
invasive diagnosis ofendometriosis. Cochrane Database of
Systematic Reviews 2016, Issue 4. Art. No: CD012165. [DOI:
10.1002/14651858.CD012165]
Intercollegiate Stroke Working Party 2012
Intercollegiate Stroke Working Party. National Sentinel Stroke
Clinical Audit 2010. Royal College of Physicians, 2012.
Intercollegiate Stroke Working Party 2016
Intercollegiate Stroke Working Party. Intercollegiate Stroke
Working Party National Clinical Guideline for Stroke. 5th
edition. London: Royal College of Physicians, 2016.
International Dysphagia Diet Std Initiative 2017
International Dysphagia Diet Standardisation Initiative.
Complete IDDSI Framework Detailed definitions. 2017. https://
iddsi.org/framework/. [http://iddsi.org/framework/]
Jiang 2016
JiangJL, FuSY, WangWH, MaYC. Validity and reliability of
swallowing screening tools used by nurses for dysphagia: a
systematic review. Ci Ji Yi Xue Za Zhi 2016;28(2):41-8. [DOI:
10.1016/j.tcmj.2016.04.006]
Johnson 2019
JohnsonCO, NguyenM, RothGA, NicholsE, AlamT, AbateD, et
al. Global, regional, and national burden of stroke, 1990–2016:
a systematic analysis for the Global Burden of Disease Study
2016. Lancet Neurology 2019;18(5):439-58.
Katan 2018
KatanM, LuA. Global burden of stroke. Seminars in Neurology
2018;38(2):208-11.
Kumar 2010
KumarS, SelimMH, CaplanLR. Medical complications aer
stroke. Lancet Neurology 2010;9:105-18.
Martino 2005
MartinoR, FoleyN, BhogalS, DiamantN, SpeechleyM, TeasellR.
Dysphagia aer stroke: incidence, diagnosis, and pulmonary
complications. Stroke 2005;36(12):2756-63.
National Stroke Foundation 2010
National Stroke Foundation. Clinical guidelines for stroke
management, 2010. https://extranet.who.int/ncdccs/
Data/AUS_D1_Clinical%20Guidelines%20for%20Stroke
%20Management.pdf.
O'Horo 2015
O’HoroJC, Rogus-PuliaN, Garcia-ArguelloL, RobbinsJ,
SafdarN. Bedside diagnosis of dysphagia: a systematic review.
Journal of Hospital Medicine 2015;10(4):256-65.
Oliveira 2001
OliveiraI, MotaL, FreitasS, FerreiraP. Dysphagia screening
tools for acute stroke patients available for nurses: a systematic
review. Nursing Practice Today 2019;6(3):103-15. [DOI: 10.18502/
npt.v6i3.1253]
Powers 2019
PowersWJ, RabinsteinAA, AckersonT, AdeoyeOM,
BambakidisNC, BeckerK, et al, on behalf of the American
Heart Association Stroke Council. Guidelines for the early
management of patients with acute ischemic stroke: 2019
update to the 2018 guidelines for the early management of
acute ischemic stroke: a guideline for healthcare professionals
from the American Heart Association/American Stroke
Association. Stroke 2019;50:e344–e418. [DOI: 10.1161/
STR.0000000000000211]
Review Manager 2014 [Computer program]
The Nordic Cochrane Centre, the Cochrane Collaboration
Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The
Nordic Cochrane Centre, the Cochrane Collaboration, 2014.
Rofes 2011
RofesL, ArreolaV, AlmirallJ. Diagnosis and management of
oropharyngeal dysphagia and its nutritional and respiratory
complications in the elderly. Gastroenterology Research and
Practice 2011;2011:13.
Schepp 2012
ScheppK, TirschwellDL, MillerRM, Longstreth WT Jr.
Swallowing screens aer acute stroke: a systematic review.
Stroke 2012;43(3):869-71.
Teasell 2019
TeasellR, SalbachNM, AcerraN, BastasiD, CarterSL, FungJ,
et al, on behalf of the Rehabilitation and Recovery following
Stroke Writing Group. Assessment and Management of
Dysphagia and Malnutrition following Stroke. In Lindsay MP,
Mountain A, Gubitz G, Dowlatshahi D, Casaubon L, de Jong
A, Smith EE (Editors); on behalf of the Canadian Stroke Best
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
34
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Practices Advisory Committee. Canadian Stroke Best Practice
Recommendations 2019:71-5.
WHF 2016
World Heart Federation. The global burden of stroke, 2016.
www.world-heart-federation.org/cardiovascular-health/stroke/.
References to other published versions of this review
Boaden 2017
BoadenE, DoranD, BurnellJ, CleggA, DeyP, HurleyM, et al.
Screening for aspiration risk associated with dysphagia in acute
stroke. Cochrane Database of Systematic Reviews 2017, Issue 6.
Art. No: CD012679. [DOI: 10.1002/14651858.CD012679]
C H A R A C T E R I S T I C S  O F  S T U D I E S
Characteristics of included studies [ordered by study ID]
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: AIS, diagnosed clinically by a neurologist; radi-
ographic (CT or MRI) confirmation of AIS
Exclusion criteria: unresolved dysphagia before stroke; history of
head/neck surgery or trauma that may impact swallowing ability;
any other concomitant neurological disorder that could impact
oropharyngeal swallowing ability
Setting: 1 × tertiary care academic medical centre with a certified
comprehensive stroke centre
Index tests Modified MASA (MMASA)
Target condition and reference standard(s) Dysphagia
MASA
Flow and timing All patients received the index test(s) and reference standard. All
patients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests ≤ 4 hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Antonios 2010
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
35
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? No
Could the conduct or interpretation of the index test have
introduced bias?
High risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Antonios 2010(Continued)
Study characteristics
Patient Sampling All patients were admitted under a standard stroke protocol
Patient characteristics and setting Inclusion criteria: patients admitted to a comprehensive stroke
centre
Exclusion criteria: unclear
Setting: 1 × hospital designated comprehensive stroke centre
Behera 2018
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
36
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Index tests The DePaul Hospital Swallow Screening tool includes a combina-
tion of non-swallow and swallow items. The 8 non-swallow items
(including tests of alertness, presence of a feeding tube, presence
of a tracheostomy tube, presence of drooling, facial asymmetry,
abnormal tongue movement, abnormal vocal quality, and abnor-
mal voluntary cough) are scored, and if patients pass (score ≤ 5),
they progresses onto the 3 oz WST. If patients fail the non-swal-
low items (score ≥ 6), or if they fail the WST (clinical signs of aspira-
tion), they are kept nil by mouth
Target condition and reference standard(s) Two analyses: dysphagia and aspiration risk
MASA
Flow and timing 374 were admitted to the stroke unit; 225 received the DHSS Index
test. The reason for the drop in numbers is not reported. 224 re-
ceived at least 1 MASA assessment 2 × 2 table is reported for 224
patients
Interventions between index/reference tests: not reported
Interval between index and reference tests: not reported
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  Unclear
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Behera 2018(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
37
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Unclear risk
Behera 2018(Continued)
Study characteristics
Patient Sampling Patients who had received at least 1 Index test plus the reference
test
Patient characteristics and setting Inclusion criteria: discharge diagnosis with ischaemic stroke (ICD9
434.X and 436)
Exclusion criteria: none recorded
Setting: 1 × tertiary care - Department of Veterans Affairs Medical
Centre
Index tests Nurse Screening Tool applied during admission process. NIHSS
applied retrospectively
Target condition and reference standard(s) Dysphagia
SLP: expert assessment
Flow and timing Flow is not possible to report. Study reported only on those who
had at least 1 Index test + the reference test
Timing not reported. In fact, study authors list possible time differ-
ences as a limitation
Comparative 
Notes QUADAS-2 is different for each index test. Stroke Severity NIHSS
(test2) reported here, as it is the 'worst', compared to the Nurse
Screening Tool (test1)
Bravata 2009
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
38
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Unclear 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? High risk
Bravata 2009(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
39
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study characteristics
Patient Sampling Convenience sample
Patient characteristics and setting Inclusion criteria: diagnosis of stroke or TIA; admitted between
8:30am and 4:30pm; no change in initial NIHSS score between
screening by the nurse and evaluation by the speech pathologist
Exclusion criteria: non-stroke and non-TIA admissions; stroke
and TIA admissions after 4:30pm; NIHSS score change from initial
screening by the nurse, and subsequent evaluation performed by
speech pathologist
Setting: 1 × neuroscience unit - part of a Joint Commission Disease
Specific certified stroke centre
Index tests NBDS
Target condition and reference standard(s) Dysphagia
SLP: expert assessment
Flow and timing 3 patients not screened by Nurse 2
Interventions between index/reference tests: not reported
Interval between index and reference tests: < 1 hour
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  High
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Campbell 2016
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
40
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Unclear risk
Campbell 2016(Continued)
Study characteristics
Patient Sampling Convenience sample
Patient characteristics and setting Inclusion criteria: medical diagnosis of stroke; age 18 or older;
ability to follow commands
Exclusion criteria: individuals who were NPO for any reason other
than swallowing problems; history of previous swallowing prob-
lems; mechanical ventilation and/or intubation longer than 24
hours during current admission; inability to follow commands
Setting: 2 × hospital - 20-bed medical neurology unit and 9-bed
neurology intermediate care unit
Index tests Nurse dysphagia screen
Target condition and reference standard(s) Dysphagia
Dysphagia evaluation by SLP
Flow and timing All patients received index test(s) and reference standard. All pa-
tients were included in 2 × 2 table
Interventions between index/reference tests: not reported
Cummings 2015
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
41
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Index to reference tests interval: ≤ 2 hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  High
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? No
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
  Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Cummings 2015(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
42
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Cummings 2015(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: new neurological deficit; stroke confirmed by
documentation of acute infarct by CT or MRI scan
Exclusion criteria: obtunded and agitated patients; those with pri-
or history of oropharyngeal dysphagia, oropharyngeal structural
damage, or neurological disease other than stroke that may pro-
duce dysphagia
Setting: 1 × Veterans Affairs Medical Center in New Orleans
Index tests Oropharyngeal assessment to include clinical swallowing assess-
ment
Target condition and reference standard(s) Dysphagia severity or risk of aspiration
VSS
Flow and timing All patients received index test(s) and reference standard. All pa-
tients included in 2 × 2 table apparently, but numbers do not real-
ly add up
Interventions between index/reference tests: not reported
Average time between test: 48 hours
Comparative 
Notes Flow and timing high risk due to 48-hour average time gap
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Daniels 1997
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
43
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Unclear
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
  Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
No 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? High risk
Daniels 1997(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: suspected stroke
Exclusion criteria: non-stroke neurological disease; head/neck
structural changes; dysphagia unrelated to stroke; TIA/stroke
ruled out; not competent/no legally authorised representative;
medically unstable; repeat stroke; previously participated in the
study; > 3 weeks from symptom onset; > 5 days from admission;
childbearing potential female; deceased
Setting: 1 × Michael E DeBakey Veterans Affairs Medical Center –
comprehensive stroke centre
Index tests RAS3 and WST from RAS3
Target condition and reference standard(s) Aspiration in patients with suspected stroke
Daniels 2016
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
44
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
VFSS
Flow and timing 8 patients who received the index test were not reported on. Rea-
sons for no VFSS included C-spine surgery evident on X-ray (n = 1)
and no oral intake before surgery (n = 1)
Reasons for exclusion from VFSS analyses included dysphagia his-
tory prior to stroke (n = 2), equipment failure (n = 1), and C-spine
damage (n = 3)
Interventions between index/reference tests: not reported
Index to reference test time interval within 2 hours of screening;
mean (SD) 0.49 (0.24) hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Daniels 2016(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
45
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? Low risk
Daniels 2016(Continued)
Study characteristics
Patient Sampling Not recorded
Patient characteristics and setting Inclusion criteria: admitted to stroke service
Exclusion criteria: none recorded
Setting: 1 × Stroke Service at Barnes-Jewish Hospital, Washington
University Medical Centre
Index tests ASDS
Target condition and reference standard(s) Aspiration risk and dysphagia
MASA
Flow and timing All patients received index test(s) and reference standard. All pa-
tients included in 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests: approximately 24 hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Edmiaston 2010
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
46
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Unclear 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Unclear risk
Edmiaston 2010(Continued)
Study characteristics
Patient Sampling Acute stroke patients prospectively enrolled from Barnes-Jewish
Hospital inpatient stroke service (p2)
Patient characteristics and setting Inclusion criteria: clinical diagnosis of stroke (ischaemic or haem-
orrhagic); age ≥ 18 years
Exclusion criteria: decreased level of alertness preventing partic-
ipation in VFSS (defined as a score of 2 on the 'Alertness' compo-
nent of the MASA); physical limitations preventing ability to sit up-
Edmiaston 2014
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
47
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
right (excluding intubation, or if treating physician had ordered
the patient to have the head of the bed flat); confirmed or suspect-
ed pregnancy
Setting: 1 × Barnes-Jewish Hospital inpatient stroke service (ur-
ban, tertiary care referral centre admitting 1300 stroke patients
annually)
Index tests BJH-SDS
Target condition and reference standard(s) Dysphagia and aspiration
VFSS
Flow and timing Study included 2 tests: 1 for dysphagia and 1 for aspiration. For
the dysphagia test, all patients received the reference test; for the
aspiration test, 2 patients were excluded and did not receive the
reference test
Interventions between index/reference tests: not reported
Interval between index and reference test: 0 to 8 hours (mean in-
terval 2 hours)
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
Edmiaston 2014(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
48
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Low risk
Edmiaston 2014(Continued)
Study characteristics
Patient Sampling Not recorded
Patient characteristics and setting Inclusion criteria: patient suffered stroke or TIA
Exclusion criteria: not recorded
Setting: 1 × small community hospital - certified primary stroke
centre
Index tests Ellis Nursing Bedside Swallowing Screen
Target condition and reference standard(s) Dysphagia
Complete dysphagia evaluation by SLT
Flow and timing 53 participants were included, baseline data for 49 participants
are given, and 46 participants received both screening tests. Out-
line data are provided for patients who were excluded or with-
drawn; however numbers do not necessarily specify the difference
between original sample and those receiving the tests
Interventions between index/reference tests: not reported
Interval between tests: not reported
Comparative 
Notes 
Ellis 2013
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
49
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  Unclear
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Unclear 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
No 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
High risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
  Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Unclear
Were all patients included in the analysis? No
Could the patient flow have introduced bias? High risk
Ellis 2013(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
50
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study characteristics
Patient Sampling Unclear
Patient characteristics and setting Inclusion criteria: diagnosis of acute stroke based on clinical and MRI
results; aged > 18 years; normal cognitive function (Mini-Mental Test
Score > 24 points)
Exclusion criteria: presence of previous stroke; neurodegenerative or
muscular disease history potentially associated with swallowing disor-
der; malignancy; history of surgery in the head and neck region; bilat-
eral cranial infarction; psychiatric disorder; presence of infectious dis-
ease such as HIV, hepatitis B or C, decompensated heart failure, and
nasal obstruction (exclusion criteria for FEES)
Setting: 1 × neurology department
Index tests Turkish version of BJH-SDS consists of 5 items, each with 2 choices
(i.e. present = yes, absent = no). The first 4 items assess conscious-
ness and asymmetry or weakness in facial, tongue, and palatal mus-
cles. Level of consciousness is assessed by the Glasgow Coma Scale,
and presence of dysarthria is identified together with the use of other
items. The fih item consists of the 3-oz water test, and the abnormal-
ity was defined as coughing, choking, or breathlessness while swal-
lowing, or wet/gurgled voice after swallowing. The screening tool is a
pass/fail
Target condition and reference standard(s) Dysphagia
FEES
Flow and timing It is not clear whether the same number of patients received index and
reference tests
2 × 2 table: not reported
Interventions between index/reference test: not reported
Interval between tests: ≤ 24 hours
Comparative 
Notes 
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Eren 2019
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
51
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Are there concerns that the included patients and set-
ting do not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge
of the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test
have introduced bias?
Low risk
Are there concerns that the index test, its conduct, or in-
terpretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the tar-
get condition?
Yes 
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its inter-
pretation have introduced bias?
Low risk
Are there concerns that the target condition as defined
by the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Unclear risk
Eren 2019(Continued)
Study characteristics
Patient Sampling Convenience sample
Patient characteristics and setting Inclusion criteria: none recorded
Exclusion criteria: none recorded
Setting: 1 × admitted to the stroke team
Index tests Registerd Dietician Dysphagia Screening Tool
Target condition and reference standard(s) Dysphagia risk
Huhmann 2004
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
52
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
SLT bedside swallow assessment
Flow and timing All patients received index test(s) and reference standard. All pa-
tients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests: not reported
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? High risk
Are there concerns that the included patients and setting do
not match the review question?
  High
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Unclear
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
  High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Huhmann 2004(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
53
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? High risk
Huhmann 2004(Continued)
Study characteristics
Patient Sampling Unclear
Patient characteristics and setting Regional non-critical care stroke unit. Patient inclusion and exclu-
sion criteria not reported
Index tests EHMBAS followed by simple WST; interpretation not reported
Target condition and reference standard(s) MASA
Flow and timing All patients received the index test(s) and reference standard. All
patients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests: not reported
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  Unclear
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
Huhn-Matesic 2015
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
54
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
If a threshold was used, was it pre-specified? Unclear
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
  Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Unclear risk
Huhn-Matesic 2015(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: diagnosis of stroke, clinical diagnosis from a neurologist,
radiographic (CT or MRI) confirmation of stroke
Exclusion criteria: history of head/neck surgery, trauma; brain tumour that
could influence swallowing abilities; any other concomitant neurological
disorder that could influence oropharyngeal swallowing ability
Setting: 1 × neurology unit
Index tests The 8-item Chinese version of the modified Standardized Swallowing As-
sessment instrument is divided into 2 parts. In part 1, patients must (1) vol-
untarily cough, (2) control saliva, (3) lick top and bottom lips, (4) breathe
freely, and (5) cannot have a wet or hoarse voice. In part 2 (items 6 to 8), pa-
tients are first given 1 mL of water. Problems are identified if no attempts
are made to swallow or water leaks straight out of the mouth, if coughing,
choking, or breathlessness is observed, or if a wet/gurgly voice develops. In
the absence of any problems, the process is repeated with second and third
tests with 1 mL of water. Gradually, increasing volumes ranging from 1 to 10
mL sequential swallowing are used based on patient tolerance. If no prob-
Jiang 2019
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
55
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
lems are evident, half a glass of water (75 mL) is administered. The screen-
ing instrument is a pass vs fail procedure
The 6-item Chinese version of the modified Standardized Swallowing As-
sessment includes the following items from the 8-item instrument: items 1,
3, and 5 of the oromotor examinations, and items 6, 7, and 8 of the WST
Target condition and reference standard(s) Dysphagia
SLP expert assessment
Flow and timing All patients received both index and reference tests. All patients were in-
cluded in the analysis
Interventions between index/reference tests: none reported
Interval between tests: ≤ 48 hours
Comparative 
Notes 
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients en-
rolled?
Yes 
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced
bias?
Low risk
Are there concerns that the included patients and
setting do not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowl-
edge of the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? No
Could the conduct or interpretation of the index
test have introduced bias?
Unclear risk
Are there concerns that the index test, its conduct,
or interpretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify
the target condition?
Yes 
Jiang 2019(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
56
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Were the reference standard results interpreted with-
out knowledge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its in-
terpretation have introduced bias?
Unclear risk
Are there concerns that the target condition as de-
fined by the reference standard does not match the
question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test
and reference standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Jiang 2019(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: acute stroke patients admitted to stroke unit of
Tan Tock Seng Hospital
Exclusion criteria: severe peripheral vascular disease; conscious-
ness level not sufficient to give informed consent; no CT evidence
of stroke or no significant neurological deficit (e.g. new hemiple-
gia) lasting > 24 hours; insufficient lip seal to retain 10 mL of water
in the mouth
Setting: 1 × stroke unit
Index tests WST and bedside aspiration (combined WST and oxygen satura-
tion test)
Target condition and reference standard(s) Aspiration
FEES
Flow and timing Patient flow is unclear - 58 patients were eligible, 50 patients re-
ceived reference and index tests, 8 patients subsequently declined
FEES
Interventions between index/reference tests: not reported
Time interval between tests: < 24 hours for 45 patients; < 48 hours
for 5 people due to 'technical issues'
Comparative 
Notes 
Methodological quality
Lim 2001
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
57
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Lim 2001(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
58
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study characteristics
Patient Sampling Consecutive. However 1 in 5 patients receiving a negative screen and
all receiving a positive screen on the index test received the refer-
ence test
Patient characteristics and setting Inclusion criteria: newly admitted to hospital; confirmed diagnosis of
brain stem stroke or cerebellar stroke and all other stroke types with
NIHSS score ≥ 4; stroke confirmed from physician’s clinical note, CT
scan or MRI
Exclusion criteria: non-brain stem and non-cerebellar stroke patients
with low NIHSS scores; patients with current respiratory compro-
mise; a non-oral feeding regime; history of non-stroke neurological
disorder; surgery to the head or neck; history of previous oropharyn-
geal dysphagia, dementia, or decreased level of consciousness; not
alert; cannot be supported to sit upright; cannot follow simple in-
structions
Setting: 2 acute settings will be used for analysis, originally 4. Inpa-
tient stroke units at 2 acute (used in data extract) and 2 rehabilitation
tertiary care hospitals (not used in data extract) in southern Ontario
Index tests TOR-BSST
Target condition and reference standard(s) Dysphagia risk
Videofluoroscopic assessment of swallowing
Flow and timing Of the 311 patients recruited, only 103 were from an acute setting,
and of these only 24 received both tests. Remaining patients were
therefore excluded from the analysis
Interventions between index/reference tests: not reported
Interval between tests ≤ 24 hours
Comparative 
Notes 
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting
do not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Martino 2009 Study 1
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
59
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or in-
terpretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the tar-
get condition?
Yes 
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpre-
tation have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and
reference standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? Low risk
Martino 2009 Study 1(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: eligible and consented stroke patients in the
original study
Exclusion criteria: not reported
Setting: 2 × acute and 2 × rehabilitation facilities
Index tests TOR-BSST
Target condition and reference standard(s) Dysphagia
VFSS
Martino 2014
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
60
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Flow and timing All patients recruited received both index and reference tests. All
patients were included in the analysis, but no 2 × 2 table was re-
ported
Interventions between index/reference tests: none reported
Interval between tests < 24 hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Martino 2014(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
61
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Martino 2014(Continued)
Study characteristics
Patient Sampling Acute stroke patients admitted to the unit
Patient characteristics and setting Inclusion criteria: acute stroke patients on the units
Exclusion criteria: history of swallowing dysfunction or neurological dis-
ease that might lead to swallowing dysfunction; medical compromise
barring transport to fluoroscopy; insufficient level of alertness to follow
directions during VFSS as determined by the care team
Setting: 1 × neuroscience critical and acute care units of a tertiary care fa-
cility
Index tests The Johns Hopkins Hospital Brain Rescue Unit Modified 3 oz Swallow
Screen is based on the 3-oz water swallow test by DePippo 1992. The
screen consists of 3 steps: (1) medical history and status; (2) 1 tsp water
swallow with palpation for hyolaryngeal excursion and observation for
signs of aspiration; (3) 3 oz water swallow with palpation for hyolaryn-
geal excursion and observation for signs of aspiration. Observation for
signs of aspiration is continuous during and up to 1 minute after each
water trial. Wet vocal quality is assessed objectively during the vocalisa-
tion trial by trained nurses. Each step is administered sequentially, and
failure of 1 step results in discontinuation and failure of the entire screen
(positive aspiration risk) with nil-by-mouth status and referral to speech
and language pathology for bedside evaluation
Target condition and reference standard(s) Dysphagia
VFSS
Flow and timing All patients recruited received both index and reference tests. All patients
were included in the analysis
Interventions between index/reference tests: none reported
Interval between tests < 72 hours
Comparative 
Notes 
Methodological quality
Item Authors' judgement Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Mulheren 2019
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
62
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Was a consecutive or random sample of patients en-
rolled?
Unclear 
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and set-
ting do not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowl-
edge of the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test
have introduced bias?
Low risk
Are there concerns that the index test, its conduct, or
interpretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the
target condition?
Yes 
Were the reference standard results interpreted without
knowledge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its inter-
pretation have introduced bias?
Low risk
Are there concerns that the target condition as de-
fined by the reference standard does not match the
question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test
and reference standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Mulheren 2019(Continued)
Study characteristics
Nishiwaki 2005
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
63
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Patient Sampling Consecutive patients
Patient characteristics and setting Inclusion criteria: stroke was diagnosed with CT or MRI. Patients
presented with ≥ 1 of the following: (1) bilateral or brain stem
stroke; (2) history of aspiration pneumonia or increased sputum
secretion; (3) cough associated with feeding and/or drinking; (4)
weight loss, decreased oral intake, or prolonged feeding times; (5)
complaint of difficulty in swallowing; (6) need for a therapeutic di-
et or non-oral feeding
Exclusion criteria: patients who could not follow commands, who
had a tracheostomy, who had a prior history of oropharyngeal im-
pairment, or who had active respiratory infection
Setting: 5 × university hospital and affiliated hospitals
Index tests Clinical swallowing tests: 6 oromotor examinations
Target condition and reference standard(s) Aspiration
VFSS
Flow and timing All patients recruited received both index and reference tests. All
patients were included in the analysis
Interventions between index/reference tests: none reported
Interval between tests < 7 days, but < 24 hours for acute patients
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
  High
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Unclear 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Nishiwaki 2005(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
64
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
  Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
No 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? High risk
Nishiwaki 2005(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: admissions with a clinical diagnosis of acute
stroke (ICD 10 codes 160-164, with or without CT confirmation)
Exclusion criteria: none recorded
Setting: 1 × study wards of Mayday University Hospital (all wards
that normally care for stroke patients with the exception of 2
female care of the elderly wards where another project was in
progress)
Index tests Standardized Swallowing Assessment tool (test 1)
Standardized Swallowing Assessment tool (test 2) (subset of test
1)
Gag reflex (test 3) (subset of test 4)
Gag reflex data from the 20-month audit period used (test 4)
Target condition and reference standard(s) Dysphagia
Summative clinical judgement - used VFS when requested by SLT
to clarify decision
Perry 2001 Study 1
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
65
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Flow and timing Flow of patients is unclear from the paper. Although participants
are discussed in the paper, results are presented as episodes. The
results also include repeat screenings for participants; partici-
pants are excluded after recruitment and are not included in the
analysis
Interventions between index/reference tests: not reported
Interval between tests: not reported
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Unclear 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Perry 2001 Study 1(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
66
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Did all patients receive the same reference standard? No
Were all patients included in the analysis? No
Could the patient flow have introduced bias? High risk
Perry 2001 Study 1(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: acute haemorrhagic or infarctive stroke; stroke
confirmed by CT scan; age 18 to 90 years
Exclusion criteria: impaired consciousness level; cognitive impair-
ment or receptive dysphasia sufficient to prevent informed con-
sent; inability to sit upright without minimal support; current low-
er respiratory infection; additional neurological condition; termi-
nal illness; any medical condition that precluded VF
Setting: 2 × university teaching hospitals in Manchester
Index tests Smith Bedside Swallowing, pulse oximetry (Minolta Pulsox 7), or
both
Target condition and reference standard(s) Aspiration and penetration
VF
Flow and timing All patients received the index test(s) and the reference standard.
All patients were included in the 2 × 2 table, but for tests 1 and 5,
the 2 × 2 was recovered in the RevMan calculator. This gave test 5
with N = 52, 1 patient missing
Interventions between index/reference tests: not reported
Interval between tests ≤ 24 hours (all tests carried out on the same
day)
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Smith 2000
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
67
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Unclear
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Smith 2000(Continued)
Study characteristics
Patient Sampling Consecutive
Trapl 2007
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
68
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Patient characteristics and setting Inclusion criteria: patients with first-ever acute stroke and sus-
pected dysphagia; admitted to the acute stroke unit on weekdays
between Monday and Thursday
Exclusion criteria: multiple infarcts visible on CT or MRI scan; dys-
phagia of other known cause; somnolence or coma within 24
hours
Setting: 1 × acute stroke unit
Index tests GUSS
Target condition and reference standard(s) Aspiration
FEES
Flow and timing In group 1, 1 patient refused FEES (reference test) and so was not
included in the 2 × 2 table
In group 2, all patients received the index test(s) and the reference
standard. All patients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests < 24 hours
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
Trapl 2007(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
69
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? No
Could the patient flow have introduced bias? Low risk
Trapl 2007(Continued)
Study characteristics
Patient Sampling Convenience sample
Patient characteristics and setting Inclusion criteria: presumptive stroke diagnosis; age ≥ 18 years;
presenting to the emergency department within 24 hours of symp-
tom onset; Glasgow Coma Scale score > 12; hospital admission
Exclusion criteria: non-stroke diagnosis (based on admitting or
consultant physician evaluation); primary brain lesion as cause of
stroke; intubation before completion of ED screening or SLP eval-
uation; history of dysphagia or modified feeding route; pre-exist-
ing neuromuscular disorder; history of head and neck cancer or
radiation; preexisting pneumonia on ED chest radiography; preg-
nancy
Setting: 1 × 850-bed, tertiary-care, TJC-certified, primary stroke
centre located in the southeast
Index tests ED dysphagia screen (2-tiered approach)
Target condition and reference standard(s) Aspiration
SLP dysphagia assessment
Flow and timing All patients received the index test(s) and the reference standard.
All patients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests ≤ 24 hours
Turner-Lawrence 2009
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
70
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? High risk
Are there concerns that the included patients and setting do
not match the review question?
  High
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Unclear 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Turner-Lawrence 2009(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
71
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Could the patient flow have introduced bias? Low risk
Turner-Lawrence 2009(Continued)
Study characteristics
Patient Sampling Consecutive
Patient characteristics and setting Inclusion criteria: first-ever stroke; admitted within 24 hours of
onset of symptoms; patients eligible for advanced dysphagia as-
sessment as defined by NIHSS score ≥ 3 points and/or who had to
present with facial palsy and/or dysarthria
Exclusion criteria: patients with history of a pre-existing dysphagia
or disease probably causing dysphagia; severely reduced state of
consciousness (i.e. stupor or coma)
Setting: not recorded
Index tests 2-step Swallowing Provocation Test
Target condition and reference standard(s) Aspiration
FEES
Flow and timing All patients received the index test(s) and the reference standard.
All patients were included in the 2 × 2 table
Interventions between index/reference tests: not reported
Interval between tests ≤ 24 hours, reported as immediately follow-
ing
Comparative 
Notes 
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Yes
Did the study avoid inappropriate exclusions? Yes
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Low risk
Are there concerns that the included patients and setting do
not match the review question?
Low concern
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Yes 
Warnecke 2008
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
72
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
If a threshold was used, was it pre-specified? Yes
Could the conduct or interpretation of the index test have
introduced bias?
Low risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
Low concern
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Yes 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Yes 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Low risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
Low concern
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Yes 
Did all patients receive the same reference standard? Yes
Were all patients included in the analysis? Yes
Could the patient flow have introduced bias? Low risk
Warnecke 2008(Continued)
Study characteristics
Patient Sampling Unclear
Patient characteristics and setting Inclusion criteria: patients suffering a first-ever hemispheric
stroke; symptoms lasting at least 24 hours; objective lesions on
cerebral imaging (CT and/or MRI) confirmed
Exclusion criteria: patients with subarachnoid haemorrhage, sub-
tentorial stroke or TIA, patients with sufficient loss of conscious-
ness to prevent oral feeding; patients with history of otolaryngo-
logical cancer; < 18 years of age; those who did not expressly agree
to participate in the study
1 × Neurology Department at university hospital. 1 × Department
of Physical Medicine and Readaptation
Index tests Clinical Predicative Scale of Aspiration; Practical Aspiration
Screening Scheme
Zhou 2011
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
73
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Target condition and reference standard(s) Reference standard: videofluoroscopic examination
Flow and timing
Comparative 
Notes This paper is classified as narrative
Methodological quality
Item Authors' judge-
ment
Risk of bias Applicability con-
cerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear
Did the study avoid inappropriate exclusions? Unclear
Was a two-gate design avoided? Yes
Could the selection of patients have introduced bias? Unclear risk
Are there concerns that the included patients and setting do
not match the review question?
  Unclear
DOMAIN 2: Index Test (All tests)
Were the index test results interpreted without knowledge of
the results of the reference standard?
Unclear 
If a threshold was used, was it pre-specified? Unclear
Could the conduct or interpretation of the index test have
introduced bias?
Unclear risk
Are there concerns that the index test, its conduct, or inter-
pretation differ from the review question?
  Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target
condition?
Unclear 
Were the reference standard results interpreted without knowl-
edge of the results of the index tests?
Unclear 
Could the reference standard, its conduct, or its interpreta-
tion have introduced bias?
Unclear risk
Are there concerns that the target condition as defined by
the reference standard does not match the question?
  Unclear
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and refer-
ence standard?
Unclear 
Zhou 2011(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
74
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Did all patients receive the same reference standard? Unclear
Were all patients included in the analysis? Unclear
Could the patient flow have introduced bias? Unclear risk
Zhou 2011(Continued)
AIS: acute ischaemic stroke.
ASDS: Acute Stroke Dysphagia Screening.
BJH-SDS: Barnes-Jewish Hospital-Stroke Dysphagia Screen.
CT: computed tomography.
ED: emergency department.
EHMBAS: Edith-Huhn-Matesic Bedside Aspiration Screen.
FEES: fibreoptic endoscopic evaluation of swallowing.
GUSS: Gugging Swallowing Screen.
MASA: Mann Assessment of Swallowing Ability.
MRI: magnetic resonance imaging.
NBDS: Nursing Bedside Dysphagia Screen.
NIHSS: National Institutes of Health Stroke Scale.
NPO: nil by mouth.
RAS3: Rapid Aspiration Screening for Suspected Stroke.
SLP: speech and language pathologist.
SLT: speech and language therapist.
TIA: transient ischaemic attack.
TOR-BSST: Toronto Bedside Swallowing Screening Test.
VF: videofluoroscopy.
VFSS: videofluoroscopic swallowing study.
WST: water-swallowing test.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Addington 1999 Study 1 No acute stroke
Addington 1999 Study 2 No acute stroke
Alsibai 2014 No outcome of interest
Anderson 2016 Does not compare tests
Archer 2015 Study 1 No index or reference test of interest
Archer 2015 Study 2 No index or reference test of interest
Armesto 2015 No outcome of interest
Aviv 1997 No outcome of interest
Aydogdu 2015 Not limited to stroke patients
Babi 2014 Does not compare tests
Bahia 2014 Does not compare tests
Bahia 2016 Not an acute setting
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
75
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study Reason for exclusion
Bax 2013 Does not compare tests
Bax 2014 No index or reference test of interest
Benjamin 2015 Not a single-gate or 2-gate study
Burks 2011 No screening for dysphagia
Carnaby 2014 No index or reference test of interest
Carrington 2013 Does not compare tests
Chavarria 2015 No screening for dysphagia
Choi 2010 No index or reference test of interest
Chong 2003 Not an acute setting
Cichero 2009 Not limited to stroke patients
Clayton 2006 No index or reference test of interest
Collins 1997 Not an acute setting
Crary 2013 Study 1 No index or reference test of interest
Crary 2013 Study 2 No index or reference test of interest
Crary 2014 Study 1 No index or reference test of interest
Crary 2014 Study 2 No index or reference test of interest
Daniels 2009 Does not compare tests
Davis-De Geus 2009 No outcome of interest
DePippo 1992 Not an acute setting
Farneti 2015 Index test undertaken by experts
Giraldo-Cadavid 2015 No outcome of interest
Guerra 2011 Does not compare tests
Guillén-Solà 2011 No screening for dysphagia
Guillén-Solà 2013 Not an acute setting
Gurcay 2018 Sample not restricted to acute stages of stroke
Higo 2003 No index or reference test of interest
Joundi 2017 Not a single-gate or 2-gate study
Karaca 2018 Reference test MASA considered an SLT dysphagia assessment
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
76
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study Reason for exclusion
Logemann 1999 Not limited to stroke patients
Mandysova 2015 Not limited to stroke patients
Marques 2008 Does not compare tests
Martino 2009 Study 2 No index or reference test of interest
Massey 2002 Not all patients received the same reference test
McCullough 2001 SLT dysphagia assessment, not screening
McCullough 2005 No acute stroke
Moalli 2016 Does not compare tests
Moon 2010 No consecutive stroke patients
Mozzanica 2017 Heterogeneous population. Stroke not analysed separately
Murray 2011 No outcome of interest
NCT00306501 No accuracy of screening
NCT00580138 No index or reference test of interest
NCT01765673 No accuracy of screening
NCT02080988 No outcome of interest
NCT02848664 Not limited to stroke patients
NCT03167892 No accuracy of screening
Nomura 2014 Does not compare tests
Oh 2016 All patients had dysphagia or aspiration; therefore sensitivity/specificity cannot be calculated
Ohira 2013 Not limited to stroke patients
Ohira 2017 Not an acute setting
Osawa 2013 No consecutive stroke patients
Ostrofsky 2016 Index tests carried out by SLT/SLP
Palli 2017 No reference test performed on same patients who had nurse swallow screen – the compari-
son was with case note data from historic SLT assessment
Pennsylvania Patient Safety Author-
ity 2009
Not limited to stroke patients
Perry 2000 Does not compare tests
Perry 2001 Study 2 Does not compare tests
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
77
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Study Reason for exclusion
Radhakrishnan 2013 No screening for dysphagia
Rosenbek 2004 SLT dysphagia assessment, not screening
Sato 2012 Not an acute setting
Schrock 2011 No index or reference test of interest
Sellars 1998 All patients had dysphagia or aspiration; therefore sensitivity/specificity cannot be calculated
Smith Hammond 2009 Index tests carried out by SLT/SLP
Sohn 2018 Reference test is a retrospective evaluation of case records
Soria 2013 Not limited to stroke patients
Stroke and Chewing 2012 No outcome of interest
Sung 2018 Does not compare tests
Sørensen 2013 Does not compare tests
Tanuma 2002 Not screening for dysphagia
Teramoto 2000 Not an acute setting
Toscano 2019 Index test undertaken by experts
Tuncay 2011 Not index or reference test of interest
Umay 2013 No acute stroke
Virvidaki 2019 Index test undertaken by experts
Warnecke 2017 Index tests carried out by SLT/SLP
Weinhardt 2008 Does not compare tests
Ye 2018 No reference test was included
Yeh 2011 Does not compare tests
Zhang 2004 All patients had dysphagia or aspiration; therefore sensitivity/specificity cannot be calculated
MASA: Mann Assessment of Swallowing Ability.
SLP: speech and language pathologist.
SLT: speech and language therapist.
D A T A
Presented below are all the data for all of the tests entered into the review.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
78
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Table Tests.  Data tables by test
Test No. of studies No. of participants
1 Registered Dietitian (RD) Dysphagia Screening tool - Huhmann (2004) 1 32
2 Bedside aspiration - Combined WST & Oxygen Saturation - Lim (2001) 1 50
3 Gugging Swallowing Screen (GUSS) - Group2 - Trappl (2007) 1 30
4 Toronto Bedside Swallowing Screening Test (TOR-BSST) - Martino (2009) 1 24
5 Standardized Swallowing Assessment tool (SSA) - Test2 - Perry (2001) Test2 1 68
6 Nursing Bedside Dysphagia Screen (NBDS) - Campbell (2016) 1 75
7 Emergency Department (ED) dysphagia screen - Turner-Lawrence (2009) 1 84
8 Acute Stroke Dysphagia Screening (ASDS) - Aspiration - Edmiaston (2010) 1 300
9 Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Aspiration - Ed-
miaston (2014)
1 223
10 Edith-Huhn-Matesic Bedside Aspiration Screen (EHMBAS) plus water swal-
low test - Huhn-Matesic (2015)
1 52
11 Standardized Swallowing Assessment tool (SSA) - Test1 - Perry (2001) 1 161
12 Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Dysphagia -
Edmiaston (2014)
1 225
13 Modified MASA (MMASA) Neurologist 1 - Antonios (2010) 1 150
14 Rapid Aspiration Screening for Suspected Stroke (RAS3) - Daniels (2016) 1 250
15 Clinical examination - Daniels (1997) 1 59
16 Acute Stroke Dysphagia Screening (ASDS) Dysphagia - Edmiaston (2010) 1 300
17 Nurse Dysphagia Screen - Cummings (2015) 1 49
18 Modified MASA (MMASA) Neurologist 2 - Antonios (2010) 1 150
19 Oxygen saturation ≥ 2% - Test2 for Aspiration - Smith (2000) 1 53
20 Bedside swallow test - WST only - Lim (2001) 1 50
21 Chinese version of the modified SSA original 8 items - Jiang (2019) 1 127
22 Chinese version of the modified SSA reduced 6 items - Jiang (2019) 1 127
23 Stroke Severity using National Institutes of Health Stroke Scale (NIHSS) -
Bravata (2009)
1 101
24 Nursing Bedside Swallowing Screen (NBSS) - Ellis (2013) 1 46
25 2-step Swallowing Provocation Test (SPT) - step 1 - 0.4 mL - Warneke (2008) 1 100
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
79
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test No. of studies No. of participants
26 Rapid Aspiration Screening for Suspected Stroke (RAS3) - WST only - Daniels
(2016)
1 250
27 Gag function - Test3 - Perry (2001) 1 22
28 DePaul Hospital Swallow Screener (DHSS) for Aspiration Risk - Behera
(2018)
1 226
29 DePaul Hospital Swallow Screener (DHSS) for Dysphagia - Behera (2018) 1 225
30 Gag function - Test4 - Perry (2001) 1 157
31 2-step swallowing provocation test (SPT) step 2 - 2.0 mL - Warneke (2008) 1 100
32 Johns Hopkins Hospital Brain Rescue Unit Modified 3 oz Swallow Screen -
Mulheren (2019)
1 48
33 Nursing Screening Tool - Bravata (2009) 1 39
34 Barnes-Jewish Hospital Stroke Dysphagia Screen (BJH-SDS) – Turkish ver-
sion (T-BJH) - Eren (2019)
1 0
35 Clinical Predicative Scale of Aspiration (CPSA) - Zhou (2011) 1 0
36 TOR-BSST water swallow item - Martino (2014) 1 0
37 Clinical swallowing tests - 6 oromotor examinations - Nishiwaki (2005) 1 0
38 Index taxonomy - water only 13 2914
39 Index taxonomy - water plus other consistencies 5 412
40 Index taxonomy - other 5 627
41 Outcome - aspiration 11 1827
42 Outcome - dysphagia 13 2126
43 Reference test - Expert Assessment and MASA 12 2491
44 Reference test - FEES 3 330
45 Reference test - VF 6 1132
46 HCP - nurse 14 2785
47 HCP - other 8 1168
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
80
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 1.  Registered Dietitian (RD) Dysphagia Screening tool - Huhmann (2004)
Test 2.  Bedside aspiration - Combined WST & Oxygen Saturation - Lim (2001)
Test 3.  Gugging Swallowing Screen (GUSS) - Group2 - Trappl (2007)
Test 4.  Toronto Bedside Swallowing Screening Test (TOR-BSST) - Martino (2009)
Test 5.  Standardized Swallowing Assessment tool (SSA) - Test2 - Perry (2001) Test2
Test 6.  Nursing Bedside Dysphagia Screen (NBDS) - Campbell (2016)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
81
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 7.  Emergency Department (ED) dysphagia screen - Turner-Lawrence (2009)
Test 8.  Acute Stroke Dysphagia Screening (ASDS) - Aspiration - Edmiaston (2010)
Test 9.  Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Aspiration - Edmiaston (2014)
Test 10.  Edith-Huhn-Matesic Bedside Aspiration Screen (EHMBAS) plus water swallow test - Huhn-Matesic (2015)
Test 11.  Standardized Swallowing Assessment tool (SSA) - Test1 - Perry (2001)
Test 12.  Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Dysphagia - Edmiaston (2014)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
82
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 13.  Modified MASA (MMASA) Neurologist 1 - Antonios (2010)
Test 14.  Rapid Aspiration Screening for Suspected Stroke (RAS3) - Daniels (2016)
Test 15.  Clinical examination - Daniels (1997)
Test 16.  Acute Stroke Dysphagia Screening (ASDS) Dysphagia - Edmiaston (2010)
Test 17.  Nurse Dysphagia Screen - Cummings (2015)
Test 18.  Modified MASA (MMASA) Neurologist 2 - Antonios (2010)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
83
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 19.  Oxygen saturation ≥ 2% - Test2 for Aspiration - Smith (2000)
Test 20.  Bedside swallow test - WST only - Lim (2001)
Test 21.  Chinese version of the modified SSA original 8 items - Jiang (2019)
Test 22.  Chinese version of the modified SSA reduced 6 items - Jiang (2019)
Test 23.  Stroke Severity using National Institutes of Health Stroke Scale (NIHSS) - Bravata (2009)
Test 24.  Nursing Bedside Swallowing Screen (NBSS) - Ellis (2013)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
84
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 25.  2-step Swallowing Provocation Test (SPT) - step 1 - 0.4 mL - Warneke (2008)
Test 26.  Rapid Aspiration Screening for Suspected Stroke (RAS3) - WST only - Daniels (2016)
Test 27.  Gag function - Test3 - Perry (2001)
Test 28.  DePaul Hospital Swallow Screener (DHSS) for Aspiration Risk - Behera (2018)
Test 29.  DePaul Hospital Swallow Screener (DHSS) for Dysphagia - Behera (2018)
Test 30.  Gag function - Test4 - Perry (2001)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
85
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 31.  2-step swallowing provocation test (SPT) step 2 - 2.0 mL - Warneke (2008)
Test 32.  Johns Hopkins Hospital Brain Rescue Unit Modified 3 oz Swallow Screen - Mulheren (2019)
Test 33.  Nursing Screening Tool - Bravata (2009)
Test 34.  Barnes-Jewish Hospital Stroke Dysphagia Screen (BJH-SDS) – Turkish version (T-BJH) - Eren (2019)
Test 35.  Clinical Predicative Scale of Aspiration (CPSA) - Zhou (2011)
Test 36.  TOR-BSST water swallow item - Martino (2014)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
86
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 37.  Clinical swallowing tests - 6 oromotor examinations - Nishiwaki (2005)
Test 38.  Index taxonomy - water only
Test 39.  Index taxonomy - water plus other consistencies
Test 40.  Index taxonomy - other
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
87
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 41.  Outcome - aspiration
Test 42.  Outcome - dysphagia
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
88
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 43.  Reference test - Expert Assessment and MASA
Test 44.  Reference test - FEES
Test 45.  Reference test - VF
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
89
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Test 46.  HCP - nurse
Test 47.  HCP - other
A D D I T I O N A L  T A B L E S
Tests (percentage)
(n = 37 tests)
Complete or narrative Complete - 2 × 2 table data extracted 33 (89%)
Narrative - 2 × 2 table data not available 4 (11%)
Participants
NaMedian (IQR) 100 (50 to 161) Min = 22, max = 300
Table 1.  Description of screening tests
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
90
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
N with dysphagia/aspira-
tiona
Median (IQR) 38 (17 to 63) Min = 8, max = 106
Mean age Median (IQR) 67.6 (64.75 to 71.4) Min = 58.6, max = 76.8
Sex % male Median (IQR) 54.7 (49 to 65.6) Min = 35, max = 100
Year recruitment started Min = 1995, max = 2016
UK and Europe 8 (22%)
USA and Canada 22 (59%)
Other 6 (16%)
Country
Not recorded 1 (3%)
Study design
≤ 24 hours 16 (43%)
> 24 hours and < 72 hours 6 (16%)
≥ 72 hours 2 (5%)
Admission to index test
Not recorded 13 (35%)
Index then reference 28 (76%)
Reference then index 1 (3%)
Mixed or not specified 5 (14%)
Order tests applied
Not recorded 3 (8%)
≤ 24 hours 18 (49%)
> 24 hours 10 (27%)
Index/reference time in-
terval
Not recorded 9 (24%)
Yes 21 (57%)Index test training given
Not recorded 16 (43%)
Water only 24 (65%)
Water plus other consistencies 6 (16%)
Index test type
Other 7 (19%)
Nurse 21 (57%)Index test HCP
Other 16 (43%)
Outcome Aspiration 15 (41%)
Table 1.  Description of screening tests(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
91
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Dysphagia 20 (54%)
NR 2 (5%)
Expert assessment and MASA 20 (54%)
FEES 6 (16%)
Reference test
VF 11 (30%)
Table 1.  Description of screening tests(Continued)
aUsing complete studies only.
FEES: fibreoptic endoscopic evaluation of swallowing.
HCP: healthcare professional.
IQR: interquartile range.
MASA: Mann Assessment of Swallowing Ability.
VF: videofluoroscopy.
Test ID Test name
Antonios 2010a Modified MASA (MMASA) Neurologist 1: Antonios 2010
Antonios 2010b Modified MASA (MMASA) Neurologist 2: Antonios 2010
Behera 2018a DePaul Hospital Swallow Screener (DHSS) Aspiration: Behera 2018
Behera 2018b DePaul Hospital Swallow Screener (DHSS) Dysphagia: Behera 2018
Bravata 2009a Nursing Screening Tool: Bravata 2009
Bravata 2009b Stroke Severity using National Institutes of Health Stroke Scale (NIHSS): Bravata 2009
Campbell 2016 Nursing Bedside Dysphagia Screen (NBDS): Campbell 2016
Cummings 2015 Nurse Dysphagia Screen: Cummings 2015
Daniels 1997 Clinical examination: Daniels 1997
Daniels 2016a Rapid Aspiration Screening for Suspected Stroke (RAS3): Daniels 2016
Daniels 2016b Rapid Aspiration Screening for Suspected Stroke (RAS3) - WST only: Daniels 2016
Edmiaston 2010a Acute Stroke Dysphagia Screening (ASDS) Aspiration: Edmiaston 2010
Edmiaston 2010b Acute Stroke Dysphagia Screening (ASDS) Dysphagia: Edmiaston 2010
Edmiaston 2014a Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Aspiration: Edmiaston 2014
Edmiaston 2014b Barnes-Jewish Hospital-Stroke Dysphagia Screen (BJH-SDS) Dysphagia: Edmiaston 2014
Ellis 2013 Nursing Bedside Swallowing Screen (NBSS): Ellis 2013
Eren 2019 Barnes-Jewish Hospital Stroke Dysphagia Screen – Turkish version (BJH-SDS) or (T-BJH): Eren 2019
Table 2.  Index test reference IDs
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
92
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Huhmann 2004 Registered Dietitian (RD) Dysphagia Screening tool: Huhmann 2004
Huhn-Matesic 2015 Edith-Huhn-Matesic Bedside Aspiration Screen (EHMBAS) followed by simple water swallow test:
Huhn-Matesic 2015
Jiang 2019a Chinese version of the modified SSA – original 8 items: Jiang 2019
Jiang 2019b Chinese version of the modified SSA – reduced 6 items: Jiang 2019
Lim 2001a Bedside aspiration - Combined WST and Oxygen Saturation: Lim 2001
Lim 2001b Bedside swallow test - WST only: Lim 2001
Martino 2009 Toronto Bedside Swallowing Screening Test (TOR-BSST): Martino 2009 Study 1
Martino 2014 TOR-BSST water swallow item: Martino 2014
Mulheren 2019 Johns Hopkins Hospital Brain Rescue Unit Modified 3 oz Swallow Screen: Mulheren 2019
Nishiwaki 2005 Clinical swallowing tests: Nishiwaki 2005
Perry 2001a Gag function - Test3: Perry 2001 Study 1
Perry 2001b Gag function - Test4: Perry 2001 Study 1
Perry 2001c Standardized Swallowing Assessment tool (SSA) - Test1: Perry 2001 Study 1
Perry 2001d Standardized Swallowing Assessment tool (SSA) – Test2: Perry 2001 Study 1
Smith 2000 Oxygen saturation ≥ 2% - Test2 for Aspiration: Smith 2000
Trapl 2007b Gugging Swallowing Screen (GUSS) - Group2: Trapl 2007
Turner-Lawrence 2009 Emergency Department (ED) dysphagia screen: Turner-Lawrence 2009
Warnecke 2008a 2-step swallowing provocation test (SPT) - step 1 - 0.4 mL: Warnecke 2008
Warnecke 2008b 2-step swallowing provocation test (SPT) - step 2 - 2.0 mL: Warnecke 2008
Zhou 2011 Clinical predicative scale of aspiration (CPSA): Zhou 2011
Table 2.  Index test reference IDs(Continued)
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp
cerebral small vessel diseases/ or exp intracranial arterial diseases/ or exp "intracranial embolism and thrombosis"/ or exp intracranial
hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
93
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. hemiplegia/ or exp paresis/ or exp Gait Disorders, Neurologic/
6. (hemipleg$ or hemipar$ or paresis or paraparesis or paretic).tw.
7. or/1-6
8. Deglutition/
9. exp Deglutition Disorders/
10. ((swallow$ or deglutit$ or dysphag$) adj3 (disturbance$ or disorder$ or diicult$ or dysfunction$ or impair$ or condition$ or abnormal
$ or damage$ or injur$)).tw.
11. ((swallow$ or deglutit$ or dysphag$) adj3 (scale$ or screen$ or checklist$ or assess$ or exam$ or identif$ or recogni$ or evaluat$ or
diagnos$ or detect$ or hazard or risk or test)).tw.
12. exp Respiratory Aspiration/ or exp Pneumonia, Aspiration/
13. ((inhal$ or aspirat$ or ingest$) adj3 (scale$ or screen$ or checklist$ or assess$ or exam$ or identif$ or recogni$ or evaluat$ or diagnos
$ or detect$ or hazard or risk or test)).tw.
14. Pharynx/ or pharyngeal muscles/ or esophageal sphincter, upper/ or exp Esophagus/
15. ((throat or oesophag$ or esophag$ or pharyn$ or oropharyn$) adj3 (disturbance$ or disorder$ or diicult$ or dysfunction$ or impair
$ or condition$ or abnormal$ or damage$ or injur$)).tw.
16. exp Fluoroscopy/ or bronchoscopy/ or laryngoscopy/ or endoscopy/ or manometry/
17. Fiber Optic Technology/
18. (fluoroscop$ or videofluroscop$ or fluorescence radiation or fluorescent scan$ or fluorophotograph$ or photofluoroscop
$ or radiofluoroscop$ or roentgenfluoroscop$ or bronchoscop$ or bronchial endoscop$ or laryngotracheobronchoscop$ or
tracheobronchoscop$).tw.
19. or/8-18
20. 7 and 19
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL)
June 2017 search – was applied to CENTRAL and HTA
December 2019 search –applied separately to CENTRAL and HTA. HTA was only available until March 2018.
ID Search Hits
#1 MeSH descriptor: [Cerebrovascular Disorders] this term only
#2 MeSH descriptor: [Basal Ganglia Cerebrovascular Disease] this term only
#3 MeSH descriptor: [Brain Ischemia] explode all trees
#4 MeSH descriptor: [Carotid Artery Diseases] explode all trees
#5 MeSH descriptor: [Cerebral Small Vessel Diseases] explode all trees
#6 MeSH descriptor: [Intracranial Arterial Diseases] explode all trees
#7 MeSH descriptor: [Intracranial Embolism and Thrombosis] explode all trees
#8 MeSH descriptor: [Intracranial Hemorrhages] explode all trees
#9 MeSH descriptor: [Stroke] explode all trees
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
94
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
#10 MeSH descriptor: [Vasospasm, Intracranial] this term only
#11 MeSH descriptor: [Vertebral Artery Dissection] this term only
#12 (stroke* or poststroke or apoplex* or cerebral vasc* or brain vasc* or cerebrovasc* or cva* or SAH):ti,ab,kw (Word variations have been
searched)
#13 ((brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) near/5 (isch?
emi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)):ti,ab,kw (Word variations have been searched)
#14 ((brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid) near/5 (h?emorrhag* or h?
ematoma* or bleed*)):ti,ab,kw (Word variations have been searched)
#15 MeSH descriptor: [Hemiplegia] this term only
#16 MeSH descriptor: [Paresis] explode all trees
#17 MeSH descriptor: [Gait Disorders, Neurologic] explode all trees
#18 (hemipleg* or hemipar* or paresis or paraparesis or paretic):ti,ab,kw (Word variations have been searched)
#19 {or #1-#18}
#20 MeSH descriptor: [Deglutition] this term only
#21 MeSH descriptor: [Deglutition Disorders] explode all trees
#22 ((swallow* or deglutit* or dysphag*) near/3 (disturbance* or disorder* or diicult* or dysfunction* or impair* or condition* or abnormal*
or damage* or injur*)):ti,ab,kw (Word variations have been searched)
#23 ((swallow* or deglutit* or dysphag*) near/3 (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or
diagnos* or detect* or hazard or risk or test)):ti,ab,kw (Word variations have been searched)
#24 MeSH descriptor: [Respiratory Aspiration] explode all trees
#25 MeSH descriptor: [Pneumonia, Aspiration] explode all trees
#26 ((inhal* or aspirat* or ingest*) near/3 (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or diagnos*
or detect* or hazard or risk or test)):ti,ab,kw (Word variations have been searched)
#27 MeSH descriptor: [Pharynx] this term only
#28 MeSH descriptor: [Pharyngeal Muscles] this term only
#29 MeSH descriptor: [Esophageal Sphincter, Upper] this term only
#30 MeSH descriptor: [Esophagus] explode all trees
#31 ((throat or oesophag* or esophag* or pharyn* or oropharyn*) near/3 (disturbance* or disorder* or diicult* or dysfunction* or impair*
or condition* or abnormal* or damage* or injur*)):ti,ab,kw (Word variations have been searched)
#32 MeSH descriptor: [Fluoroscopy] explode all trees
#33 MeSH descriptor: [Bronchoscopy] this term only
#34 MeSH descriptor: [Laryngoscopy] this term only
#35 MeSH descriptor: [Endoscopy] this term only
#36 MeSH descriptor: [Manometry] this term only
#37 MeSH descriptor: [Fiber Optic Technology] this term only
#38 (fluoroscop* or videofluroscop* or fluorescence radiation or fluorescent scan* or fluorophotograph* or photofluoroscop*
or radiofluoroscop* or roentgenfluoroscop* or bronchoscop* or bronchial endoscop* or laryngotracheobronchoscop* or
tracheobronchoscop*):ti,ab,kw (Word variations have been searched)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
95
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
#39 {or #20-#38}
#40 #19 and #39
Appendix 3. Embase search strategy
1. cerebrovascular disease/ or brain disease/ or exp basal ganglion hemorrhage/ or exp brain hemangioma/ or exp brain hematoma/ or
exp brain hemorrhage/ or exp brain infarction/ or exp brain ischemia/ or exp carotid artery disease/ or exp cerebral artery disease/ or exp
cerebrovascular accident/ or exp cerebrovascular malformation/ or exp intracranial aneurysm/ or exp occlusive cerebrovascular disease/
or exp vertebrobasilar insuiciency/
2. (stroke$ or poststroke or apoplex$ or cerebral vasc$ or brain vasc$ or cerebrovasc$ or cva$ or SAH).tw.
3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA$ or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) adj5 (isch?
emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.
4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracran$ or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli$ or putaminal or putamen or posterior fossa or hemispher$ or subarachnoid) adj5 (h?emorrhag$ or h?
ematoma$ or bleed$)).tw.
5. exp hemiplegia/ or exp paresis/ or neurologic gait disorder/
6. (hemipleg$ or hemipar$ or paresis or paraparesis or paretic).tw.
7. or/1-6
8. dysphagia/
9. swallowing/
10. ((swallow$ or deglutit$ or dysphag$) adj3 (disturbance$ or disorder$ or diicult$ or dysfunction$ or impair$ or condition$ or abnormal
$ or damage$ or injur$)).tw.
11. ((swallow$ or deglutit$ or dysphag$) adj3 (scale$ or screen$ or checklist$ or assess$ or exam$ or identif$ or recogni$ or evaluat$ or
diagnos$ or detect$ or hazard or risk or test)).tw.
12. aspiration pneumonia/ or aspiration/
13. acid aspiration/
14. ((inhal$ or aspirat$ or ingest$) adj3 (scale$ or screen$ or checklist$ or assess$ or exam$ or identif$ or recogni$ or evaluat$ or diagnos
$ or detect$ or hazard or risk or test)).tw.
15. exp pharynx/
16. exp esophagus/ or esophagus muscle/ or upper esophagus sphincter/
17. ((throat or oesophag$ or esophag$ or pharyn$ or oropharyn$) adj3 (disturbance$ or disorder$ or diicult$ or dysfunction$ or impair
$ or condition$ or abnormal$ or damage$ or injur$)).tw.
18. fluoroscopy/ or fluoroscopy system/
19. exp bronchoscopy/ or bronchus examination/
20. exp laryngoscope/ or exp laryngoscopy/
21. endoscopy/ or fiberscope endoscopy/ or videoendoscopy/
22. manometry/
23. (fluoroscop$ or videofluroscop$ or fluorescence radiation or fluorescent scan$ or fluorophotograph$ or photofluoroscop
$ or radiofluoroscop$ or roentgenfluoroscop$ or bronchoscop$ or bronchial endoscop$ or laryngotracheobronchoscop$ or
tracheobronchoscop$).tw.
24. or/8-23
25. 7 and 24
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
96
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Appendix 4. CINAHL search strategy
S1 (MH "Cerebrovascular Disorders") OR (MH "Basal Ganglia Cerebrovascular Disease+") OR (MH "Carotid Artery Diseases+") OR (MH
"Cerebral Ischemia+") OR (MH "Cerebral Vasospasm") OR (MH "Intracranial Arterial Diseases+") OR ( (MH "Intracranial Embolism and
Thrombosis") ) OR (MH "Intracranial Hemorrhage+") OR (MH "Stroke") OR (MH "Vertebral Artery Dissections") OR (MH "Stroke Patients")
OR (MH "Stroke Units")
S2 TI ( stroke or poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH ) or AB ( stroke or
poststroke or post-stroke or cerebrovasc* or brain vasc* or cerebral vasc or cva or apoplex or SAH)
S3 TI ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) N5
TI ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus*)
S4 AB ( brain or cerebr* or cerebell* or vertebrobasil* or hemispher* or intracran* or intracerebral or infratentorial or supratentorial or
middle cerebral artery or MCA* or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) N5
AB ( ischemi* or ischaemi* or infarct* or thrombo* or emboli* or occlus*)
S5 TI ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) N5 TI ( haemorrhage* or
hemorrhage* or haematoma* or hematoma* or bleed* )
S6 AB ( brain* or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial
or supratentorial or basal gangli* or putaminal or putamen or posterior fossa or hemispher* or subarachnoid ) N5 AB ( haemorrhage* or
hemorrhage* or haematoma* or hematoma* or bleed* )
S7 (MH "Hemiplegia") or (MH "Gait Disorders, Neurologic+")
S8 TI ( (hemipleg* or hemipar* or paresis or paretic) ) OR AB ( (hemipleg* or hemipar* or paresis or paretic) )
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S10 (MH "Deglutition") OR (MH "Gagging")
S11 (MH "Deglutition Disorders")
S12 TI ( (swallow* or deglutit* or dysphag*) N5 (disturbance* or disorder* or diicult* or dysfunction* or impair* or condition* or abnormal*
or damage* or injur*) ) OR AB ( (swallow* or deglutit* or dysphag*) N5 (disturbance* or disorder* or diicult* or dysfunction* or impair*
or condition* or abnormal* or damage* or injur*) )
S13 TI ((swallow* or deglutit* or dysphag*) N5 (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or
diagnos* or detect* or hazard or risk or test)) OR AB ((swallow* or deglutit* or dysphag*) N5 (scale* or screen* or checklist* or assess* or
exam* or identif* or recogni* or evaluat* or diagnos* or detect* or hazard or risk or test))
S14 (MH "Aspiration")
S15 (MH "Pneumonia, Aspiration")
S16 (MH "Risk for Aspiration (NANDA)")
S17 TI ((inhal* or aspirat* or ingest*) N5 (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or diagnos*
or detect* or hazard or risk or test)) OR AB ((inhal* or aspirat* or ingest*) N5 (scale* or screen* or checklist* or assess* or exam* or identif*
or recogni* or evaluat* or diagnos* or detect* or hazard or risk or test))
S18 (MH "Pharynx+")
S19 (MH "Esophagus")
S20 TI ((throat or oesophag* or esophag* or pharyn* or oropharyn*) N5 (disturbance* or disorder* or diicult* or dysfunction* or impair*
or condition* or abnormal* or damage* or injur*)) OR AB ((throat or oesophag* or esophag* or pharyn* or oropharyn*) N5 (disturbance* or
disorder* or diicult* or dysfunction* or impair* or condition* or abnormal* or damage* or injur*))
S21 (MH "Fiber Optics")
S22 TI ( (fluoroscop* or videofluroscop* or fluorescence radiation or fluorescent scan* or fluorophotograph* or photofluoroscop*
or radiofluoroscop* or roentgenfluoroscop* or bronchoscop* or bronchial endoscop* or laryngotracheobronchoscop* or
tracheobronchoscop*) ) OR AB ( (fluoroscop* or videofluroscop* or fluorescence radiation or fluorescent scan* or fluorophotograph* or
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
97
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
photofluoroscop* or radiofluoroscop* or roentgenfluoroscop* or bronchoscop* or bronchial endoscop* or laryngotracheobronchoscop*
or tracheobronchoscop*) )
S23 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22
S24 S9 AND S23
Appendix 5. HTA search strategy
1. cerebrovascular disorders/ or exp brain ischemia/ or exp carotid artery diseases/ or exp cerebral small vessel diseases/ or exp intracranial
arterial diseases/ or exp "intracranial embolism and thrombosis"/ or exp intracranial hemorrhages/ or stroke/ or exp brain infarction/ or
vasospasm, intracranial/ or vertebral artery dissection/
2. (stroke or strokes or poststroke or cerebral vasc* or brain vasc$ or cerebrovasc* or cva or SAH) any field
3. ((brain or cerebr* or cerebell* or vertebrobasil* or hemisphere* or intracran* or intracerebral or infratentorial or supratentorial or middle
cerebral artery or MCA or anterior circulation or posterior circulation or basilar artery or vertebral artery or space-occupying) and (ischemi*
or ischaemi* or infarct* or thrombo* or emboli* or occlus* or hypoxi*)) any field
4. ((brain or cerebr* or cerebell* or intracerebral or intracran* or parenchymal or intraparenchymal or intraventricular or infratentorial or
supratentorial or posterior fossa or hemisphere* or subarachnoid) and (haemorrhag* or hemorrhag* or hematoma* or haematoma* or
bleed*)) any field
5. exp paresis/ or exp Gait Disorders, Neurologic/
6. (hemipleg* or paresis or paraparesis or paretic) any field
7. or/1-6
8. Deglutition/
9. exp Deglutition Disorders/
10. ((swallow* or deglutit* or dysphag*) and (disturbance* or disorder* or diicult* or dysfunction* or impair* or condition* or abnormal*
or damage* or injur*)) any field
11. ((swallow* or deglutit* or dysphag*) and (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or
diagnos* or detect* or hazard or risk or test)) any field
12. exp Pneumonia, Aspiration/
13. ((inhal* or aspirat* or ingest*) and (scale* or screen* or checklist* or assess* or exam* or identif* or recogni* or evaluat* or diagnos*
or detect* or hazard or risk or test)) any field
14. Pharynx/ or pharyngeal muscles/ or exp Esophagus/
15. ((throat or oesophag* or esophag* or pharyn* or oropharynx*) and (disturbance* or disorder* or diicult* or dysfunction* or impair*
or condition* or abnormal* or damage* or injur*)) any field
16. exp Fluoroscopy/ or bronchoscopy/ or laryngoscopy/ or endoscopy/ or manometry/
17. (fluoroscop* or videofluoroscop* or fluorescence radiation or fluorescent scan* or fluorophotograph* or photofluoroscop*
or radiofluoroscop* or roentgenfluoroscop* or bronchoscop* or bronchial endoscop* or laryngotracheobronchoscop* or
tracheobronchoscop*) any field
18. or/8-17
29. 7 and 18
Appendix 6. List of targeted grey literature sources (CADTH, 2018)
Health Quality Council of Alberta (HQCA) http://hqca.ca/studies-and-reviews/completed-reviews/
Institut national d’excellence en santé et en services sociaux (INESSS) [formerly AETMIS] http://www.inesss.qc.ca/en/publications/
publications.html
Manitoba Centre for Health Policy (MCHP) http://mchp-appserv.cpe.umanitoba.ca/deliverablesList.html
NLCAHR : Newfoundland and Labrador Centre for Applied Health Research. Contextualized Health Research Synthesis Program (CHRSP)
http://www.nlcahr.mun.ca/CHRSP/CompletedCHRSP.php
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
98
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Ottawa Hospital Research Institute (OHRI) http://www.ohri.ca/ksgroup/publications.asp
Therapeutics Initiative. Therapeutics Letter http://www.ti.ubc.ca/TherapeuticsLetter
University of British Columbia. Centre for Health Services and Policy Research http://chspr.ubc.ca/publications/
World Health Organization Regional Oice for Europe. Health Evidence Network (WHO HEN) http://www.euro.who.int/en/data-and-
evidence/evidence-informed-policy-making/publications/by-keyword
Australian Government. Department of Health and Ageing. Australia and New Zealand Horizon Scanning Network (ANZHSN). http://
www.horizonscanning.gov.au/internet/horizon/publishing.nsf/Content/technologies-assessed-lp-2
Australian Government Department of Health and Ageing. Medical Services Advisory Committee (MSAC). http://www.msac.gov.au/
internet/msac/publishing.nsf/Content/completed-assessments
Joanna Briggs Institute (JBI). The Joanna Briggs Institute EBP Database http://connect.jbiconnectplus.org/Search.aspx
Monash Health. Centre for Clinical Eectiveness (CCE). Centre for Clinical Eectiveness – Publications http://monashhealth.org/health-
professionals/cce/cce-publications/
Queensland Government (Australia). Health Technology Reference Group. Health Technologies Evaluated-Reports and Briefs (COAG
Health Council). https://www.coaghealthcouncil.gov.au/AHMAC/Health-Technology-Reference-Group/Reports-and-Briefs
Kenniscentrum voor de Gezondheidszorg / Le Centre d'expertise des soins de santé. Belgian Health Care Knowledge Centre (KCE)
https://kce.fgov.be/en/all-reports
Sundhedsstyrelsen. Danish Health and Medicines Authority (DHMA). http://sundhedsstyrelsen.dk/en/publications
Haute Autorité de santé/ French National Authority for Health (HAS). Haute Autorité de santé http://www.has-sante.fr/portail/jcms/
c_946986/en/english-toutes-nos-publications-ligne-principale?portal=r_1457306
Health Service Executive. Irish Health Repository (Lenus) http://www.lenus.ie/hse/
De Gezondheidsraad (GR). Health Council of the Netherlands http://www.gezondheidsraad.nl/en/publications
Zorginstituut Nederland. National Health Care Institute Netherlands https://english.zorginstituutnederland.nl/publications
Folkehelseinstituttet. Norwegian Institute of Public Health. Publications https://www.fhi.no/en/publ/
Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS). Agency for Health Quality and Assessment of Catalonia http://
aquas.gencat.cat/ca/publicacions/
Sahlgrenska Universitetssjukhuset. Sahlgrenska University Hospital. Regional activity-based HTA. https://www.sahlgrenska.se/
forskning/htacentrum/
Healthcare Improvement Scotland. http://www.healthcareimprovementscotland.org/
NHS National Institute for Health and Care Excellence (NICE). http://www.nice.org.uk/
UK Department of Health (NHS). International Resource for Infection Control (INRIC) https://www.nric.org.uk/resources
Agency for Healthcare Research and Quality (AHRQ). Technology Assessments https://www.ahrq.gov/research/findings/ta/index.html
Institute for Clinical and Economic Review (ICER). https://icer-review.org/materials/
Appendix 7. QUADAS-2 tool: risk of bias and applicability judgements
Domain 1. Patient selection
1. Risk of bias
Describe methods of patient selection:
· Was a consecutive or random sample of patients enrolled? Yes/No/Unclear
Was a case-control design avoided? Yes/No/Unclear
Did the study avoid inappropriate exclusions? Yes/No/Unclear
· Could the selection of patients have introduced bias? RISK: LOW/HIGH/UNCLEAR
1. Concerns regarding applicability
Describe included patients (prior testing, presentation, intended use of index test and setting):
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
99
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Is there concern that the included patients do not match the review question? CONCERN: LOW/HIGH/UN-
CLEAR
Domain 2. Index test(s) (if more than 1 index test was used, please complete for each test)
1. Risk of bias
Describe the index test and how it was conducted and interpreted:
Were the index test results interpreted without knowledge of results of the reference stan-
dard?
Yes/No/Unclear
If a threshold was used, was it prespecified? Yes/No/Unclear
· Could conduct or interpretation of the index test have introduced bias? RISK: LOW/HIGH/UNCLEAR
1. Concerns regarding applicability
Is there concern that the index test, its conduct, or its interpretation differ from the review
question?
CONCERN: LOW/HIGH/UN-
CLEAR
Domain 3. Reference standard
1. Risk of bias
Describe the reference standard and how it was conducted and interpreted:
Is the reference standard likely to correctly classify the target condition? Yes/No/Unclear
Were the reference standard results interpreted without knowledge of results of the index
test?
Yes/No/Unclear
· Could the reference standard, its conduct, or its interpretation have introduced bias? RISK: LOW/HIGH/UNCLEAR
1. Concerns regarding applicability
Is there concern that the target condition as defined by the reference standard does not
match the review question?
CONCERN: LOW/HIGH/UN-
CLEAR
Domain 4. Flow and timing
1. Risk of bias
Describe any patients who did not receive the index test(s) and/or reference standard or who were excluded from the 2 ×2 ta-
ble (refer to flow diagram):
Describe the time interval and any interventions between index test(s) and reference standard:
Was there an appropriate interval between index test(s) and reference standard? Yes/No/Unclear
Did all patients receive a reference standard? Yes/No/Unclear
Did patients receive the same reference standard? Yes/No/Unclear
Were all patients included in the analysis? Yes/No/Unclear
· Could the patient flow have introduced bias? RISK: LOW/HIGH/UNCLEAR
(Continued)
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
100
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
Appendix 8. Description of screening tests
Bedside Aspiration Test ( Lim 2001 a)
Stage 1: the Water Swallow Test assessed patient’s ability to swallow 50 mL of water in 10-mL aliquots. The patient is seated upright and
is asked to drink all of the 50 mL. Patients were deemed to be clinically aspirating if they coughed or choked during the water drinking
test or had a change in their voice quality following the swallow. Patients were monitored for these signs of possible aspiration for up to
5 minutes aer swallowing.
Stage 2: aer a rest period of 10 minutes, the Oxygen Saturation Test was conducted. The finger probe of a Novametrix Oxypleth pulse
oximeter (model 520A) was placed on the index finger of the unaected hand of the patient, with the patient in an upright position. Aer
equilibrating for 5 minutes, a baseline oxygen saturation reading was taken. A drop > 2% in arterial oxygen saturation was considered
clinically significant (Collins and Bakheit 1997). Maximum and minimum oxygen saturation readings during and for up to 2 minutes aer
swallowing 10 mL of water were noted 3 times, and highest and lowest readings were taken. If oxygen saturation fell by 5% or more,
the test was stopped immediately to stop an additional decline in arterial blood oxygenation levels, especially in patients who may have
compromised pulmonary function. Aspiration was deemed present if overt signs of aspiration and/or oxygen desaturation of 2% or more
was noted.
Gugging Swallowing Screen ( Trapl 2007 b)
The Bedside Gugging Swallow Screen (GUSS) consists of two parts. Part 1, the preliminary assessment, involved a simple saliva swallow
test. Patients who were unable to produce enough saliva because of dry mouth were given saliva spray as a substitute. Vigilance, voluntary
cough, throat clearing, and saliva swallowing were assessed. Part 2 consisted of 3 sequentially performed subtests, starting with semisolid
(thickened distilled water), then liquid (increasing amounts of 3, 5, 10, 20, and 50 mL), and finally solid textures (5 tests with dry bread).
Ten seconds is the time limit for a small solid bolus, including the oral preparatory phase. The test was stopped if 1 of the 4 aspiration signs
(deglutition, cough, drooling, and voice change) was positive. Patients must successfully complete all repetitions in the subtest to achieve
the full score of 5 points. If a subtest results in < 5 points, the examination is stopped and a special oral diet and/or further investigation by
videofluoroscopy or fibreoptic endoscopy is recommended. Diet recommendations are then oered, aligned to the functional oral intake
scale, and are given according to points reached in the GUSS.
The Toronto Bedside Swallow Screening Test ( Martino 2009 Study 1 )
The Toronto Bedside Swallowing Screening Test (TOR-BSST) included the following tests: the Kidd 50 mL water swallow test, pharyngeal
sensation, tongue movement, and general dysphonia split into 2 items - 'voice before' and 'voice aer'. A pass/fail response was assigned
to each item, so that failure on any item constitutes a positive screen result and therefore increased risk for dysphagia. Administration
continues only until the first TOR-BSST item is failed.
W H A T ' S  N E W
Date Event Description
13 July 2021 Amended Paper submitted with amendments in response to reviewers'
comments
H I S T O R Y
Protocol first published: Issue 6, 2017
Date Event Description
26 February 2021 Amended Paper submitted with amendments in response to reviewers'
comments
30 September 2020 Amended Paper submitted
30 January 2017 Amended Protocol amended in response to reviewers' comments
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
101
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
Cochrane Database of Systematic Reviews
C O N T R I B U T I O N S  O F  A U T H O R S
EB, JB, and LH draed the review and developed the background section with support from CW. PD, AC, MH, and CW, who also provided
advice regarding the methodological perspective and content. EB, JB, LH, PD, LL, ML, HR, EM, AA, and CW provided support for data
collection and analysis, and MH provided statistical expertise. All review authors commented on all sections of the review and reviewed
the final version prior to submission.
D E C L A R A T I O N S  O F  I N T E R E S T
Elizabeth Boaden: none known.
Jane Burnell: none known.
Lucy Hives: none known.
Paola Dey: "my institution has received funding for consultancies and grants in aid from NHS, government and research charities. I have
also been in receipt of a travel bursary from the organisers of the United European Gastroenterology Week in Berlin in 2006"
Andrew Clegg: none known.
Mary W Lyons: none known.
C Elizabeth Lightbody: none known.
Margaret A Hurley: none known.
Hazel Roddam: none known.
Elizabeth McInnes: none known.
Anne Alexandrov: none known.
Caroline L Watkins: none known.
S O U R C E S  O F  S U P P O R T
Internal sources
No sources of support provided
External sources
No sources of support provided
D I F F E R E N C E S  B E T W E E N  P R O T O C O L  A N D  R E V I E W
We did not perform meta-analyses, as the number of studies for each individual index test was insuicient, that is, did not include at
least four per group. We have presented only descriptive analyses grouped by general categories. Hence we performed no analysis of the
influence of sources of heterogeneity, no subgroup analysis, and no sensitivity analysis. None of the included studies used scintigraphy
as the reference test. We included studies in which the index test was carried out by any healthcare professionals with the exception of
speech and language therapists (SLTs).
Screening for aspiration risk associated with dysphagia in acute stroke (Review)
Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
102
... Dysphagia is among the potential neurological deficits resulting from a stroke, and according to the literature, it can affect up to 78% of stroke survivors [1]. This incidence may be influenced by the type and severity of stroke, history of stroke, and individual patient characteristics, including comorbidities like diabetes mellitus. ...
... This incidence may be influenced by the type and severity of stroke, history of stroke, and individual patient characteristics, including comorbidities like diabetes mellitus. On the other hand, the reported incidence of post-stroke dysphagia varies depending on the type of swallowing assessment test employed and the timing of its application after the event [1,2]. The neural circuit responsible for initiating the swallowing process is located in the rostral part of the medulla oblongata. ...
... Patients with post-stroke dysphagia, particularly those without an early screening, face a three to four times higher risk of developing pneumonia [1]. This rises further to approximately 11 times in patients with confirmed aspiration [1,5]. ...
Article
Full-text available
Introduction: Dysphagia is a common post-stroke neurological disorder. Early screening for dysphagia can identify patients at risk of aspiration, thereby reducing the occurrence of pulmonary complications, morbidity, and mortality in this population. Objectives: This study aims to evaluate the impact of an intervention in a stroke unit, following a retrospective study carried out in the same unit in 2020, which investigated the association between dysphagia and acute cerebrovascular disease and analyzed the prevalence of readmissions due to respiratory tract infections (RTI) and mortality. An assessment of the factors related to a higher risk of developing post-stroke dysphagia was also performed. Material and methods: A retrospective observational study analyzed 210 clinical records of patients with acute cerebrovascular disease, including clinical history, neurological examination, imaging, and Gugging Swallowing Screen in the initial 48 hours. Patient follow-up for three months through medical records was used to evaluate RTI and mortality. Results: Among the 210 clinical records examined, 209 (99.5%) underwent dysphagia assessment, contrasting with the previously reported casuistic from this unit (40.8%). The prevalence of dysphagia was also higher (50.7% vs. 32.4%). Over a three-month follow-up, RTI occurred in 19% of all patients, in 35.8% of all dysphagic patients, and in 67.7% (p<0.001) of those with severe dysphagia. The overall three-month mortality rate was 9.0% and 12.3% in dysphagic patients, particularly in patients with severe dysphagia (29.0%; p<0.001). Compared to the previous report, this study found a decrease of 1.4% in all-cause mortality (9.0% vs. 10.4%), 11.9% in all-cause mortality in dysphagic patients (12.3% vs. 24.2%), and 46% in all-cause mortality in patients with severe dysphagia (29.0% vs. 75.0%). A higher risk of dysphagia was significantly associated with older age (p<0.001), female gender (p<0.006), severe stroke (p<0.001), hemorrhagic stroke (p=0.005), strokes involving the carotid territory (p=0.040), dysarthria (p=0.004), aphasia (p<0.001), and type of aphasia, particularly global and Broca's aphasia (p=0.022). Conclusions: The recent rates of all-cause mortality at the three-month follow-up, especially in the severe dysphagia group, indicate an overall improvement in the quality of patient care in the stroke unit intervened with regard to dysphagia, while the higher prevalence of RTI post-stroke at three months may not only reflect the larger number of patients screened for dysphagia but also aging, multimorbidity, and the increasing incidence of stroke on the Portuguese population. The type of cerebrovascular disease, vascular territory, age, gender, National Institutes of Health Stroke Scale and Glasgow Coma Scale scores, dysarthria, aphasia, and type of aphasia were significant associated factors to post-stroke dysphagia. The intervention of a multi-professional team with the implementation of a protocol for early dysphagia screening is crucial to optimizing the outcomes of patients with post-stroke dysphagia.
... Dysphagia is observed in 20-70% of stroke patients in the acute period, 10-40% in the subacute period, and 5-25% in the chronic period [2]. These rates depend on the type of stroke, its severity, individual characteristics, and the type of diagnostic assessment used to detect dysphagia and the time elapsed until the assessment [3]. Patients with post-stroke dysphagia may face complications such as malnutrition, dehydration, weight loss, aspiration, and even death. ...
Article
Full-text available
The aim of the present study was to investigate the effects of game-based electromyography (EMG)-biofeedback therapy on swallowing functions and quality of life in patients with post-stroke dysphagia. The prospective, double-blind, randomized controlled trial included 33 patients with post-stroke dysphagia. The study group performed the Mendelsohn maneuver and effortful swallow using game-based EMG-biofeedback, while the control group performed the Mendelsohn maneuver and effortful swallow using only verbal feedback for 30 min in 15 sessions in total. Before and during the trial, patients were evaluated using clinical swallowing assessments such as the Functional Oral Intake Scale (FOIS), Penetration–Aspiration Scale (PAS), Dysphagia Outcome and Severity Scale (DOSS), and Dysphagia Handicap Index (DHI). Statistically significant improvement was found in FOIS scores (p = 0.038), PAS-Liquid scores (p = 0.026), and DOSS scores (p = 0.003) in the study group, while there was no statistically significant change in the control group. While PAS-Semisolid scores improved in both groups (study group, p = 0.002; control group, p = 0.023), post-treatment scores were statistically significantly higher in the study group than in the control group (p = 0.031). Although statistically significant improvement was found in DHI total, physical, emotional, and functional scores in both groups at the end of treatment (p < 0.05 for all), the post-treatment DHI scores were statistically significantly higher in the study group compared to those in the control group (p < 0.05 for all). The addition of game-based EMG-biofeedback to conventional treatment improved clinical and radiological assessments demonstrated by FOIS, PAS-Liquid, and DOSS scores and resulted in a statistically significant improvement in PAS-Semisolid and DHI scores. In conclusion, we believe that the inclusion of game-based EMG-biofeedback therapy in swallowing rehabilitation programs may have a positive impact on treatment outcomes.
... This complication not only increases mortality risk but also necessitates extended hospital stays, adding strain on healthcare resources. 12 Beyond the immediate threat of pneumonia, post-stroke dysphagia (PSD) can lead to a series of other health issues. Difficulty swallowing can make it hard to maintain proper nutrition and hydration, potentially causing malnutrition and dehydration. ...
Article
Background: Post-Stroke Dysphagia (PSD) is a common complication that significantly affects the quality of life and health outcomes of stroke survivors. Traditional treatments often have limitations, necessitating the exploration of new therapeutic approaches. This systematic review and meta-analysis aimed to evaluate the efficacy of intermittent Theta Burst Stimulation (iTBS) as an innovative treatment for PSD. Methods: Following the PRISMA guidelines, a comprehensive literature search was conducted in PubMed, Embase, and Cochrane Library up to July 2024. Studies included were randomized controlled trials (RCTs) involving stroke patients with confirmed dysphagia, comparing iTBS to control treatments. Data extraction and quality assessment were performed independently by two reviewers using the Cochrane RoB 2 tool. Primary outcomes were changes in the Penetration-Aspiration Scale (PAS) and Swallowing Severity Scale (SSA). Meta-analyses were conducted using Review Manager (RevMan) 5.4. Results: Four RCTs with a total of 199 participants were included. iTBS significantly improved SSA (MD = -3.26, 95% CI [-4.66, -1.86], p < 0.001) and PAS (MD = -1.67, 95% CI [-2.49, -0.86], p < 0.001) immediately after treatment compared to sham stimulation. No significant adverse events were reported. Conclusion: iTBS appears to have a positive immediate effect on improving swallowing function and reducing aspiration risk in PSD patients compared to sham stimulation. However, these effects may not persist in the long term, and further large-scale RCTs are needed to confirm these findings and establish standardized treatment protocols.
... Hence, the higher the age, the higher the risk of dysphagia. [28][29][30] Our study found that, time since stroke onset played an significant role in dysphagia occurence after stroke. This has been shown in other studies as well, 31,32 the patient's brain damage will be more severe over time, which increases the risk of swallowing disorders to some extent. ...
Article
Full-text available
Background This study aimed to construct machine-learning models for prediction of severe dysphagia after ischemic stroke based on clinical features and identify significant clinical predictors. Methods Patients hospitalized with dysphagia after ischemic stroke in Affiliated Hospital of Jiangnan University were retrospectively analyzed and randomly divided into training and validation sets at a ratio of 7:3. Additional patients from Huai’an Hospital were selected as test set. 19 relevant clinical characteristics were collected. According to the water swallowing test (WST), patients were divided into severe dysphagia group and non-severe dysphagia group. K-nearest neighbor (KNN), decision tree (DT), random forest (RF), support vector machine (SVM), light gradient boosting machine (LGBM), and extreme gradient boosting (XGBoost) were applied to predict severe dysphagia. Receiver operating characteristic (ROC) curves were plotted, the area under the ROC (AUC) was calculated to assess predictive power, and DeLong’s test was used to compare the AUCs among six models. Finally, an optimal model was obtained, and significant clinical predictors of severe dysphagia after stroke were screened. Results A total of 724 patients were enrolled, 422 in training set, 182 in validation set and 120 in test set, respectively, with no statistically differences in baseline information (P>0.05). In the training set, the AUCs of KNN, DT, RF, SVM and XGBoost were higher than that of LGBM (P<0.05). In the validation and test sets, the AUCs of XGBoost were also higher. The performance metrics of XGBoost were better in terms of accuracy, precision, recall, and F1-score. Therefore, XGBoost was the best model, with good clinical practicality. Furthermore, the top five features based on XGBoost were NIHSS score, BI, BMI, age and time since stroke onset. Conclusion Among all clinical feature-based machine-learning models for the prediction of severe dysphagia after ischemic stroke, XGBoost had the best predictive value.
Article
Full-text available
Background: Post-stroke dysphagia is a common complication of acute stroke, which could increase the risk of mortality and aspiration pneumonia. Aim: This study aimed to assess the relationship between early dysphagia screening and the incidence of pneumonia among acute stroke patients. Research design: A correlational descriptive design was utilized in this study. Setting: The study was conducted at the stroke and neurology intensive care units at As-Salam International Hospital. Subject: a purposive sample of 87 adult patients newly admitted with a diagnosis of acute stroke was included in the study. Tools: Three tools were used in this study, Tool I: patients' structured interview questionnaire. It consisted of patients' demographic data and current and past history. Tool II gagging swallowing screen. Tool III: Assessment of stroke-associated pneumonia. Results: The study findings revealed that more than one third of the studied patients had dysphagia, and the minority of the studied patients had pneumonia with a statistically significant relation between the incidence of pneumonia and the incidence of dysphagia. As well as there was a positive correlation between the incidence of dysphagia and the incidence of pneumonia. Conclusion: There was a statistically significant relation between early dysphagia screening and the incidence of pneumonia among acute stroke patients. Recommendation: Early dysphagia screening practices should be applied to acute stroke patients before oral intake and within 24 hours of admission to reduce the incidence of pneumonia.
Article
Full-text available
Objective This study evaluated the effectiveness of an enhanced dysphagia assessment method combined with dietary interventions for patients experiencing dysphagia post-stroke. Methods A prospective randomized controlled trial was conducted with 98 hospitalized post-stroke patients suffering from dysphagia. Participants were randomly assigned into two groups: the study group (receiving enhanced dysphagia assessment and dietary interventions) and the control group (receiving standard nursing care), using a computer-generated randomization list. Swallowing function was assessed using the Mann Assessment of Swallowing Ability (mMASA), Dysphagia Severity Scale (DSS), and Wada’s water swallowing test. Additionally, quality of life and nutritional status were evaluated for both groups, before and after the intervention. Results Post-intervention, the study group exhibited significantly better scores on mMASA and Wada’s water swallowing test, and lower DSS scores compared to the control group (all P < 0.05). Initially, no significant differences were observed between the groups concerning aspiration symptoms, nutritional and respiratory dysfunction, psychological disorders, and total scores (all P > 0.05). However, post-intervention, the study group showed significant improvements in these parameters and lower scores compared to the control group (all P < 0.05). Additionally, the study group demonstrated higher BMI, albumin (ALB), and hemoglobin (Hb) levels post-intervention (all P < 0.05), and a markedly lower incidence of aspiration and aspiration pneumonia (all P < 0.05). Conclusion Enhanced dysphagia assessment combined with dietary interventions significantly improves swallowing function, quality of life, and nutritional status in post-stroke dysphagia patients. This approach also reduces the incidence of related complications, suggesting substantial clinical benefits.
Article
Systemic, nonneurological complications are common after ischemic and hemorrhagic strokes, affect different organ systems, and have a major impact on patient outcomes. Despite their obvious implications, this area in stroke management remains inadequately researched, and current literature offers fragmentary guidance for care. The purpose of this scientific statement is to elucidate the major systemic complications of strokes that occur during hospitalization, to synthesize evidence from current literature and existing guidelines, to address gaps in knowledge, and to provide a coherent set of suggestions for clinical care based on interpretation of existing evidence and expert opinion. This document advocates for improved interdisciplinary collaboration, team effort, and effective implementation strategies to reduce the burden of these events in clinical practice. It also calls for further research on strategies for preventing and managing systemic complications after stroke that improve outcomes in stroke survivors.
Article
Full-text available
Dysphagia is common after stroke, leading to adverse outcome. The Effortful Swallow (ES) is recommended to improve swallowing but it is not known if dysphagic patients can increase muscle activity during the exercise or if age affects performance. Providing surface electromyographic (sEMG) biofeedback during dysphagia therapy may enhance exercise completion, but this has not been investigated and the technique’s acceptability to patients is not known. Aims: To determine if age or post-stroke dysphagia affect the ability to increase submental muscle activity during the ES, if sEMG biofeedback improves ES performance and if sEMG is an acceptable addition to therapy. In a Phase I study submental sEMG amplitudes were measured from 15 people with dysphagia < 3 months post-stroke and 85 healthy participants aged 18–89 years during swallowing (NS) and when they performed the ES with and without sEMG biofeedback. Participant feedback was collected via questionnaire. Measurements were compared with repeated measures ANOVA and age effects were examined with linear regression. Both groups produced significantly greater muscle activity for the ES than NS (p < 0.001) and significantly increased activity with biofeedback (p < 0.001) with no effect of age. Participant feedback about sEMG was very positive; over 98% would be happy to use it regularly. The ES is a physiologically beneficial dysphagia exercise, increasing muscle activity during swallowing. sEMG biofeedback further enhances performance and is considered an acceptable technique by patients. These findings support the potential application of sEMG biofeedback and the ES in dysphagia therapy in stroke, justifying further investigation of patient outcome.
Article
Full-text available
Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations in a single document for clinicians caring for adult patients with acute arterial ischemic stroke. The intended audiences are prehospital care providers, physicians, allied health professionals, and hospital administrators. These guidelines supersede the 2013 Acute Ischemic Stroke (AIS) Guidelines and are an update of the 2018 AIS Guidelines. Methods— Members of the writing group were appointed by the American Heart Association (AHA) Stroke Council’s Scientific Statements Oversight Committee, representing various areas of medical expertise. Members were not allowed to participate in discussions or to vote on topics relevant to their relations with industry. An update of the 2013 AIS Guidelines was originally published in January 2018. This guideline was approved by the AHA Science Advisory and Coordinating Committee and the AHA Executive Committee. In April 2018, a revision to these guidelines, deleting some recommendations, was published online by the AHA. The writing group was asked review the original document and revise if appropriate. In June 2018, the writing group submitted a document with minor changes and with inclusion of important newly published randomized controlled trials with >100 participants and clinical outcomes at least 90 days after AIS. The document was sent to 14 peer reviewers. The writing group evaluated the peer reviewers’ comments and revised when appropriate. The current final document was approved by all members of the writing group except when relationships with industry precluded members from voting and by the governing bodies of the AHA. These guidelines use the American College of Cardiology/AHA 2015 Class of Recommendations and Level of Evidence and the new AHA guidelines format. Results— These guidelines detail prehospital care, urgent and emergency evaluation and treatment with intravenous and intra-arterial therapies, and in-hospital management, including secondary prevention measures that are appropriately instituted within the first 2 weeks. The guidelines support the overarching concept of stroke systems of care in both the prehospital and hospital settings. Conclusions— These guidelines provide general recommendations based on the currently available evidence to guide clinicians caring for adult patients with acute arterial ischemic stroke. In many instances, however, only limited data exist demonstrating the urgent need for continued research on treatment of acute ischemic stroke.
Article
Full-text available
Background: Socioeconomic status (SES) is associated with stroke incidence and mortality. Distribution of stroke risk factors is changing worldwide; evidence on these trends is crucial to the allocation of resources for prevention strategies to tackle major modifiable risk factors with the highest impact on stroke burden. Methods: We extracted data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. We analysed trends in global and SES-specific age-standardised stroke incidence, prevalence, mortality, and disability-adjusted life years (DALYs) lost from 1990 to 2017. We also estimated the age-standardised attributable risk of stroke mortality associated with common risk factors in low-, low-middle-, upper-middle-, and high-income countries. Further, we explored the effect of age and sex on associations of risk factors with stroke mortality from 1990 to 2017. Results: Despite a growth in crude number of stroke events from 1990 to 2017, there has been an 11.3% decrease in age-standardised stroke incidence rate worldwide (150.5, 95% uncertainty interval [UI] 140.3-161.8 per 100,000 in 2017). This has been accompanied by an overall 3.1% increase in age-standardised stroke prevalence rate (1300.6, UI 1229.0-1374.7 per 100,000 in 2017) and a 33.4% decrease in age-standardised stroke mortality rate (80.5, UI 78.9-82.6 per 100,000 in 2017) over the same time period. The rising trends in age-standardised stroke prevalence have been observed only in middle-income countries, despite declining trends in age-standardised stroke incidence and mortality in all income categories since 2005. Further, there has been almost a 34% reduction in stroke death rate (67.8, UI 64.1-71.1 per 100,000 in 2017) attributable to modifiable risk factors, more prominently in wealthier countries. Conclusions: Almost half of stroke-related deaths are attributable to poor management of modifiable risk factors, and thus potentially preventable. We should appreciate societal barriers in lower-SES groups to design tailored preventive strategies. Despite improvements in general health knowledge, access to healthcare, and preventative strategies, SES is still strongly associated with modifiable risk factors and stroke burden; thus, screening of people from low SES at higher stroke risk is crucial.
Article
Full-text available
Background There is still a strong need for an optimal clinician‐friendly screening tool for the identification of aspiration risk in stroke patients. In this study, we present the development of a novel, context‐specific screening tool for the prediction of aspiration risk on recent stroke survivors, the Functional Bedside Aspiration Screen (FBAS), and examine its construct validity, reliability with the predictive values toward pragmatic patients' outcomes. Methods We conducted a prospective validation study of 104 acute ischemic stroke patients admitted to clinical wards in a tertiary university hospital. A group of experts developed and administered the FBAS 10‐point scale to all patients. Outcome measures were compared with those of the validated Yale Swallow Protocol (YSP, reference measure) and health indicators. Key Results A strong association was found between the FBAS cutoff criterion and the YSP (Pearson χ² = 54.92, P < .001). A score of ≤8 on the FBAS presented with 93.3% sensitivity and 83.3% specificity in deeming patient with reduced safety for oral nutrition (AUC = 0.934, CI = 0.884‐0.985). An inverse relationship was found between performance on the FBAS and in‐hospital and long‐term outcome indicators. Patients who failed the FBAS were 1.82 times more likely to develop aspiration pneumonia (95% CI = 1.42‐2.35) and 1.35 times more likely to develop pneumonia within 3 months postonset (95% CI = 1.15‐1.59). Conclusions and Inferences The FBAS is a potentially useful tool for timely prediction of aspiration risk and health outcome in acute stroke.
Article
Full-text available
Background & Aim: There is a high incidence of dysphagia after stroke that, depending on the assessment, methodology and time elapsed, can range from 8.1% to 80%. Early and systemic dysphagia screening is associated with a decreased risk of aspiration pneumonia and prevents inadequate hydration/nutrition. The purpose of this systematic review was to identify dysphagia screening tools for acute stroke patients available for nurses validated against reference test. The research question was: which dysphagia screening tools for acute stroke patients available for nurses? Methods & Materials: Three electronic databases were searched from January 2007 to November 2017: on PubMed, Scielo and CINAHL Plus. Two independent reviewers screened all titles and abstracts, assessed methodological quality and extracted data. The methodological quality analysis and evaluation was guided according to four domains: patient selection, index test, reference standard and flow and timing. Divergences between reviewers in data extraction were consensualized through discussion. Results: From the 377 articles retrieved, only three articles met criteria for review: Barnes-Jewish Hospital-Stroke Dysphagia Screen; the Gugging Swallowing Screen and, The Toronto Bedside Swallowing Screening Test. None of the screening tools complies with all psychometric properties, which means that a still significant proportion of patients will be kept nil by mouth without being necessary or that some patients will “fall through the cracks” interrupting the diagnostic process. The tools identified are different from each other, making their comparison impracticable. Conclusion: Due to psychometric proprieties and dietary recommendations adjusted to dysphagia severity, of all available tools, GUSS is a suitable screening tool for nurses in clinical practice.
Article
Full-text available
Summary Background Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, prevalence, deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). DALYs were generated by summing YLLs and YLDs. Cause-specific mortality was estimated using an ensemble modelling process with vital registration and verbal autopsy data as inputs. Non-fatal estimates were generated using Bayesian meta-regression incorporating data from registries, scientific literature, administrative records, and surveys. The Socio-demographic Index (SDI), a summary indicator generated using educational attainment, lagged distributed income, and total fertility rate, was used to group countries into quintiles. Findings In 2016, there were 5·5 million (95% UI 5·3 to 5·7) deaths and 116·4 million (111·4 to 121·4) DALYs due to stroke. The global age-standardised mortality rate decreased by 36·2% (−39·3 to −33·6) from 1990 to 2016, with decreases in all SDI quintiles. Over the same period, the global age-standardised DALY rate declined by 34·2% (−37·2 to −31·5), also with decreases in all SDI quintiles. There were 13·7 million (12·7 to 14·7) new stroke cases in 2016. Global age-standardised incidence declined by 8·1% (−10·7 to −5·5) from 1990 to 2016 and decreased in all SDI quintiles except the middle SDI group. There were 80·1 million (74·1 to 86·3) prevalent cases of stroke globally in 2016; 41·1 million (38·0 to 44·3) in women and 39·0 million (36·1 to 42·1) in men. Interpretation Although age-standardised mortality rates have decreased sharply from 1990 to 2016, the decrease in age-standardised incidence has been less steep, indicating that the burden of stroke is likely to remain high. Planned updates to future GBD iterations include generating separate estimates for subarachnoid haemorrhage and intracerebral haemorrhage, generating estimates of transient ischaemic attack, and including atrial fibrillation as a risk factor.
Article
Introduction: Nurses and other nonspecialists in dysphagia are often trained to screen swallowing poststroke. There are many basic tools that test water only, they are usually conservative, and patients that fail the test remain nil by mouth until a speech and language therapy assessment. More comprehensive tests also allow nonspecialists to recommend modified oral intake. Little is known about the accuracy, clinical utility and cost-effectiveness of these tests. Methods: Following PRISMA guidelines, a systematic review was conducted to describe comprehensive swallowing tests that are available for use in acute stroke by nurses or other nonspecialists in dysphagia. A meta-analysis was performed to evaluate accuracy and the clinical utility of the tests was considered. Searches and analyses, conducted by two reviewers, included MEDLINE, Embase, trial registries and grey literature up to December 2018. Validated studies were assessed for quality and risk of bias using QUADAS-2. Results: Twenty studies were included, describing five different tests, three of which had undergone validation. The tests varied in content, recommendations and use. There was no test superior in accuracy and clinical utility. Three studies validating the Gugging Swallow Screen provided sufficient data for meta-analysis, demonstrating high sensitivity; 96% (95% CI 0.90-0.99), but low specificity, 65% (95% CI 0.47-0.79), in line with many water swallow tests. Results should be interpreted with caution as study quality and applicability to the acute stroke population was poor. Conclusions: There is no comprehensive nurse dysphagia assessment tool that has robustly demonstrated good accuracy, clinical utility and cost-effectiveness in acute stroke. Relevance to clinical practice: Nurses and other clinicians can develop competencies in screening swallowing and assessing for safe oral intake in those with poststroke dysphagia. It is important to use a validated assessment tool that demonstrates good accuracy, clinical utility and cost-effectiveness.